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Message from  
Volker Trautz, CEO
Basell’s first full year since being acquired 
by the Access Industries group was 
exceptional in many respects. In 2006, the 
company strengthened its position as the 
global leader in polyolefins; enhanced a 
legacy of growth through innovation that 
has been cultivated for more than half a 
century, and also achieved its best-ever 
results in financial performance and 
working safely.
Indeed, there were many highlights  
in Basell in 2006.
Financial performance. The results 
were the best since the formation of the 
company in October 2000. This record-
breaking performance – including an 
EBITDA value in excess of €1 billion 
– included strong contributions from  
all three businesses.
Sales. Through the development 
of important new business and the 
reinvigoration of long-standing and  
highly valued customer associations, 
Basell recorded all-time highs for  
sales in polypropylene, polyethylene, 
advanced polyolefins and catalysts.
Technology. The Licensing business 
again affirmed Basell’s technological 
leadership in polyolefins by signing new 
agreements for 2.5 million tonnes of 
annual capacity (including the company’s 
200th polyolefin process license) while 
also establishing the new Spherizone 
process as the current industry standard 
for polypropylene manufacturing.
Expansion. The company formed two 
new joint ventures in Saudi Arabia, 
SEPC and Al-Waha, and upgraded its 
presence in Asia Pacific by increasing its 
participation in three joint ventures – HMC 
Polymers (Thailand), PolyMirae (Korea) and 
SunAllomer (Japan) – while also selling 
its position in Taiwan Polypropylene 
Company. Additionally, Basell was 
selected by the government of  
Kazakhstan as a strategic partner for 
the development of the petrochemical 
industry in that country.
Feedstock integration. The acquisition 
of the Ruhr Öl GmbH steam cracker in 
Münchsmünster, Germany substantially 
increased Basell’s European feedstock 
integration. In addition, the decision to 
build a new Hostalen Advanced Cascade 
Process high density polyethylene plant at 
the same industrial park will enhance the 
company’s manufacturing asset footprint.
All across the company there are 
challenging goals for 2007 and beyond 
– each designed to strengthen Basell’s 
industry leadership in the face of 
significant business and competitive 
pressures. These goals include:
Safety first. Quite simply, the 
expectation is further improvement in 
every aspect of working safely, always 
striving to be ‘the best of the best’ in  
the polyolefins industry. 
Asset reliability and operational 
excellence. Further improvement in the 
company’s manufacturing operations is 
critical to Basell’s commitment to have  
the highest quality products supplied 
reliably to customers around the world.
New markets. Pursuing new joint 
venture projects and expanding Basell’s 
presence in high-growth, feedstock-
advantaged regions are key elements 
in further strengthening the company. 
In 2007, initiatives in these areas will 
include building a second polypropylene 
compounding plant in China and 
inaugurating the company’s first 
compounding line in Mexico.
Volker Trautz, 
President and Chief Executive Officer, 
Basell Polyolefins
The 2007 outlook is favourable but will 
depend on growth in Basell’s key markets. 
The expectation is that new polyolefin 
products and applications will support 
growth in consumer demand for plastics 
and that inter-material substitution will 
accelerate as pressure for environmentally 
friendly technological solutions increases. 
Asia will be the growth engine with 
demand growth for polypropylene and 
polyethylene, and the more mature 
markets of Europe and North America  
will see growth at levels lower than the 
world average.
Although the evolution of the global 
economic cycle can – and usually does 
– provide both negative and positive 
surprises, Basell faces the future 
confidently. This conviction is based upon  
a sound business strategy and a readiness 
to pursue opportunities to grow and 
further strengthen the company.
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BASELL IS ORGANISED  
INTO THREE BUSINESSES
Technology Business: 
licensing polyolefin processes, 
developing, producing and 
selling polyolefin catalysts, 
technology services and  
new ventures
Advanced Polyolefins 
Business: manufacturing 
and selling polypropylene 
compounds and other 
specialty products
Polyolefins Business: 
manufacturing and  
selling polypropylene  
and polyethylene
About Basell
The spirit of discovery that created the polyolefins industry  
and the two most widely used plastic materials in the world 
– polypropylene and polyethylene – is the foundation upon 
which Basell’s legacy has been built for more than half a century.
Today, Basell is the global leader in 
polyolefins technology, production and 
marketing. It is the largest producer 
of polypropylene and advanced 
polyolefin products; a leading supplier 
of polyethylene and catalysts, and the 
industry leader in licensing polypropylene 
and polyethylene processes, including 
providing technical services for its 
proprietary technologies. 
Basell, together with its joint ventures,  
has manufacturing facilities in 19 
countries and research & development 
and technical support centres in Europe, 
North America and the Asia-Pacific region. 
The company’s products are sold in more 
than 120 countries. 
An industry’s beginnings
Polyethylene was first synthesized by a 
German chemist, Hans von Pechmann, 
who prepared it by accident in 1898. The 
first industrial production of low density 
polyethylene (LDPE) was in 1939 after 
which researchers at Basell predecessor 
companies advanced this breakthrough by 
producing LDPE through the discovery of 
the high pressure tubular process in the 
1940s. The first commercial plant was in 
Ludwigshafen, Germany and was owned 
by Basell predecessor company BASF AG.
In 1953, Professor Karl Ziegler and his 
research staff at the Max-Planck-Institut für 
Kohlenforschung in Germany discovered 
the catalytic process for manufacturing 
high density polyethylene (HDPE). The first 
full-scale HDPE plant was started up by 
Basell predecessor company Hoechst AG  
in Frankfurt, Germany in 1955.
Basell’s senior management team and areas of responsibility (from left): Rick Gutierrez, Human Resources and Corporate 
Communications; Massimo Covezzi, Research & Development; Just Jansz, Technology Business; Eberhard Faller, Corporate Controller 
and Deputy Chief Financial Officer; Manfred Dressel, Manufacturing & Services; Anton de Vries, Advanced Polyolefins Business;  
Volker Trautz, President and Chief Executive Officer; Ian Dunn, Polyolefins International; Michael Mulrooney, Polyolefins North America; 
Alan Bigman, Chief Financial Officer; Werner Breuers, Polyolefins Europe; Cees Los, General Counsel.
Catalyst produced by Basell
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Shortly after Ziegler’s discovery, 
Professor Giulio Natta in 1954, working 
for yet another Basell predecessor 
company, Montecatini, in Milan, Italy, 
produced solid polypropylene (PP) for 
the first time. This resulted in the first 
industrial production of PP in 1957,  
in Ferrara, Italy.
Ziegler and Natta shared the great 
distinction of the Nobel Prize for 
Chemistry awarded in 1963 for their  
work in bringing about today’s 
polyolefins industry. Basell is proud 
of this history and continues to highly 
value innovation.
Technology Business
For Basell, creating innovative polyolefin 
products is a way of life. A focus on 
close integration among the company’s 
marketing, R&D and manufacturing 
units ensures that new developments 
in polyolefin catalysts, processes and 
products are continuously offered to 
customers.
Basell is the leading licensor of 
polyolefins process technologies.  
The company’s Spheripol technology 
is the most widely used manufacturing 
process for polypropylene and the 
Spherizone process, which has been 
licensed by Basell since 2004, is the 
new benchmark for polypropylene 
production.
Basell’s portfolio of licensed  
technologies and associated technical 
services is comprised of:
·  Spherizone – latest generation 
polypropylene technology based  
on new multi-zone circulating  
reactor technology
·  Spheripol – leading polypropylene 
technology for the production 
of homopolymer, random and 
heterophasic copolymers
·  Spherilene – advanced swing gas 
phase process for the production  
of LLDPE, MDPE and HDPE
·  Hostalen – leading low-pressure  
slurry process for the production  
of bimodal HDPE
·  Lupotech T – leading high- 
pressure tubular reactor process  
for the production of LDPE and  
EVA copolymers
·  Metocene PP – technology for  
the production of specialty 
polypropylene products using  
single-site catalyst systems
Basell is also the leading supplier of 
polyolefin catalysts and its family of 
advanced catalysts provides optimum 
performance for Basell’s process 
technologies as well as other third party 
processes. Basell’s ability to offer a 
complete technology portfolio enables 
polyolefin producers to have a single 
provider for all polyolefin processes  
and catalyst systems.
Basell’s portfolio of catalyst systems  
is comprised of:
·  Avant ZN – Ziegler-Natta catalysts  
for polypropylene
·  Avant Z – Ziegler catalysts  
for polyethylene
·  Avant C – Chromium catalysts  
for polyethylene
·  Avant M – Metallocene catalysts  
for polypropylene
Polypropylene blown film production line
Spheripol polypropylene production unit at Basell’s Louisiana, USA site
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Advanced Polyolefins Business
Advanced Polyolefins is a global business 
that comprises an innovative family of 
specialty polyolefins – highly engineered 
polyolefin materials and polypropylene 
compounds that have enhanced 
characteristics. Generally formulated for 
specific applications, advanced polyolefins 
are in many cases proprietary and 
usually priced according to their value in 
the application in which they are used. 
They are characterised by exceptional 
cost/performance balance and they are 
formulated to include properties such 
as superior paint adhesion, scratch 
resistance, dimensional stability, low 
thermal expansion, good low temperature 
impact and soft touch.
Basell’s advanced polyolefins bring 
together the cost-effectiveness of 
polyolefins with the performance of 
engineering resins, thereby providing 
significant customer value for a vast  
array of end uses.
There are three main Advanced 
Polyolefins’ product lines: 
·  Polypropylene-based composite 
materials and alloys (PCMA) are 
made with additives ranging from 
rubber, which provides softness and 
elasticity, to talc and mineral fillers and 
glass fibres, for stability and rigidity. 
Properties can be tailored to fit specific 
applications;
·  Catalloy process resins are 
produced using a unique combination 
of catalysts, process technology and 
monomers and provide enormous 
capabilities for tailoring product 
properties. Catalloy process products 
cover a range from very soft to 
extremely rigid properties, and
·  Polybutene-1 resins for use in seal 
peel, film modification, hot melt and 
polyolefin modification applications.
(Note: Basell does not sell polybutene-1 for use 
in pipe applications intended for use in North 
America, and requires its customers not to sell 
products made from PB-1 into North America 
pipe applications.)
Polyolefins Business
Polyolefins, the term used to collectively 
describe polypropylene and polyethylene, 
are the world’s most widely used plastic 
materials. Polyolefins is also the largest 
of Basell’s three core businesses; this 
business is organised by region: Europe, 
North America and International.
The three main types of polypropylene 
produced and marketed by Basell are:
Homopolymers, which have high heat 
resistance and good rigidity are used in  
a vast range of customer applications;
Copolymers, which are made by 
incorporating different monomers, are 
extremely resilient materials and have 
wide uses in automotive and industrial 
applications; and
Random copolymers, which are made 
by introducing ethylene links into the 
polymer chain, tend to have improved 
optical properties, and are used by 
customers in applications such as 
packaging where transparency is required.
By expanding the range of 
polypropylene’s properties, Basell can 
continue to reinvent the resin’s end uses, 
often displacing traditional materials and 
other plastics.
Polyethylene produced by Basell is used  
in a wide variety of applications:
High density polyethylene (HDPE), 
which is dense, strong and stiff, is used 
by customers for blow-moulded bottles 
and injection moulded pails, bottle caps 
and toys;
Medium density polyethylene (MDPE), 
which has a high degree of resistance to 
chemicals and is very easy to keep clean, 
is used by customers for items such as 
tanks and floats;
Low density polyethylene (LDPE), 
which is highly flexible, is used by 
customers for packaging film, trash and 
grocery bags, agricultural mulch, wire and 
cable insulation, squeeze bottles, toys and 
housewares.
Basell high performance resins are used to produce components for Jaguar
Basell Annual Report 2006 | About Basell
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For example, with the Spherizone process, 
new products have been successfully 
introduced that combine the stiffness of a 
homopolymer with the transparency and 
processability of a random copolymer, 
offering a material rejuvenation in both 
traditional and new market segments. 
Now, innovative products with very high 
melt strengths such as Higran grades 
are being introduced. New heterophasic 
copolymers combining very high stiffness 
with outstanding low temperature impact 
resistance are being used in sewage 
pipe applications, competing against 
traditional materials.
New grades, introduced under the brand 
name Clyrell, combine transparency and 
low temperature impact resistance. These 
grades include new low stress whitening 
impact copolymers for car starter 
batteries, food packaging and appliances 
and new high transparency random 
copolymers for blown film, BOPP and cast 
film applications.
As a result of the successful introduction 
of Metocene PP in textile and packaging 
applications, in 2006 Basell began 
licensing this technology, which is used  
in the production of polyolefins based  
on single-site catalyst systems. 
Improved generations of materials 
produced using Basell’s Catalloy process 
technology have been further reinforcing 
market leadership in important segments 
such as automotive and building and 
construction.
New applications for polyolefins were 
also developed by market-oriented 
innovation teams who have been 
focusing on inter-material replacement 
opportunities. These new Basell grades 
are displacing traditional materials and 
technical thermoplastics. Customer needs 
have been further addressed through 
innovation workshops at strategic Basell 
accounts.
Basell continuously focuses its 
developments in catalysts, processes, 
products and applications in order to 
deliver unique solutions that respond and 
anticipate the needs of our customers and 
the new trends in today’s dynamic market 
environment.
New catalysts and process technologies have enabled the 
development and marketing of new products and applications 
which contributed significantly to Basell’s success in 2006.
Innovation
Continuous improvement of the Avant 
catalyst portfolio was the focus of a 
successful set of new developments  
in 2006.
In addition, new polyethylene grades 
developed using the Hostalen Advanced 
Cascade Process (ACP) were successfully 
introduced for blow moulding, caps 
& closures, film, medical and pipe 
applications. These grades, which have 
outstanding processability and an 
excellent balance of mechanical and 
optical properties, are providing a clear 
advantage to Basell customers in their 
efforts to differentiate their products.
New and improved polypropylene 
products were developed by leveraging 
Basell’s proprietary technologies – in 
particular, the Spherizone process. This 
manufacturing process makes possible 
the development of products that are not 
attainable using other older polypropylene 
technologies. 
‘As the technology leader in polyolefins we know 
that we always must be innovative in the way we 
produce new products and in the way we meet the 
unique needs of our customers around the world.’
Massimo Covezzi, President, Research & Development
Right: Basell polypropylene  
is used to produce these clear  
blow moulded water bottles
Below: Clear frozen food packaging 
produced using Basell’s innovative 
polypropylene resins
Left: Blown film produced with 
Basell polyethylene resins
7
Innovation | Basell Annual Report 2006
NET CASH FLOW 
FROM OPERATING 
ACTIVITIES
€656 
million
NIAT
€277 
million
REVENUE
€10.5 
billion
EBITDA
€1,030 
million
TRR
1.6
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Highlights of 2006
WORLD-CLASS  
WORKPLACE SAFETY
Basell’s safety record, as measured 
by Total Recordable Rate for 
employees and contractors, was  
the best in its history and among  
the best in the industry.
BEST-EVER FINANCIAL RESULTS
Basell’s 2006 results were the best 
since the formation of the company 
in October 2000 – a record-breaking 
performance that included an 
EBITDA value in excess of €1 billion 
and strong contributions from all 
three businesses.
TECHNOLOGY LEADERSHIP 
AFFIRMED
The Licensing business signed new 
process license agreements for 2.5 
million tonnes of annual capacity 
(including Basell’s 200th polyolefin 
process license) while further 
establishing the Spherizone process 
as the new industry standard in 
polypropylene manufacturing.
ADVANCED POLYOLEFINS 
PERFORMANCE ENHANCED
The Advanced Polyolefins Business 
had a very strong performance in 
2006, including an EBITDA result  
65 % ahead of the previous 
year. Sales volumes were 14 % 
higher than 2005 and there was 
a significant improvement in the 
Catalloy process resins business.
2 NEW JOINT VENTURES FORMED
The establishment of two new  
Saudi Arabia joint ventures, SEPC 
and Al-Waha, further strengthened 
Basell’s presence in this feedstock-
rich section of the world.
CATALYST BUSINESS 
STRENGTHENED
The acquisition of Akzo Nobel’s 
Polymerization Catalysts & 
Components business in Edison, 
New Jersey, USA and the completion 
of a project to expand the capacity 
of a manufacturing facility in 
Ferrara, Italy by 40 % strengthened 
Basell’s catalyst business.
FEEDSTOCK INTEGRATION 
INCREASED
The purchase of the steam cracker 
at the Münchsmünster, Germany 
petrochemical site from Ruhr Öl 
GmbH (ROG) was another key step 
in strengthening Basell’s position 
in ethylene, propylene and other 
cracker products in Europe. 
GROWTH IN EASTERN  
EUROPE MARKET
Building on the success of the Basell 
Orlen Polyolefins joint venture in 
Poland, Basell opened a new sales 
office in Moscow and is working 
with the government of Kazakhstan 
as strategic partner for the 
development of the petrochemical 
industry in that country.
Basell faces significant business and 
competitive pressures and recognises the 
necessity to constantly create sustainable 
value for its shareholder, while operating 
in a socially responsible manner. In order 
to achieve a strong financial performance, 
Basell has defined several strategic 
themes and developed guidelines  
to face its key strategic challenges.  
The four Basell strategic themes are: 
Portfolio and geographical mix
Basell will continue to develop the 
enhanced value derived from a diversified 
portfolio in the Polyolefins, Advanced 
Polyolefins and Technology businesses, 
particularly through investments in 
profitable growth opportunities in the 
developing regions. To access such 
opportunities, Basell will leverage its 
position in licensing, catalyst and global 
marketing leadership. 
Integration and cost  
advantaged feedstock
Basell will continue to seek opportunities 
to make its polyolefins position more 
robust by widening its access to the full 
value chain from olefins to polyolefins 
products. 
Strengthen competitive  
position in polyolefins
Basell develops alternative offerings  
and sets up appropriate customer facing 
organisations in order to meet a wider  
range of requirements and expectations 
from customers while bringing costs 
in line with the market offering. 
The manufacturing footprint will be 
continuously reviewed to ensure assets 
are leading in their supply markets.
Enhance position in  
differentiated markets
Basell’s leadership in the differentiated 
markets will be further expanded by 
continued investment in targeted R&D 
programmes which will enhance the 
product offering from technologies 
and catalysts to engineered polyolefin 
materials.
Strategic 
Themes
Highlights 2006 and Strategic Themes | Basell Annual Report 2006
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Basell is the technology leader in polyolefins. The company’s Technology Business has four 
cornerstones: process licensing, catalyst sales, technology services and new ventures. Basell’s 
licensing portfolio is the broadest in its industry and consists of the Spheripol process, the most 
widely used polypropylene manufacturing technology; the new Spherizone process, which is the new 
industry benchmark for polypropylene production; Metocene PP technology, and a complete range of 
polyethylene technologies, Hostalen, Spherilene and Lupotech T. Basell also produces and supplies 
catalysts for the manufacturing of polypropylene and polyethylene under the Avant trademark. The 
Technology Business’ technical services unit expertly supports licensees around the world and its 
new ventures business unit identifies and assesses new opportunities for expanding Basell’s global 
joint venture network.
The Technology Business performed very 
well in 2006, exceeding its financial goals, 
including an EBITDA 25 % ahead of the 
previous year, and taking full advantage of 
the positive polyolefins industry climate. 
In licensing, Basell retained its leading 
global position by signing new 
agreements for 2,500 kta of annual 
capacity; of this figure, about 80 % of the 
new agreements were for polypropylene 
plants, reflecting the different investment 
cycles for polypropylene and polyethylene. 
In 2005, Basell’s licensing business 
was more heavily weighted toward 
polyethylene. Globally, close to 50 % of  
the polyolefin projects under construction 
are based on Basell technologies.
Among the main licensing achievements 
for Basell in 2006 was the continuing 
emergence of the Spherizone technology. 
Spherizone process plants can produce 
the full range of polypropylene grades, 
as well as new families of propylene-
based polymers with enhanced product 
properties. This process allows further 
development of new applications, down-
gauging and material replacement. Last 
year, Basell signed four new Spherizone 
process licenses representing 1,200 kta 
Technology Business
‘With four new license agreements signed in 2006, 
the continuing emergence of Basell’s Spherizone 
technology as the new benchmark for the 
production of polypropylene in all parts of the 
world was a top highlight for our business.’
Just Jansz, President, Technology Business
AT A GLANCE
Excellent financial results
200th polyolefin  
license sold
Continued emergence  
of Spherizone process
Launch of Metocene PP 
licensing
Expansion of catalyst 
business
Successfully started up  
12 licensed plants
2 new joint ventures  
formed in Saudi Arabia
Hostalen ACP technology plant at Basell 
Orlen Polyolefins joint venture in Poland
Basell Annual Report 2006 | Technology Business
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in annual capacity, and licenses for this 
technology have now been sold in all 
regions of the world. 
Also in 2006, Basell began licensing its 
Metocene PP technology, which is used in 
the production of polyolefins based on 
single-site catalyst systems. Metocene PP 
technology can be adapted to virtually 
any polypropylene process and is a highly 
versatile technology that extends the 
product range of conventional PP.
Important steps were taken in 2006 to 
further develop the company’s Spherilene 
gas phase technology for polyethylene 
by introducing a single reactor option 
– Spherilene S – featuring low investment 
and operating costs. Spherilene S process 
plants have true swing capability between 
HDPE and LLDPE since both products 
can be produced from the same Ziegler 
catalyst family. Spherilene S technology 
is designed to produce products with 
narrow and medium molecular weight 
distribution. The Spherilene technology 
also can be designed with two gas phase 
reactors in series – Spherilene C – for the 
production of bimodal grades with further 
enhanced properties.
During the year Basell celebrated the 
milestone of granting its 200th polyolefins 
process license.
Catalyst revenue grew by 7 % over 2005 
as Basell took key steps to strengthen this 
vital element in polyolefin production. 
Basell purchased Akzo Nobel’s 
Polymerisation Catalysts & Components 
business in Edison, New Jersey, USA and 
also completed a project to expand the 
capacity of its catalyst manufacturing 
facility in Ferrara, Italy by 40 %.
The Ferrara plant is the largest polyolefins 
catalyst manufacturing facility in the 
world. When combined with the Edison 
plant and the company’s catalyst 
manufacturing facilities in Ludwigshafen 
and Frankfurt, Germany, Basell is uniquely 
positioned to serve the global polyolefins 
catalyst market.
The Technology Business’ new ventures 
unit added two joint ventures in Saudi 
Arabia to a Basell portfolio that already 
included Saudi Polyolefins Company.
In technology services, Basell, in 2006, 
extended its offering to customers linked 
to Basell via licensing agreements. The 
achievements for this unit included the 
successful management of a record 
number of 12 licensed polyolefin plant 
start-ups and the delivery of seven process 
design packages. This unique track 
record helps to further strengthen Basell’s 
reputation as a technology provider. A 
number of major Basell capital investment 
projects were successfully executed safely 
with zero TRR, on schedule and within 
budget in a challenging engineering  
and construction market.
Plant workers at Basell’s Brindisi, Italy site
11
Technology Business | Basell Annual Report 2006
Advanced Polyolefins Business
AT A GLANCE
14 % increase in  
sales volumes
Excellent results in 
compounding operations
Strong comeback for  
Catalloy process resins
Growth driving expansion  
in China
Reorganisation and tighter 
cost controls paying off
The Advanced Polyolefins Business provides tailored products for Basell customers primarily 
in the automotive, appliances, film, pipes and roofing sectors. There are three Advanced 
Polyolefins’ business units: polypropylene-based composite materials and alloys (PCMA), 
Catalloy process resins and polybutene-1. Basell has the largest PCMA compounding capacity 
in the world and is the only manufacturer of Catalloy process resins. Catalloy process resins 
are hybrids of different polymers; they exhibit a wide range of properties, spanning from 
very soft to extremely rigid plastics. Polybutene-1 materials offer flexibility and outstanding 
durability; typical applications for these materials are seal-peel film, consumer packaging, 
piping and adhesives.
‘Strong performances from our new compounding 
plants in China and Brazil, a significant turnaround 
in the Catalloy process resins business and a  
14 % increase in advanced polyolefins sales volumes 
were major factors in our success in 2006.’
Anton de Vries, President, Advanced Polyolefins Business
The Advanced Polyolefins Business had 
a very strong performance in 2006, 
including an EBITDA result 65 % ahead 
of the previous year. Sales volumes were 
14 % higher than 2005, with all three 
business units exceeding prior year levels.
Key factors in the significant year-to-year 
improvement were strong growth in sales 
volumes in a positive market environment 
and tighter cost controls due, in part, to a 
reorganisation of the business that took 
place in 2006. There were many success 
stories around the world for the Advanced 
Polyolefins Business.
Basell’s PCMA operations in Europe and 
North America improved their results 
on the back of increased volumes to the 
automotive and electrical appliances 
sectors and continued cost control. The 
compounding operations in China and 
Brazil, where Basell’s plants are new 
Basell’s Catalloy process 
resins are used to produce 
roofing applications
Basell Annual Report 2006 | Advanced Polyolefi ns Business
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and state-of-the-art, performed very well 
in highly competitive environments. 
In both countries, Basell increased its 
compounded products market share.
Basell’s strong PCMA presence in China 
and Brazil reinforces the company’s 
strategy of combining its global technical 
and manufacturing expertise with 
local market knowledge to meet the 
requirements of a diverse customer base.
Inaugurated in 2005, Basell’s Suzhou, 
China compounding plant is already 
being expanded to meet the growing 
demands of global automotive customers. 
Production capacity was increased by 
15 kta to 27 kta in 2006. Also, due 
to business growth, the schedule for 
building a warehouse extension and 
creating a product development centre 
Photograph courtesy of Gabo
had to be advanced and these projects  
are now expected to be completed in  
the first half of 2007. 
Basell inaugurated its new Brazilian 
polypropylene compounding plant in 
Pindamonhangaba, Sao Paulo, in March 
2006 and the company is now moving 
ahead with plans to expand the capacity 
of the facility. Current capacity is 35 kt 
per year. 
The Catalloy process resins business 
demonstrated a significant improvement 
from 2005. This was a result of a number 
of factors, including an improved market 
presence and stronger commercial focus 
in all regions; commercialisation of several 
innovation projects, in particular some 
highly competitive grades launched into 
the North American film market; good 
market conditions in all regions, including 
very strong growth in single-ply roofing in 
North America; availability of new Catalloy 
process resins capacity at Lake Charles, 
Louisiana, and lower fixed costs and 
control of inventory.
A number of activities are under way 
to further improve the polybutene-1 
results. They include increasing Basell’s 
participation in pipe applications in under-
floor heating systems and introducing 
speciality products designed to replace 
competing materials in high-end pipe 
applications.
Basell high performance resins are used to produce components for BMW
Left: Under-floor heating pipes produced 
using Basell’s polybutene-1 resin
Below: Washer and dryer featuring 
components produced with Basell’s 
Hostacom resins
Advanced Polyolefi ns Business | Basell Annual Report 2006
13
The Polyolefins Business encompasses Basell’s polypropylene and polyethylene production, 
marketing and sales activities and is organised by region: Europe, North America and 
International. Polypropylene and polyethylene are highly versatile polyolefins, ranging from 
tough, rigid materials for pipes and car parts to soft, flexible fibres for textiles. Some polyolefins 
have high heat resistance for sterilisable containers, while others melt easily and can be used 
for heat-sealable food packaging. Through its strong commitment to research and development, 
Basell is continuously discovering new opportunities for polyolefins to replace other polymers 
and traditional materials in a wide range of applications.
Polyolefins Business
Polyolefins Europe, which had record-
breaking results, was very effective at 
achieving improved spreads and also 
benefited from good demand and a  
tight supply. The region recorded its  
best-ever EBITDA result, which was  
25 % ahead of 2005. In recent years 
this business has improved significantly 
by tailoring its offering – including 
effective use of Basell’s online, ‘no frills’ 
channel to market, Alastian – to reflect 
AT A GLANCE
Excellent results in Europe 
and International
Improvement initiatives 
under way in North America
Feedstock integration 
strengthened in Europe
2 new joint ventures  
formed in Saudi Arabia
Restructuring actions 
continuing to pay off
‘By focusing on achieving improved spreads  
and fully leveraging what has been done to 
simplify our structure, systems and processes,  
we achieved our best results ever.’
Werner Breuers, President, Polyolefins Europe
Overall, Basell’s Polyolefins Business  
had excellent results in 2006, including 
an EBITDA of €667 million, 18 % or  
€102 million ahead of the previous year. 
This success was led by the European 
and International regions, both of which 
performed significantly ahead of their 
2005 levels. In North America, the 
business did not meet plan targets  
amidst a second straight year of no 
market growth.
‘In the fast growing markets of the International 
region we focused on delivering value to customers 
based on Basell’s leading product portfolio, and in 
building the capability of our local sales and supply 
chain teams. In doing so we delivered record 
financial results that were well above plan.’
Ian Dunn, President, Polyolefins International
‘Our new “sweat the assets” strategy for  
improving our business is already paying off  
with increased sales volumes and our goal  
for 2007 is full capacity utilisation.’
Michael Mulrooney, President, Polyolefins North America
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what customers want today in terms of 
polyolefin products and service as well 
as what they regard as affordable. In 
addition, key steps have been taken to 
simplify the European organisation’s 
structure, systems and processes to 
further reduce costs.
In the past two years Basell has taken two 
major steps to strengthen the company’s 
position in ethylene, propylene and other 
cracker products in Europe. In 2005, 
the company became 100 % owner of 
the Société du Craqueur de l’Aubette 
by acquiring the position of its former 
partner in the French cracker joint 
venture, Shell Pétrochimie Méditerranée. 
In 2006, Basell purchased the cracker 
at the Münchsmünster, Germany 
petrochemical site from Ruhr Öl GmbH 
(ROG), a joint venture between Deutsche 
BP and PdVSA, the Venezuelan state-
owned oil company.
The Münchsmünster cracker will supply 
ethylene for the new Hostalen Advanced 
Cascade Process high density polyethylene 
plant Basell is building at Münchsmünster. 
The new unit is scheduled to start up in 
early 2009 and will replace the plant that 
was damaged by an explosion and fire in 
December 2005. 
Polyolefins International had an EBITDA 
result that was 50 % ahead of 2005. 
The wholly owned Basell polypropylene 
operations in Australia and Argentina both 
performed very well in a year when the 
company also made important strategic 
enhancements to its polyolefin joint 
venture portfolio; Basell formed two new 
joint ventures in the Middle East and made 
key changes in its Asia-Pacific ventures.
Saudi Ethylene and Polyethylene Company 
(SEPC), in which Basell is partnered 
with Tasnee Petrochemicals and Sahara 
Petrochemical Company, is constructing  
a cracker with a capacity of 1,000 kta  
of ethylene and 285 kta of propylene; a  
400 kta high density polyethylene plant 
based on Basell’s latest generation 
Hostalen ACP process, and a 400 kta  
low density polyethylene plant based  
on Basell’s Lupotech T technology. Start 
up is planned for fourth quarter 2008.
The other new Middle East joint venture, 
Al-Waha Petrochemical Company, 
which is owned by Basell and Sahara 
Petrochemical Company, is constructing 
a propane dehydrogenation unit and a 
450 kt polypropylene plant based on the 
Spherizone process, with commercial 
production foreseen in first quarter 2009.
In the Asia-Pacific region, Basell sold 
its position in Taiwan Polypropylene 
Company (TPP) to Lee Chang Yung 
Chemical Industry Corporation of Taiwan. 
In conjunction with this sale, Basell 
acquired all shares that had been held  
by TPP in three other Basell joint ventures, 
SunAllomer in Japan, PolyMirae in South 
Korea and HMC Polymers Company in 
Thailand; in doing so, Basell enhanced its 
ability to support the further development 
of these companies.
HMC is building a 300 kta Spherizone 
process plant at Map Ta Phut, Rayong, 
Thailand and an associated propane 
dehydrogenation plant to supply the 
required feedstock. Start up of both  
plants is expected in 2009. Also, PTT,  
the publicly listed natural resources 
company of Thailand, through the 
purchase of new and existing shares  
in HMC, became a 40 % owner of HMC  
last year.
Although Polyolefins North America’s 
full-year EBITDA was disappointing and 
trailed 2005, the region made progress in 
its efforts to restore profitability and grow 
the business. Actions included initiating 
a ‘sweat the assets’ strategy in the latter 
part of 2006 to increase plant utilisation. 
In addition, the Polyolefins North America 
headquarters will be moved from Elkton, 
Maryland to a more cost-effective site 
before the end of 2007. This is consistent 
with actions taken in other parts of 
Basell in recent years to ensure that the 
company’s business needs are being  
met in the most effective way.
The Mexican joint venture, Indelpro, 
is anticipating the completion of 
construction of the first North American 
Spherizone process polypropylene plant,  
a 300 kta state-of-the-art unit that is due 
on stream in 2008.
Basell’s Clyrell polypropylene resin is used in clear food packaging
Below: Basell’s polypropylene resin is 
used to produce nonwoven fibre material
Bottom: Pipe produced using Basell’s 
Hostalen PP
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Manufacturing & Services
‘Our goal is to be highly responsive to the needs 
of our customers by applying our manufacturing 
resources in a safe, environmentally responsible 
and cost efficient manner.’
Manfred Dressel, Executive Vice President,  
Manufacturing & Services
Manufacturing & Services has three 
main areas of activity: management of 
manufacturing operations and service on 
a global basis; global corporate services, 
and global business services. Each of 
these functions has been designed to 
provide cost effective and world class 
operations and services. A key goal for 
each is maximising the opportunities 
to achieve synergies and apply ‘best 
practice’ across the whole of Basell in the 
areas of feedstock and material provision, 
corporate and manufacturing advice and 
support, and the execution of projects.
AT A GLANCE
Production in 19 countries
A focus on doing  
things effectively
Global ‘best practice’ 
approach
New cooperative  
initiative aims to make  
Basell even safer
For the world’s largest producer of polyolefins, the organisation 
with the largest number of employees is Manufacturing & 
Services. With production operations in 19 countries around  
the world, Manufacturing & Services has a vital role 24 hours  
a day, seven days a week in keeping Basell customers supplied 
with the products they want and when they want them.
Manufacturing & Services focuses on 
doing things effectively – and this includes 
ongoing exchanges of key information 
about planning, reporting, asset utilisation 
and reliability, quality and cost structures. 
Safety is always the top priority.
In 2006, the management of 
Manufacturing & Services called on 
employees and contractors to help 
uncover safety issues that can be added 
to findings generated in audits and 
inspections in a new programme called 
‘Operational Integrity Initiative’.
The main goal of the initiative is to make 
Basell even safer while also improving 
overall operational integrity. The 
programme allows the operational experts 
at, for example, Basell sites in Europe and 
North America to exchange information 
with their counterparts at other locations 
– and it encourages employees in all plant 
roles to ask their colleagues in other parts 
of the company questions about a wide 
range of operational matters. Experienced 
machine operators in Europe and North 
America are now paying visits to similar 
plants at other sites to mirror their own 
issues against the picture they obtain 
from their hosting plant.
The Operational Integrity Initiative is 
intended to fill gaps by examining 
hard facts related to company facilities 
more closely, identifying shortcomings 
and developing and implementing the 
appropriate corrective measures by 
obtaining a bottom-up perspective.
Plant worker inspecting resin pellets
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Health, Safety and Environment
Basell is unwavering in its commitment to the highest standards of Health, Safety and Environmental 
(HSE) performance. This includes managing resources and impacts to create products that contribute 
to sustainable development.
The polyolefin products the company 
creates are indispensable in many 
applications considered to be necessities 
in daily life. In designing, manufacturing 
and marketing these products at Basell, 
meticulous attention is paid to HSE critical 
factors such as worker health and safety. 
Furthermore, managing the environmental 
impact and resource intensity of Basell’s 
operations are key elements in the 
company’s product stewardship approach 
and HSE policy.
In the area of workplace safety, Basell  
has established a best-in-class record  
and is dedicated to continuously 
improving its approach to employee  
and contractor safety.
The safety trend in the chart on this page 
depicts the company’s Total Recordable 
(Injury) Rate or TRR – a measure of the 
number of injuries per million man hours 
that covers both Basell employees and 
contractors (it equates roughly to the 
number of injuries per 500 workers  
per year).
Basell’s commitment to safeguarding 
the well-being of its employees extends 
beyond ensuring that a safe working 
environment is provided. The company 
regards the health of its employees as 
a business-critical matter and, as such, 
encourages a holistic approach to health.
Elements in the company’s approach 
to collaborating with its employees to 
promote good health include: stress 
management, work/life balance, coping 
with change, addressing the challenges 
of an ageing workforce, and dealing with 
long-term disabilities. 
In addition, Basell has a long tradition 
of innovation in process development, 
where enhanced product capability 
has gone hand-in-hand with improved 
environmental impact and reduced 
resource intensity. Basell takes 
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AT A GLANCE
Best-in-class record in safety
A focus on employees’ health 
as a business-critical matter
Environmentally responsible 
manufacturing processes
environmental performance criteria  
very seriously and has adopted the 
ISO 14001 Standard across all Basell 
manufacturing facilities.
At Basell’s manufacturing sites, 
continuous control of the environmental-
related aspects of operations and the  
ISO 14001 audit findings form the 
basis for improvement programmes 
that address issues regarded as local 
environmental priorities.
Key environmental indicators such as 
total energy consumption, solid waste 
generation and emissions to air and water 
are monitored and measured at the site 
level and that information is consolidated 
on a global basis.
Basell Safety Performance (TRR) 
Employees & Contractors
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SALES IN  
MORE THAN
120
COUNTRIES
10
JOINT VENTURES
No. 1
IN POLYOLEFINS 
WORLDWIDE
PRODUCTION IN
19
COUNTRIES
6,850
EMPLOYEES
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Human Resources
Basell’s success depends in large measure on the contributions of its employees and how they apply 
their talents and energy to achieve the company’s business objectives. Key to Basell’s standing as the 
global leader in polyolefins are the company’s strong values around having a diverse workforce and 
its commitment to invest significantly in the development of employees – wherever they are working 
around the globe.
AT A GLANCE
6,850 employees worldwide
Talent development is a key  
to success
2 new offices opened and  
others were expanded
A new focus on employee  
health awareness
Talent development at Basell is a shared 
responsibility between the individual 
employee and management, and a key 
element in employee development is 
performance management. In 2006 there 
was significant improvement in this 
process; the upgrades included a better 
reporting system and increased focus on 
learning and personal development for 
staff in the professional and managerial 
categories.
A new tool was introduced to assist 
Human Resources staff and company 
managers in assessing the effectiveness 
of a wide range of training programmes, 
many of which are geared to aligning 
business objectives to individual tasks 
and targets. Basell provides recognition 
for individual achievements and the 
company’s performance management 
system is closely linked to the reward 
mechanism.
Basell continuously looks for talented, 
ambitious and flexible men and women 
to join the company and put into practice 
what they have learned in university 
classrooms and laboratories. The hiring 
requirements, in any year, reflect a mix 
of seasoned professionals as well as 
those younger in their careers and those 
fresh from educational institutions. 
Operating successfully on a global basis 
means understanding the unique needs 
and goals of very diverse customers in 
widespread and vastly different markets. 
And for Basell this means having the 
best people possible – regardless of their 
identifying characteristics.
In 2006, the company recruited more 
than 250 new employees across all the 
geographies where Basell operates, 
with a particular emphasis on capturing 
opportunities in high growth areas for 
polyolefins. Last year, the company 
opened offices in Malaysia, Dubai and 
Moscow and expanded the workforce 
in other offices, including Mumbai and 
Istanbul.
At the end of 2006, Basell had 
6,850 employees. Of that number, 
approximately 75 % work in Europe, where 
restructuring activities have rationalised 
the company’s office and manufacturing 
footprints. Also last year, there was a 
reorganisation in North America, where 
approximately 15 % of Basell’s employees 
reside. During 2006, Basell acquired a 
new catalyst business in Edison, New 
Jersey, USA and Human Resources had 
a key support role in the transition and 
integration of the workforce there to 
Basell systems, processes and structures.
The company’s presence in Latin America, 
Asia Pacific and Africa and the Middle East 
is steadily growing and these regions now 
account for approximately 10 % of Basell’s 
total employee population.
Basell management is placing increased 
attention on raising employee awareness 
about health and the impact that it can 
have on productivity.
‘One of Basell’s main strengths is its diversity. 
A unique blend of talent, experiences and 
cultures that sets our company apart from the 
competition in a rigorous business environment.’
Rick Gutierrez, Executive Vice President,  
Human Resources and Corporate Communications
Human Resources | Basell Annual Report 2006
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2006 in Review
During 2006, the first full financial year 
since the sale of Basell to Access, the 
Group significantly strengthened its 
position as the global leader in polyolefins 
technology, production and marketing. 
In addition, the financial results marked 
new historic highs since Basell’s formation 
in October 2000. The foundation for this 
record-breaking performance is based 
on Basell’s technological innovation and 
leadership position, which dates back 
more than half a century and enabled  
an operating result of €619 million 
(EBITDA was in excess of €1 billion).  
All three of Basell’s operational business 
units contributed strongly to the record 
financial results during a year when 
the company also achieved a best-
ever safety performance underpinning 
its commitment to health and safety. 
The company also progressed with its 
strategic agenda through continued 
active portfolio management and further 
improvement of its feedstock integration 
through a cracker acquisition in Europe.
Technology Business – 
Licensing, Catalysts,  
Technology Services  
and New Ventures
The Licensing Business again 
demonstrated Basell’s technological 
leadership by granting in 2006 new 
process licenses for 2.5 million tons of 
annual polyolefins capacity – including the 
sale of the company’s 200th polyolefin 
process license – and establishing the 
Spherizone process technology as the new 
global industry standard in polypropylene. 
Management Report
In the Catalyst business, revenue grew 
further and exceeded the previous year’s 
result1 by 7 %. Basell continued investing 
in this business through the acquisition of 
Akzo’s polymerisation catalyst operation 
at Edison, USA and the construction of a 
second catalyst production line at Basell’s 
Ferrara, Italy site to ensure continued 
leadership and in anticipation of the 
growing polyolefin market capacity. 
The 2006 Technology Business operating 
result of €104 million significantly 
exceeded the 2005 result even when 
excluding the effect of a new accounting 
policy for license income recognition, as 
described in note 4, which the company 
adopted in 2006 to better reflect the 
economic substance of all underlying 
licensing contracts.
Advanced Polyolefins Business 
(APO) – Polypropylene 
Compounds and other 
Specialty Products
The 2006 APO Business operating result 
of €110 million was much higher than the 
comparable figure for the previous year. 
Also, EBITDA strengthened by 60 % on a 
like-for-like basis excluding the earnings 
from the PCMA operations in Argentina 
and Brazil (both acquired 1 September 
2005). This achievement is based on 
strong volume growth (+14 %), particularly 
in PCMA products and Catalloy process 
grades; an increase in higher value 
products, and cost reductions attained 
from business restructuring initiatives. 
These included an additional optimisation 
of the company’s PCMA asset footprint in 
both North America and Europe as well as 
investments in new capacities: a Catalloy 
process plant in North America and PCMA 
plants in Brazil and China. The capacities 
of the company’s state-of-the-art plants 
in Brazil and China will be expanded near 
term to match future market growth.
Polyolefins Business 
– Polyolefins Europe, North 
America and International
The 2006 Polyolefins Business reached 
an operating result of €401 million which 
is well ahead of 2005 despite continued 
volatility in feedstock prices and record 
high oil prices. The Group was able to 
increase focus on specialty grades.
The overall growth in the polyolefin 
markets in 2006 was lower than Basell’s 
business plan premises. Nonetheless, 
the supply-demand balance tightened in 
Europe, particularly in the first part of 
the year, when converter inventory levels 
were low and virtually no new capacity 
came on stream. This resulted in good 
polymer spreads compensating for the 
low cracker margins achieved in the first 
three quarters of the year.
The rather favourable market environment 
in Europe and in the International region 
1. As explained in note 1, comparative financial information for 2005 in these financial statements 
only includes 5 months since formation of the company. For a transparent comparison on a like-for-
like basis this Management Report was prepared using the year 2005 pro-forma values based on the 
full year 2005.
Alan Bigman, 
Chief Financial Officer
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was somewhat offset by the disappointing 
North American market. Basell’s 2006 
European sales volumes (+5 %) and 
spreads were ahead of 2005, whereas 
Basell’s North American sales volumes 
were in line with the previous year but the 
extreme month to month monomer price 
volatility contributed to weaker spreads. 
Strategic Measures
During 2006 Basell implemented  
a number of strategic measures. 
In Asia Pacific, Basell sold its stake in 
Taiwan Polypropylene Company (‘TPP’) 
and as part of the transaction acquired 
TPP’s positions held in other Basell joint 
ventures: SunAllomer Co. Ltd. (Japan), 
PolyMirae Co. Ltd. (South Korea) and 
HMC Polymers Co. Ltd. (Thailand). PTT, 
the publicly listed natural resources 
company in Thailand, became a partner 
in Basell’s existing joint venture HMC. 
This allowed HMC to expand its business 
activities through the construction of a 
new propane dehydrogenation unit and a 
Spherizone process polypropylene plant. 
In the Middle East, Basell participated in 
the formation of two new joint ventures 
in Saudi Arabia, SEPC and Al-Waha with 
the start ups planned for 2008/2009. The 
SEPC site will include a cracker, a Hostalen 
ACP high density polyethylene plant 
and a Lupotech T process low density 
polyethylene plant. The Al-Waha site will 
have a propane dehydrogenation unit and 
a Spherizone process polypropylene plant.
In Europe, Basell acquired from Ruhr Öl 
GmbH a steam cracker at Münchsmünster, 
Germany. This acquisition and the 
decision to rebuild a new Hostalen 
Advanced Cascade Process polyethylene 
plant at the site will improve Basell’s 
feedstock integration in Europe and 
further enhance the asset footprint  
in the Polyolefins Business.
Looking forward, Basell was selected 
by the government of Kazakhstan as 
strategic partner for the development of 
the petrochemical industry, establishing  
a foundation for Basell in that fast 
growing country.
Special Items 2006
The company’s financial performance was 
subject to several exceptional items which 
overall slightly impacted Profit before tax 
(- €7 million). Other income of €61 million 
resulted from expected net insurance 
proceeds recorded prior to the rebuild of 
the Münchsmünster plant, and gains on 
the sale of various assets and a part of the 
HMC stake. These amounts were offset 
by Other expenses totalling €56 million 
due to asset impairments in Canada and 
France and further restructuring and 
redundancy charges (further details of 
these items can be found in the Notes  
to these Financial Statements).
Outlook for 2007
The 2007 outlook remains good based 
on the expected continuation of Basell’s 
successful market positioning and a solid 
supply demand picture. This assessment 
remains, however, dependent on the 
actual economic growth in these key 
markets, the underlying feedstock price 
development and other key economic 
parameters.
The first quarter polymer demand 
is expected to remain strong, which 
should push polymer prices higher. 
The Polyolefins Business is seeking to 
further enhance its financial performance 
by benefiting from the results of the 
recently acquired cracker, announced 
asset footprint changes and recent 
restructurings in North America  
and Europe.
Basell’s strong financial performance 
enables the Company to explore 
refinancing options as well as value-
enhancing acquisitions.
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Consolidated Financial Statements 
Basell AF S.C.A.
For the year from 1 January 2006 to 31 December 2006
Basell AF S.C.A. is represented by Basell AFGP S.à.r.l.:
A. Bigman,  
Manager
R. Floor,  
Manager
P. Kassin,  
Manager
K. Potter,  
Manager
Luxembourg, 23 February 2007
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1. Consolidated balance sheet as at 31 December 2006
€ MILLION NOTE 2006 2005*
ASSETS
Property, plant and equipment 11 2,526 2,564
Intangible assets 12 417 541
Investments in associates and joint ventures 13 802 585
Other investments 13 10
Available-for-sale financial assets 14 45 41
Employee benefits 21 7 8
Deferred charges 23 25
Other financial assets 10 7
Deferred tax assets 23 22 80
Total non-current assets 3,865 3,861
Inventories 15 1,016 1,002
Receivables from tax authorities 152 160
Trade receivables 16 1,551 1,478
Other receivables 17 161 116
Prepayments 12 23
Cash and cash equivalents 18 670 590
Total current assets 3,562 3,369
Total assets 7,427 7,230
EQUITY
Issued capital 50 50
Share premium 810 810
Other reserves (3) 4
Retained earnings 413 134
Total equity 19 1,270 998
LIABILITIES
Interest-bearing loans and borrowings 20 2,384 2,745
Employee benefits 21 504 514
Deferred income 22 90 36
Deferred tax liabilities 23 381 313
Provisions 24 289 305
Other non-current liabilities 25 46 27
Total non-current liabilities 3,694 3,940
Interest-bearing loans and borrowings 20 698 603
Trade payables 26 1,123 1,065
Other payables 10 29
Payables to tax authorities 27 147 149
Provisions 24 34 37
Employee benefits 21 119 99
Accrued liabilities 28 332 310
Total current liabilities 2,463 2,292
Total liabilities 6,157 6,232
Total equity and liabilities 7,427 7,230
* Adjusted to reflect change in accounting policies (note 4) and changes due to provisional accounting (note 6).
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€ MILLION NOTE 2006 2005 
(20 APR – 31 DEC)*
Revenue 10 10,495 3,769
Cost of sales (9,388) (3,425)
Gross profit 1,107 344
Other income 30 66 15
Selling expenses (155) (61)
General and administrative expenses (240) (123)
Research and development expenses (103) (48)
Other expenses 31 (56) (47)
Operating profit before finance costs 619 80
Finance income 35 12
Finance expense (273) (124)
Net finance costs 32 (238) (112)
Net results from associates and joint ventures  
accounted for under the equity method
13 102 25
Profit / (loss) before tax 483 (7)
Income tax (expense) / benefit 33 (207) 2
Excess of fair value of identifiable assets, liabilities and contingent 
liabilities of acquired businesses over the cost of the acquisition
9 1 139
Profit for the period 277 134
* Adjusted to reflect change in accounting policies (note 4) and changes due to provisional accounting (note 6).
2. Consolidated income statement for the year ended 31 December 2006
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€ MILLION SHARE 
CAPITAL
SHARE 
PREMIUM
OTHER 
RESERVES
RETAINED 
EARNINGS
TOTAL
Balance at 20 April 2005 – – – – –
Capital contribution 26 July 2005 50 810 – – 860
Dutch capital tax duty levied on equity 
contributions to Basell Holdings B.V.
– – (4) – (4)
Total net capital contribution 50 810 (4) – 856
Exchange differences on translating  
foreign operations
– – 3 – 3
Change in fair value cash flow hedges – – 3 – 3
Change in fair value of cash flow hedges accounted 
for by associates and joint ventures
– – 1 – 1
Unrealised gain for securities available for-sale 
accounted for by associates and joint ventures
– – 1 – 1
Total income for the period  
recognised directly in equity
– – 8 – 8
Profit for the period
Including €14 million of profit related to  
a change in accounting policy (see note 4)
– – – 134 134
Total income for the period – – 8 134 142
Balance at 31 December 2005 50 810 4 134 998
Exchange differences on translating  
foreign operations
– – (19) – (19)
Change in fair value of cash flow hedges – – 12 – 12
Increase in fair value of cash flow hedges 
accounted for by a joint venture
– – 1 – 1
Decrease in fair value of cash flow  
hedges accounted for by an associate
– – (1) – (1)
Realised revaluation step-up acquisition  
(see note 18)
– – – 2 2
Total income for the period recognised 
directly in equity
– – (7) 2 (5)
Profit for the period
Including €25 million of profit related to a change 
in accounting policy (see note 4)
– – – 277 277
Total income for the period – – (7) 279 272
Balance at 31 December 2006 50 810 (3) 413 1,270
3. Consolidated statement of changes in equity for the years 2005 and 2006
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€ MILLION 2006 2005 
(20 APR - 31 DEC)*
Profit for the period 277 134
Adjustments for:
Excess of fair value of identifiable assets, liabilities and contingent liabilities  
of acquired business over the cost of the acquisition
(1) (139)
Depreciation, amortisation and impairment losses 411 181
Associates and joint ventures: dividends more / (less) than net results (69) 2
Gain on disposal of property, plant and equipment (24) –
Amortised financing costs 9 17
Interest expense 250 104
Interest income (35) (12)
Current taxation 77 64
Deferred taxation 130 (66)
Operating cash flow before changes in working capital and provisions 1,025 285
Movements in: inventories (35) (29)
 trade receivables (111) (29)
 other receivables and current assets (79) (57)
 trade payables 84 129
 other payables and accrued liabilities 56 130
 provisions (13) 11
 other liabilities 29 18
Cash flow generated from operations 956 458
Interest paid (222) (78)
Interest received 34 12
Net income tax paid (112) (41)
Net cash flows from operating activities 656 351
Acquisitions, net of cash acquired (78) (2,117)
Directly attributable acquisition costs – (39)
Capital expenditures paid (203) (106)
Proceeds from disposal of property, plant and equipment 24 2
Sale (purchase) of available-for-sale financial assets 3 (4)
Proceeds from disposal of non-current assets held for sale – 275
Proceeds from disposal of investments in associates 53 –
Investment in joint ventures and associates (224) (15)
Net cash flows used in investing activities (425) (2,004)
Cash obtained through capital contribution – 860
New financing upon acquisition of Basell Group – 2,742
Repayment of financing acquired upon acquisition of Basell Group – (1,142)
Financing and arrangement fees paid at acquisition of Basell Group – (70)
Repayments of financing after acquisition of Basell Group (265) (1,495)
New financing after acquisition of Basell Group 61 1,359
Financing and arrangement fees paid after acquisition of Basell Group – (13)
Movements in securitisation programmes 58 –
Net cash flows from financing activities (146) 2,241
Net increase in cash and cash equivalents 85 588
Cash and cash equivalents at beginning of the period 590 –
Effect of exchange rate fluctuations on cash held (5) 2
Cash and cash equivalents at end of the period 670 590
* Adjusted to reflect change in accounting policies (note 4) and changes due to provisional accounting (note 6).
4. Consolidated cash flow statement for the years 2005 and 2006
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1. General information
Basell AF S.C.A., hereafter referred to  
as ‘the Company’, was incorporated in  
the Grand Duchy of Luxembourg as a 
private limited liability company on  
20 April 2005 by its sole shareholder  
BI S.à r.l, a Luxembourg private limited 
liability company, affiliated with the 
Access Industries group.
The Company together with its directly 
and indirectly owned subsidiaries, 
hereafter referred to as ‘the Group’ 
or ‘Basell’, is a major player in 
polyolefins production, marketing and 
technology. The Group’s main products 
are polypropylene, polyethylene and 
advanced polyolefins, which are complex, 
polyolefinic compounds and alloys. 
The Group actively licenses certain of 
its technologies and manufactures and 
sells catalysts. The Group, including 
its associates and joint ventures, has 
manufacturing activities in more than 
20 countries around the world with 
customers in more than 120 countries 
across five continents.
These statements are prepared for 
the year from 1 January 2006 through 
31 December 2006. The comparative 
information represents the period from 20 
April 2005 (date of incorporation) through 
31 December 2005 (end of first financial 
year). The financial statements comprise 
the Group and its interest in associates 
and joint ventures.
On 26 July 2005, BI S.à r.l., the Company’s 
immediate shareholder, contributed to 
the Company all its assets and liabilities 
at a value of €860 million by the issuance 
of 403,226 new shares with a par value 
of €124 each. This resulted in a new 
share capital of €50,012,424 and a share 
premium of €809,999,976. Immediately 
thereafter the Company decided to 
decrease the subscribed share capital by  
€12,400 (100 shares) to €50,000,024.
The financial position and results for 
the period 1 January 2006 through 31 
December 2006 were impacted by the 
following acquisitions and disposals:
·  The acquisition of the Polymerisation 
Catalyst & Components business of 
Akzo Nobel (located in Edison, New 
Jersey, USA). The acquired Components 
business was subsequently disposed 
off through a separate transaction;
·  The acquisition of interests in 
SunAllomer Ltd. (Japan), PolyMirae Co. 
Ltd. (South Korea) and HMC Polymers 
Co. Ltd. (Thailand) from Taiwan 
Polypropylene Co. Ltd. (Taiwan);
·  The disposal of the Group’s interest  
in Taiwan Polypropylene Co. Ltd. 
(Taiwan); and
·  The acquisition of a naphtha cracker 
and related activities located in 
Münchsmünster (Germany).
The acquisitions and disposals are  
further described in note 9.
The financial position and results for 
the period from 20 April 2005 through 
31 December 2005 were significantly 
impacted by the following transactions:
·  The acquisition and financing of the 
Basell group as at 1 August 2005;
·  The acquisition of the remaining 50 % 
interests in the former joint ventures 
Petroken Petroquimica Ensenada S.A. 
(Argentina) and Société du Craqueur  
de l’Aubette S.A.S. (France);
·  The divestment of the Group’s 50 % 
interest in the 160 kt polypropylene 
plant in Tarragona (Spain);
·  The divestment of Transformadora 
De Propileno A.I.E., and its 100 % 
subsidiary Basell Brasil Poliolefinas  
Ltda. (Brazil), a company holding a  
50 % interest in Polibrasil Participaçoes 
S.A. (Brazil). Immediately prior 
to the divestment of Basell Brasil 
Poliolefinas Ltda., the Group acquired 
the polypropylene compounding 
business of Polibrasil Participaçoes S.A. 
through the purchase of all shares in 
Norcom Compostos Termoplásticos do 
Nordeste S.A. (Brazil).
During 2006, the Group changed its 
accounting policies for licensing revenue 
recognition and the classification of the 
interest component of defined benefit 
costs related to pensions and other post-
retirement benefits. The impact on the 
financial statements is further described 
in note 4.
2. Statement of compliance
These consolidated financial statements 
have been prepared in accordance 
with International Financial Reporting 
Standards (IFRSs) as adopted by the 
European Union (EU) further to the IAS 
Regulation (EC 1606/2002) (‘IFRSs as 
adopted by the EU’).
These financial statements are based 
on IFRSs that are adopted by the EU and 
effective at 31 December 2006, which  
are further referred to as IFRS.
3. Summary of significant 
accounting policies
The accounting policies as described 
in this note are the Group’s policies in 
respect of ongoing business transactions 
and other economic circumstances.
During 2006, the Group changed the 
accounting policies for licensing revenue 
recognition and related intellectual 
property rights and the presentation of 
the interest component of defined benefit 
plants, which are further described in  
note 4.
3-1 Basis of preparation
The financial statements are presented 
in Euro, the Group’s functional and 
presentation currency, rounded to the 
nearest million. They are prepared on 
the historical cost basis except that the 
following assets and liabilities are stated 
at their fair value: derivative financial 
instruments, financial instruments held 
for trading, and financial instruments 
classified as available-for-sale. 
The preparation of financial statements 
in conformity with IFRSs requires 
management to make judgements, 
estimates and assumptions that affect 
the application of policies and reported 
amounts of assets, liabilities, income and 
expenses. The estimates and underlying 
assumptions are based on historical 
experience and various other factors that 
are believed to be reasonable under the 
Notes to the Consolidated 
Financial Statements
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circumstances, the results of which form 
the basis of making the judgements about 
carrying values of assets and liabilities 
that are not readily apparent from other 
sources. Actual results may differ from 
these estimates. The estimates and 
underlying assumptions are reviewed on 
an ongoing basis. Revisions to accounting 
estimates are recognised in the period 
in which the estimate is revised if the 
revision affects only that period, or in the 
period of the revision and future periods 
if the revision affects both current and 
future periods.
Judgements made by management in the 
application of IFRSs that have a significant 
effect on the financial statements and 
estimates with a significant risk of 
material adjustments in the next year  
are as followed:
·  Judgement as to the existence of 
indications for an impairment of 
property, plant and equipment;
·  Estimating the value in use to evaluate 
the recoverability of property, plant 
and equipment;
·  Estimating taxable income during 
the foreseeable future for the 
determination of deferred tax assets;
·  Actuarial assumptions used for 
measurement of the present value of 
post-retirement benefit obligations;
·  As a result of the underlying inherent 
uncertainty the measurement of 
provisions.
All in all these judgements and estimates 
relate to the currently endorsed business 
plan of management for the years 2007 
to 2011.
3-2 Consolidation
Subsidiaries
Subsidiaries are entities controlled by 
the Company. Control exists when the 
Company has the power, directly or 
indirectly, to govern the financial and 
operating policies of an entity so as to 
obtain benefits from its activities. In 
assessing control, potential voting rights 
that presently are exercisable are taken 
into account. The financial statements 
of subsidiaries are included in the 
consolidated financial statements from 
the date that control commences until  
the date that control ceases.
Transactions eliminated  
on consolidation
Intra-group balances and any unrealised 
gains and losses or income and expenses 
arising from intra-group transactions, are 
eliminated in preparing the consolidated 
financial statements.
Unrealised gains arising from transactions 
with associates and joint ventures are 
eliminated to the extent of the Group’s 
interest in the entity. Unrealised losses are 
eliminated in the same way as unrealised 
gains, but only to the extent that there is 
no evidence of impairment.
3-3 Business combinations
The Group applies for its accounting 
for acquisitions the purchase method 
according to IFRS 3 Business Combinations, 
which contains the following key elements:
·  The total of the purchase consideration 
plus any costs directly attributable to 
the acquisition determine the total costs 
of the acquisition. When a business 
combination agreement provides 
for an adjustment to the cost of the 
combination contingent on future 
events, the Group includes an amount 
of the adjustment in the cost of the 
acquisition at the acquisition date if 
the adjustment is probable and can 
be measured reliably. Any subsequent 
changes to the contingent consideration 
will result in an adjustment to the 
initially recognised goodwill.
·  At the acquisition date, being the date 
on which effective (joint) control is 
transferred to (significant influence is 
obtained by) the Group, all identifiable 
assets, liabilities and contingent liabilities 
are measured at their fair values.
·  When the Group’s share in the fair 
value of all identifiable assets, liabilities 
and contingent liabilities is less than 
the total cost of acquisition, the excess 
is recognised as goodwill, a separate 
component within intangible assets.
·  When the Group’s share in the 
fair value of all identifiable assets, 
liabilities and contingent liabilities 
exceeds the total cost of acquisition, a 
reassessment of the identifiable assets, 
liabilities, contingent liabilities and 
purchase consideration is required. 
If after the reassessment a surplus 
remains, it is recognised as negative 
goodwill in the income statement 
immediately following the acquisition.
3-4 Foreign currency 
translation
Foreign currency transactions
Transactions in foreign currencies are 
translated at the foreign exchange rate 
ruling at the date of the transaction. 
Monetary assets and liabilities 
denominated in foreign currencies at the 
balance sheet date are translated to Euro 
at the foreign exchange rate ruling at that 
date. Foreign exchange differences arising 
on translation are recognised in the 
income statement. Non-monetary assets 
and liabilities that are measured in terms 
of historical cost in a foreign currency are 
translated using the exchange rate at the 
date of the transaction. Non-monetary 
assets and liabilities, with the exception of 
available-for-sale non-monetary financial 
assets, denominated in foreign currencies 
that are stated at fair value are translated 
to Euro at foreign exchange rates ruling at 
the dates the fair value was determined, 
with translation differences recognised as 
currency exchange gains or losses in the 
income statement. Translation gains or 
losses on available-for-sale non-monetary 
financial assets are recognised in Other 
reserves within Equity, net of tax.
Financial statements  
of foreign operations
The assets and liabilities of foreign 
operations, including goodwill and 
fair value adjustments arising on 
consolidation, are translated to Euro 
at foreign exchange rates ruling at the 
balance sheet date. The revenues and 
expenses of foreign operations are 
translated to Euro at the foreign exchange 
rates prevailing at the date of any 
individual transactions as approximated 
by the monthly average rates whereby  
the translation result is recognised in 
Other reserves within Equity.
Net investment in foreign operations
Exchange differences arising from the 
translation of net investments in foreign 
operations, and of related hedges, are 
taken to the Other reserves within Equity. 
They are released to the income statement 
upon disposal of the foreign operation.
3-5 Segment reporting
A segment is a distinguishable component 
of the Group that is engaged either in 
providing products or services (business 
segment), or in providing products or 
services within a particular economic 
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environment (geographical segment), 
which is subject to risks and rewards 
that are different from those of other 
segments. The primary format for 
segment reporting is based on business 
segments and the secondary format is 
based on geographical segments due 
to the fact the Group’s risks and rates 
of return are affected predominantly by 
differences in products. 
The Group has identified three separately 
reportable business segments, 
‘Polyolefins’, ‘Advanced Polyolefins’ and 
‘Technology’ and reports under ‘Other’ 
the costs of major restructuring, certain 
corporate headquarter costs, costs 
associated with senior management 
compensation schemes and management 
fees paid to AI Petrochemicals LLC.
Transfer pricing between the segments 
is on an arm’s length basis. The segment 
assets and liabilities consist of trade 
and licensing receivables, inventories, 
property, plant and equipment, intangible 
assets, investments in associates, other 
investments, available-for-sale financial 
assets, trade payables, deferred income 
and long-term liabilities that can be 
allocated to the segments. Other segment 
assets and liabilities consist of assets and 
liabilities which can not be reasonably 
allocated to the business segments.  
These include employee benefit 
obligations, provisions and deferred  
tax assets/liabilities.
3-6 Revenue
Goods sold and services rendered
Revenue is recognised to the extent that 
it is probable that the economic benefits 
will flow to the Group and the revenue can 
be reliably measured. Revenue related to 
the sales of goods is recognised when the 
significant risks and rewards of ownership 
of the goods have passed to the customer. 
Revenue is determined by reference to 
the sales price of the goods delivered and 
services rendered during the period, net 
of related rebates, discounts, sales taxes 
and other duties. Costs are charged to the 
income statement in the same period in 
which the related revenue is recognised. 
Shipping and handling costs are included 
in cost of sales. Transactions whereby the 
Group sells products for third parties for 
whom the Group receives commissions 
and whereby the Group does not take 
credit or inventory risk are reported 
as part of revenue for the amount of 
commissions earned.
Licensing revenue
For licensing contracts whereby the 
Group receives the vast majority of the 
contract value in cash at or before the 
customer’s license acceptance date, the 
Group recognises the full contract value 
as revenue when significant risks and 
rewards have been transferred to the 
licensee, and the Group has no continuing 
managerial involvement, which usually 
occurs on the date the process design 
packages are delivered to the licensee. 
For other contracts involving a significant 
running royalty element or a longer cash 
collection period, the Group recognises 
revenue over the average economic life  
of such contracts presently approximating 
10 years.
3-7 Cost of sales
Cost of sales comprises of a) 
manufacturing costs of own-produced 
goods and b) cost of purchased trading 
goods to the extent sold and delivered. 
Cost of sales includes depreciation of 
property, plant and equipment and 
amortisation of intangible assets to 
the extent it directly relates to Basell’s 
production or trading activities. 
Additionally royalties, logistic and 
packaging costs, cost for maintenance 
and repair and any inventory write-downs 
to lower net realisable value are included 
in cost of sales.
3-8 Leases
Leases whereby the Group does not 
assume substantially all the risks and 
benefits of ownership of the asset are 
treated as operating leases. Operating 
lease payments are recognised as an 
expense in the income statement on a 
straight-line basis over the contractual 
lease term.
3-9 Property, plant  
and equipment
Owned assets
Items of property, plant and equipment 
are stated at cost less accumulated 
depreciation and impairment losses (see 
accounting policy 3-13). The cost of 
self-constructed assets includes the cost 
of materials, direct labour, technology 
acquired to construct the plant and an 
appropriate proportion of production 
overheads. The cost of self-constructed 
assets and acquired assets includes 
(1) the initial estimate at the time of 
installation and during the period of use, 
when relevant, of the costs of dismantling 
and removing the items and restoring the 
site on which they are located, and (2) 
changes in the measurement of existing 
liabilities recognised for these costs 
resulting from changes in the timing or 
outflow of resources required to settle the 
obligation or from changes in the discount 
rate. The cost of major newly constructed 
tangible fixed assets includes interest 
incurred during the construction period.
Where parts of an item of property, plant 
and equipment have different useful 
lives, they are accounted for as separate 
components of property, plant and 
equipment.
Subsequent costs
The Group recognises in the carrying 
amount of an item of property, plant and 
equipment the cost of replacing part of 
such an item when that cost is incurred 
if it is probable that the future economic 
benefits embodied with the item will 
flow to the Group and the cost of the 
item can be measured reliably. Costs of 
major inspections or overhauls occurring 
at regular intervals over the useful life 
of the asset are also considered to be a 
component and consequently capitalised 
and depreciated. All other costs are 
recognised in the income statement  
as an expense as incurred.
Depreciation
Depreciation is charged to the income 
statement on a straight-line basis over the 
estimated useful lives of each component 
of property, plant and equipment. Land 
is not depreciated. The estimated useful 
lives are as follows:
· Buildings up to 30 years
·  Plant and equipment and  
major components up to 20 years
Residual values of asset components are 
reassessed annually, unless insignificant.
3-10 Intangible assets
Goodwill
All business combinations are accounted 
for by applying the purchase method. 
Goodwill represents amounts arising on 
acquisition of subsidiaries, associates and 
joint ventures. Goodwill represents the 
positive difference between the cost of the 
acquisition and the Group’s share in the 
fair value of the identifiable assets and 
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(contingent) liabilities acquired.
Goodwill is stated at cost less any 
accumulated impairment losses. Goodwill 
is allocated to cash-generating units and 
is tested annually for impairment (see 
accounting policy 3-13). In respect of 
associates and joint ventures, the carrying 
amount of goodwill is included in the 
carrying amount of the investment in  
the associate or joint venture.
Any excess of fair value of identifiable 
assets, liabilities and contingent liabilities 
of acquired business over the cost of 
the acquisition (negative goodwill) is 
recognised directly as profit in the  
income statement.
Research and development
Expenditure on research activities, 
undertaken with the prospect of gaining 
new scientific or technical knowledge  
and understanding, is recognised in  
the income statement as an expense  
as incurred.
Expenditure on development activities 
whereby research findings are applied to 
a plan or design for the production of new 
or substantially improved products and 
processes, are capitalised when they  
meet the following criteria:
·  Technical feasibility of completing  
the intangible asset so that it will  
be available-for-sale;
·  Intention to complete the intangible 
asset and to use or sell it;
·  Ability to use or sell the intangible 
asset;
·  It is probable that the asset will 
generate future economic benefits;
·  Availability of adequate technical, 
financial and other resources to 
complete the development and  
to use or sell the intangible asset;
·  Ability to measure reliably the 
expenditure attributable to  
the intangible asset during  
its development.
The expenditure capitalised includes the 
cost of materials, direct labour and an 
appropriate proportion of overheads. 
Other development expenditure is 
recognised in the income statement 
as an expense as incurred. Capitalised 
development expenditure is stated at 
cost less accumulated amortisation and 
impairment losses.
Expenditure incurred subsequent to 
the completion is capitalised only when 
it is probable that it will give rise to 
future economic benefits in excess 
of the originally assessed standard of 
performance of the assets and it can  
be measured and attributed to the  
asset reliably.
Development costs are amortised over 
their estimated useful lives, which are 
determined for each project separately, 
however not exceeding 15 years. The 
estimated useful lives are reviewed at 
least once a year.
Intellectual property rights  
and customer relationships
Intellectual property rights and customer 
relationships in respect of licensing and 
catalyst sales activities were valued at the 
date of the acquisition of the Basell group 
at their estimated fair value based on the 
net present value of the future benefits 
from licenses and catalyst sales. Patents, 
licenses, trademarks and similar rights 
purchased from third parties are valued at 
cost. The amortisation of the intellectual 
property rights regarding signed 
licensing contracts as per the date of the 
acquisition of the Basell group match the 
related revenue recognition (accounting 
policy 3-6). Other intellectual property 
rights and customer relationships are 
amortised on a straight-line basis over 
periods of up to 15 years, the period 
management expects the benefits from 
these relationships to arise.
Software
Certain costs related to the development 
or purchase of internal-use software are 
capitalised as software and subsequently 
amortised over the estimated useful life 
of the software not exceeding 5 years. 
Costs related to the preliminary project 
stage and the post-implementation 
and operation stages in an internal-use 
computer software development project 
are expensed as incurred.
Emission rights
Emission rights are recognised as 
intangible assets at their initial fair value. 
If allowances are granted by governments 
for less than fair value, the difference 
between the fair value and the amount 
paid, is accounted for as deferred income 
and amortised to the income statement 
over the period for which the allowances 
were granted. After initial recognition, 
both the intangible assets and related 
deferred income are not revalued for any 
changes in market prices. As emissions 
occur, a provision is recognised on the 
balance sheet for the obligation to deliver 
allowances to cover those emissions 
whereby the cost of the incurred 
emissions are based on the initial  
fair value of allowances granted.
3-11 Investments
General
All regular purchases and sales of 
financial assets are recognised on the 
trade date i.e. the date that the Group 
commits to purchase or sell the asset. 
Regular purchases or sales are purchases 
or sales of financial assets that require 
delivery of assets within the time frame 
generally established by regulation or 
convention in the marketplace.
Derecognition of a financial asset takes 
place when the contractual rights to the 
cash flows are expired or sold, when 
substantially all of the asset’s risks and 
rewards are transferred, or when control 
of the asset is transferred.
Associates and joint ventures
Associates are those entities in which the 
Group has significant influence, but not 
control, over the financial and operating 
policies. The consolidated financial 
statements include the Group’s share of 
the total recognised income and expenses 
of associates on an equity accounted 
basis, from the date that significant 
influence commences until the date that 
significant influence ceases. Joint ventures 
are those entities over whose activities the 
Group has joint control, established by 
contractual agreement. The consolidated 
financial statements include the Group’s 
share of the total recognised income 
and expenses of joint ventures on an 
equity accounted basis, from the date 
that joint control commences until the 
date that joint control ceases. When the 
Group’s share of expenses exceeds its 
interest in an associate or joint venture, 
the Group’s carrying amount is reduced 
to nil and recognition of further losses is 
discontinued except to the extent that the 
Group has incurred legal or constructive 
obligations, or made payments on behalf 
of an associate or joint venture, or related 
loans to the associate or joint venture 
have become impaired.
Available-for-sale financial assets
After initial recognition, investments 
classified as available-for-sale are stated 
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at fair value, with any resultant gain or 
loss being recognised directly in equity, 
net of tax, except for impairment losses 
and, in the case of monetary items such 
as debt securities, foreign exchange gains 
and losses. When these investments are 
derecognised, the cumulative gain or loss 
previously recognised directly in equity is 
recognised in profit or loss. Where these 
investments are interest-bearing, interest 
calculated using the effective interest 
method is recognised in profit or loss.
For investments that are actively traded 
in organised financial markets, fair value 
is determined by reference to Stock 
Exchange quoted market bid prices at the 
close of business on the balance sheet 
date. For investments not actively traded, 
Basell is determining the fair value using  
a Discounted Cash Flow model.
3-12 Borrowing costs
Interest costs are capitalised if and to the 
extent that they are directly attributable 
to the acquisition, construction or 
production of an asset that necessarily 
takes a substantial period of time to get 
ready for its intended use or sale, as part 
of the cost of that asset.
3-13 Impairment of assets
The carrying amounts of the Group’s 
assets other than inventories (see 
accounting policy 3-15) and deferred tax 
assets (see accounting policy 3-19), are 
reviewed at each balance sheet date to 
determine whether there is any indication 
of impairment. If any such indication 
exists, the asset’s recoverable amount  
is estimated.
For goodwill, intangible assets with 
an indefinite useful life and intangible 
assets that are not yet available for use 
and capitalised development costs, the 
recoverable amount is estimated at least 
once a year.
An impairment loss is recognised 
whenever the carrying amount of an asset 
or its cash-generating unit exceeds its 
recoverable amount. Impairment losses 
are recognised in ‘other expenses’ in the 
income statement.
When a decline in the fair value of an 
available-for-sale financial asset has 
been recognised directly in equity and 
there is objective evidence that the 
asset is impaired, the cumulative loss 
that had been recognised directly in 
equity is recognised in profit or loss 
even though the financial asset has not 
been derecognised. The amount of the 
cumulative loss that is recognised in 
profit or loss is the difference between 
the acquisition cost and current fair value, 
less any impairment loss on that financial 
asset previously recognised in profit  
or loss.
Calculation of recoverable amount
The recoverable amount of the Group’s 
receivables carried at amortised cost 
is calculated as the present value of 
estimated future cash flows, discounted  
at the original effective interest rate 
(i.e., the effective interest rate computed 
at initial recognition of these financial 
assets). Receivables with a short duration 
are not discounted.
The recoverable amount of other assets 
is the greater of their fair value less costs 
to sell and value in use. Fair values are 
based on market values or, in case reliable 
market values are not available, cash 
flow methodologies. In assessing value 
in use, the estimated future cash flows 
are discounted to their present value 
using a discount rate that reflects current 
market assessments of the time value 
of money and the risks specific to the 
asset. For an asset that does not generate 
largely independent cash inflows, the 
recoverable amount is determined for 
the cash-generating unit to which the 
asset belongs. A cash-generating unit 
includes a plant and related infrastructure, 
equipment and goodwill if specifically 
allocated.
Reversal of impairment
An impairment loss in respect of 
receivables carried at amortised cost 
and available-for-sale monetary assets 
is reversed if the subsequent increase 
in recoverable amount can be related 
objectively to an event occurring after  
the impairment loss was recognised.
An impairment loss in respect of an 
investment in an equity instrument 
classified as available-for-sale is not 
reversed through profit or loss. If the 
fair value of a debt instrument classified 
as available-for-sale increases and the 
increase can be objectively related to 
an event occurring after the impairment 
loss was recognised in profit or loss, the 
impairment loss is reversed, with the 
amount of the reversal recognised in 
profit or loss.
In respect of other assets, an impairment 
loss is reversed if there has been a change 
in the estimates used to determine the 
recoverable amount.
An impairment loss is reversed only to the 
extent that the asset’s carrying amount 
does not exceed the carrying amount 
that would have been determined, net 
of depreciation or amortisation, if no 
impairment loss had been recognised.
An impairment loss in respect of goodwill 
is not reversed.
3-14 Government grants
Government grants are recognised at 
their fair value where there is reasonable 
assurance that the grant will be received 
and all conditions will be complied with. 
When the grant relates to an expense 
item, it is recognised as income over 
the period necessary to match the grant 
on a systematic basis to the costs that 
it is intended to compensate. Where the 
grant relates to an asset, the fair value 
is recorded as deferred income and is 
released to the income statement over 
the expected useful life of the associated 
asset by equal annual instalments.
3-15 Inventories
Inventories are stated at the lower of cost 
and net realisable value. Net realisable 
value is the estimated selling price in 
the ordinary course of business, less the 
estimated costs of completion and selling 
expenses.
The cost of inventories is based on the 
first-in first-out principle and includes 
expenditure incurred in acquiring the 
inventories and bringing them to their 
existing location and condition. In the 
case of manufactured inventories and 
work in progress, cost includes an 
allocated share of overheads based  
on a normal operating capacity.
3-16 Trade and  
other receivables
Trade receivables, which generally have 
30-90 day terms, are recognised and 
carried at original invoice amount less an 
allowance for bad debts. Such allowance is 
made when collection of the full amount is 
no longer probable, based on discounted 
expected future cash flows.
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3-17 Cash and  
cash equivalents
Cash and cash equivalents comprise  
cash balances and call deposits.
3-18 Interest-bearing  
loans and borrowings
All interest-bearing loans and borrowings 
are initially recognised at cost, being the 
fair value of the consideration received  
net of upfront paid arrangement fees  
and other financing related costs.
After initial recognition, interest-bearing 
loans and borrowings are subsequently 
measured at amortised cost. Under the 
amortised cost method, the upfront paid 
arrangement fees and other financing 
related costs are recognised as finance 
expense over the term of the underlying 
loans or borrowings using the effective 
interest method.
3-19 Income tax
Income tax on profit or loss for the period 
comprises current and deferred tax. 
Income tax is recognised in the income 
statement except to the extent that it 
relates to items recognised directly in 
equity, in which case it is recognised  
in equity.
Current tax is the expected tax payable 
on taxable income for the period, using 
tax rates enacted or substantially enacted 
at the balance sheet date, and any 
adjustment to tax payable in respect  
of previous periods.
Deferred tax is provided using the 
balance sheet liability method, providing 
for temporary differences between the 
carrying amounts of assets and liabilities 
for financial reporting purposes and the 
amounts used for taxation purposes.
The following permanent differences  
are not provided for:
· Initial recognition of goodwill;
·  Initial recognition of assets or liabilities 
that affect neither accounting nor 
taxable profit;
·  Differences relating to investments  
in subsidiaries to the extent that 
they will probably not reverse in the 
foreseeable future.
The amount of deferred tax provided 
is based on the expected manner of 
realisation or settlement of the carrying 
amount of assets and liabilities, using tax 
rates enacted or substantively enacted at 
the balance sheet date.
A deferred tax asset is recognised only to 
the extent that it is probable that future 
taxable profits will be available against 
which the asset can be utilised. Deferred 
tax assets are reduced to the extent that  
it is no longer probable that the related 
tax benefit will be realised.
Additional income taxes that arise 
from the distribution of dividends are 
recognised at the same time as the 
liability to pay the related dividend.
3-20 Provisions
A provision is recognised in the balance 
sheet when the Group has a present 
legal or constructive obligation as a 
result of a past event, and it is probable 
that an outflow of economic benefits 
will be required to settle the obligation. 
If the effect is material, provisions are 
determined by discounting the expected 
future cash flows at a pre-tax rate that 
reflects current market assessments 
of the time value of money and, where 
appropriate, the risks specific to the 
liability. Recoveries from third parties, 
which are probable of realisation, are 
separately recorded, and are not offset 
against the related liability.
A provision for restructuring is recognised 
when the Group has approved a detailed 
and formal restructuring plan, and the 
restructuring has either commenced or 
has been announced publicly. Future 
operating costs are not provided for.
In accordance with the Group’s 
environmental policy and applicable 
legal requirements, a provision 
for site restoration in respect of 
contaminated land is recognised when 
the land is contaminated. Liabilities for 
environmental remediation resulting 
from past operations or events are 
recognised where an obligation to a third 
party is probable and the amount can 
be reasonably estimated. Measurement 
of liabilities is based on current legal 
requirements and existing technology. 
Liabilities are determined independently 
of expected recoveries. Such recoveries 
are recorded when realisation is  
virtually certain.
A provision for onerous contracts is 
recognised when the expected benefits 
to be derived by the Group from a 
contract are lower than the unavoidable 
cost of meeting its obligations under the 
contract and when such provision can be 
reasonably estimated.
3-21 Employee benefits
Defined contribution plans
Obligations for contributions to defined 
contribution pension plans are recognised 
as an expense in the income statement  
as incurred.
Defined benefit plans
The Group’s net obligation in respect of 
defined benefit pension plans is calculated 
separately for each plan by estimating the 
amount of future benefits that employees 
have earned in return for their service in 
the current and prior periods; that benefit 
is discounted to determine its present 
value, and the fair value of any plan assets 
is deducted. The discount rate is the yield 
at the balance sheet date on AAA credit 
rated bonds that have maturity dates 
approximating to the terms of the Group’s 
obligations. The calculation is performed 
by a qualified actuary using the projected 
unit credit method.
When the benefits of a plan are improved, 
the portion of the increased benefit 
relating to past service by employees is 
recognised as an expense in the income 
statement on a straight-line basis over 
the average period until the benefits 
become vested. To the extent that the 
benefits vest immediately, the expense 
is recognised immediately in the income 
statement.
Actuarial gains and losses that arise in 
calculating the Group’s obligation in 
respect of a plan, to the extent that any 
cumulative unrecognised actuarial gain 
or loss exceeds 10 % of the greater of 
the present value of the defined benefit 
obligation and the fair value of plan 
assets, are recognised in the income 
statement over the expected average 
remaining working lives of the employees 
participating in the plan. Otherwise, the 
actuarial gain or loss is not recognised.
Interest expense and expected return 
on plan assets included in net periodic 
pension cost are presented within finance 
expense. All other components of net 
periodic pension cost are presented in  
the respective functional cost.
Where the calculation results in a 
benefit to the Group, the recognised 
asset is limited to the net total of any 
unrecognised actuarial losses and past 
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service costs and the present value of any 
future refunds from the plan or reductions 
in future contributions to the plan.
In case of being a participant in a multi-
employer defined benefit pension plan, 
the Group accounts for such a plan as 
a defined benefit plan, or, if sufficient 
information is not available, as a defined 
contribution plan.
Long-term service benefits
The Group’s net obligation in respect  
of long-term service benefits, other than 
pension plans, is the amount of future 
benefits that employees have earned in 
return for their service in the current and 
prior periods. The obligation is calculated 
using the projected unit credit method 
and is discounted to its present value 
and the fair value of any related assets is 
deducted. The discount rate is the yield 
at the balance sheet date on AAA credit 
rated bonds that have maturity dates 
approximating to the terms of the  
Group’s obligations.
The individual components of net periodic 
cost related to these plans are presented 
in the same lines as net periodic pension 
cost related to defined benefit plans. 
3-22 Share-based payments 
and other compensation plans
Stock options and stock appreciation 
rights granted to employees on the stock 
of Royal Dutch Shell plc and BASF AG 
are measured at fair value at the end of 
each reporting period. The fair value of 
the options and rights at grant date is 
recognised as employee expense over 
the vesting period. Any change in the 
fair value of the stock options and stock 
appreciation rights is recognised as 
finance income or expense. The fair value 
of stock options and stock appreciation 
rights is calculated using the market price 
of the underlying shares and an option 
valuation model.
The fair value of equity instruments, 
including bonus shares granted to 
employees as part of their remuneration 
package are recognised as employee 
expenses over the period in which the 
services are provided.
3-23 Share capital and  
share premium
Share capital represents the value of 
issued shares at their nominal value. 
Any surplus value upon the issuance of 
shares is accounted for as Share premium. 
Incremental costs directly attributable 
to issue shares are recognised as a 
deduction from Other reserves.
3-24 Financial instruments
A financial instrument is recognised if the 
Group becomes a party to the contractual 
provisions of the instrument. Financial 
assets are derecognised if the Group’s 
contractual rights to the cash flows 
from the financial assets expire or if the 
Group transfers the financial asset to 
another party without retaining control or 
substantially all risks and rewards of the 
asset. Regular way purchases and sales of 
financial assets are accounted for at trade 
date, i.e. the date that the Group commits 
itself to purchase or sell the asset. 
Financial liabilities are derecognised  
if the Group’s obligations specified in  
the contract expire or are discharged  
or cancelled.
3-25 Derivative financial 
instruments and hedging 
activities
General
The Group uses derivative financial 
instruments principally in the 
management of its foreign currency, 
interest rate and commodity price risks 
(see note 34). The Group measures all 
derivative financial instruments based  
on fair values derived from market prices 
or a valuation model.
Fair value hedges
Where derivative financial instruments 
have been designated as a fair value 
hedge, gains or losses arising from 
changes in the fair value of the 
instruments are recognised in the income 
statement during the period in which they 
arise. To the extent that the derivative 
financial instruments have no hedging 
designation or are ineffective they are 
recognised in the income statement in 
the period in which they arise. The gains 
and losses on the designated derivatives 
substantially offset the gains and losses 
in the risks being hedged in the values 
of the recognised hedged items, which 
are recognised as gains and losses in the 
income statement. 
Cash flow hedges
Changes in the fair value of the derivative 
hedging instrument designated as a 
cash flow hedge are recognised directly 
in equity to the extent that the hedge 
is effective. To the extent the hedge 
is ineffective, changes in fair value are 
recognised in the income statement.
If the hedging instrument no longer meets 
the criteria for hedge accounting, expires 
or is sold, terminated or exercised, 
then hedge accounting is discontinued 
prospectively. The cumulative gain or loss 
previously recognised in equity remains 
until the forecasted transaction occurs.
Net Investment hedges
Changes in the fair value of derivative 
financial instruments that are effective 
and designated as a net investment 
hedge, are recorded in Other reserves 
within Equity.
Effectiveness and discontinuation  
of hedge accounting
If derivative financial instruments qualify 
and are designated as hedges, the 
Group formally assesses both at the 
hedge’s inception and on an ongoing 
basis, whether these derivative financial 
instruments are effective in offsetting 
changes in fair values, cash flows or 
investment values of the items being 
hedged. When it is determined that a 
derivative is not effective as a hedge or 
that it has ceased to be effective, the 
Group discontinues hedge accounting 
prospectively. 
When fair value hedge accounting is 
discontinued because it is determined 
that the derivative financial instrument no 
longer qualifies as an effective hedge, the 
Group continues to carry the derivative on 
the balance sheet at its fair value, and no 
longer adjusts the hedged asset or liability 
for changes in fair value. The fair value 
adjustment made to the hedged asset or 
liability is amortised over the remaining 
useful life, based on the recalculated 
effective interest rate.
When cash flow hedge accounting is 
discontinued because it is probable that a 
forecasted transaction will not occur, the 
Group continues to carry the derivative 
financial instrument on the balance sheet 
at its fair value, and gains and losses 
that were accumulated in Other reserves 
within Equity are recognised immediately 
to income.
When net investment hedge accounting 
is discontinued, due to divestment of 
an investment on which gains or losses 
were accumulated in Other reserves 
within Equity, the portion related to 
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the investment is taken to the income 
statement.
3-26 New standards  
and Interpretations  
not yet adopted
A number of new standards, amendments 
to standards and interpretations are 
not yet effective for the year ended 31 
December 2006, and have not been 
applied in preparing these consolidated 
financial statements:
·  IFRS 7 Financial Instruments: 
Disclosures and the Amendment to IAS 
1 Presentation of Financial Statements: 
Capital Disclosures require extensive 
disclosures about the significance of 
financial instruments for an entity’s 
financial position and performance, 
and qualitative and quantitative 
disclosures on the nature and extent 
of risks. IFRS 7 and amended IAS 1, 
which become mandatory for the 
Group’s 2007 financial statements, will 
require extensive additional disclosures 
with respect to the Group’s financial 
instruments and share capital.
·  IFRS 8 Operating Segments sets 
out requirements for disclosure 
of information about an entity’s 
operating segments and also about 
the entity’s products and services, 
the geographical areas in which they 
operate, and its major customers. IFRS 
8, which becomes mandatory for the 
Group’s 2009 financial statements,  
will require additional disclosures  
on these items.
·  IFRIC 7 Applying the Restatement 
Approach under IAS 29 Financial 
Reporting in Hyperinflationary 
Economies addresses the application of 
IAS 29 when an economy first becomes 
hyperinflationary and in particular 
the accounting for deferred tax. IFRIC 
7, which becomes mandatory for the 
Group’s 2007 financial statements, is 
not expected to have an impact on the 
consolidated financial statements.
·  IFRIC 8 Scope of IFRS 2 Share-based 
Payment addresses the accounting 
for share-based payment transactions 
in which some or all of goods or 
services received cannot be specifically 
identified. IFRIC 8 will become 
mandatory for the Group’s 2007 
financial statements, with retrospective 
application required. IFRIC 8 is not 
expected to have an impact on the 
consolidated financial statements.
·  IFRIC 9 Reassessment of Embedded 
Derivatives requires a reassessment  
of whether embedded derivative should 
be separated from the underlying host 
contract; it concludes that this should 
be made only when there are changes 
to the contract. IFRIC 9, which becomes 
mandatory for the Group’s 2007 
financial statements, is not expected 
to have an impact on the consolidated 
financial statements.
·  IFRIC 10 Interim Financial Reporting 
and Impairment prohibits the reversal 
of an impairment loss recognised in 
a previous interim period in respect 
of goodwill, an investment in an 
equity instrument or a financial 
asset carried at cost. IFRIC 10 will 
become mandatory for the Group’s 
2007 financial statements, and will 
apply to goodwill, investments in 
equity instruments, and financial 
assets carried at cost prospectively 
from the date of incorporation of the 
Company (20 April 2005). IFRIC 10 is 
not expected to have an impact on the 
consolidated financial statements.
·  IFRIC 11 IFRS 2 – Group and Treasury 
Share Transactions provides guidance 
in applying IFRS 2 Share-based 
Payment in three circumstances:
 –  Share-based payment involving  
an entity’s own equity instruments 
in which the entity chooses or is 
required to buy its own equity 
instruments (treasury shares) to  
settle the share-based payment 
obligation – is this an equity-settled 
or cash-settled transaction? 
 –  A parent grants rights to its equity 
instruments to employees of its 
subsidiary – how to account in 
the individual entities’ financial 
statements? 
 –  A subsidiary grants rights to equity 
instruments of its parent to its 
employees – how to account in 
the individual entities’ financial 
statements?
IFRIC 11 will become mandatory for the 
Group’s 2008 financial statements and  
is not expected to have an impact on  
the consolidated financial statements.
3-27 Interest rates
Basell applied the following interest rates during 2005 and 2006:
% 2006 2005
Discount rate for impairment testing property, plant & equipment  
using WACC (Weighted average cost of capital)
6.50 – 8.50 6.90
Non-current accounts receivable 5.50 – 7.00 5.25 – 7.00
Non-current payables and provisions 4.00 3.90
Decommissioning obligation 3.80 – 5.00 3.55 – 4.75
Capitalised borrowing costs 6.00 6.00
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4. Change in accounting 
policies and presentation
License revenue recognition
During 2006 the Group changed its 
accounting policy for licensing revenue 
recognition following changes in the 
licensing market and consequently the 
pattern of marketing Basell’s process 
technology licenses. The previous 
policy generally required that all fixed 
fees (usually described as lump-sums 
or down payments) defined by license 
contracts were recognised on a straight-
line basis as revenue over an eight-year 
period following the effective delivery 
of the license package, which period 
represented the average economic life of 
the license contracts. In the view of Basell 
management’s the old policy no longer 
represents the economic nature of Basell’s 
license contracts in the current market 
environment and therefore adopted a  
new policy. Under the new policy the 
Group performs a contract-by-contract 
analysis and determines if and when it  
has substantially ‘sold its product’. 
Licensing contracts for which the 
Company contractually is entitled to 
receive the vast majority of the contract 
value in cash at or before the customer’s 
license acceptance date, the Group 
will recognise the full contract value as 
revenue if all significant risks and rewards 
under the contract have been transferred 
to the licensee and the Group has no 
continuing managerial involvement. This 
relevant date is usually the delivery day 
of the process design packages. For other 
contracts involving a significant running 
royalty element or a longer contractual 
cash collection period, the Group will 
continue to recognise revenue pro-rata 
over the average economic life of such 
contracts, presently estimated at 10 years.
Following the change in the licensing 
revenue recognition, the amortisation 
of Intellectual property rights recorded 
under intangible assets (fair valued upon 
acquisition of the Basell group) had to be 
adjusted accordingly. The amortisation 
effect is included in ‘Cost of Sales’.
The change in accounting policy has been 
applied retrospectively in accordance 
with IAS 8. The assets acquired through 
the acquisition of the Basell group as at 
1 August 2005 have been adjusted to 
represent the new policy. Additionally,  
the comparative information presented  
in the income statement for the period  
20 April through 31 December 2005  
has been adjusted.
Presentation of interest component 
and expected return on plan assets  
of defined benefit costs
During 2006 Basell changed its 
presentation of the interest component 
and expected return on plan assets 
of defined benefit costs (‘the interest 
component’) related to pensions and other 
post-retirement benefits. The interest 
component previously included under cost 
of sales and operating expenses is now 
presented as finance expense.
The new classification follows market 
practise and reflects more appropriately 
the nature of the components of the 
defined benefit costs resulting from 
The effect on the income statement 2005 and 2006 is as follows:
€ MILLION 2006 2005 
(20 APR – 31 DEC)
Increase in revenue 58 37
Increase in cost of sales (20) (24)
Increase in operating profit 38 13
Decrease / (Increase) in finance expense 3 (1)
(Increase) in income tax expense (16) (5)
Increase in excess of fair value of identifiable assets, liabilities and contingent  
liabilities of acquired business over the cost of the acquisition
– 7
Increase in profit for the period 25 14
The effects on the balance sheet and equity as at 31 December are as follows:
€ MILLION 2006 2005
Decrease in intangible assets (62) (42)
Increase in working capital 125 64
Increase in deferred tax liability (24) (8)
Total change in net assets (equity) 39 14
Cumulative increase in equity recognised in previous periods 14 –
Increase in profit for the period 25 14
Total change in equity 39 14
the unwinding of the discount on the 
net present value of the defined benefit 
obligations and the expected return on 
plan assets.
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The amounts for each period as well as the income statement lines affected are as follows:
€ MILLION 2006 2005 
(20 APR – 31 DEC) 
Decrease in cost of sales 10 4
Decrease in selling expenses 2 1
Decrease in general and administrative expenses 3 1
Decrease in research and development expenses 2 1
Increase in operating profit 17 7
(Increase) in finance expense (17) (7)
Pensions 10 4
Other post-retirement benefits 7 3
Total 17 7
5. Fair valuation of acquired 
assets, liabilities and 
contingent liabilities
Acquisitions described in notes 6 
(regarding 2005) and 9 (regarding 2006) 
are considered business combinations 
and therefore purchase price allocations 
(‘PPA’) according to IFRS 3 Business 
Combinations have been made. As a 
result the fair value of all identifiable 
assets and (contingent) liabilities had to 
be determined. The term ‘fair value’ is 
defined as the amount at which an asset 
could be exchanged, or a liability settled, 
between knowledgeable, willing parties,  
in an arm’s length transaction. 
The selection of the valuation method 
for each asset depends on the facts and 
circumstances relating to the specific 
assets. In determining fair values there 
are different conceptual approaches that 
can be applied according to the following 
priority: firstly the market approach, 
secondly the income approach or the 
cost approach. By applying the income 
approach, the information in determining 
the fair values is being derived from the 
most recent, applicable and approved 
management’s five year business plan.
The fair value of property, plant & 
equipment was determined based  
on the following valuation hierarchy:
·  Market approach, wherever a market 
value was available.
·  Cost approach, representing the 
depreciated replacement costs 
determined by an external appraiser. 
However, where indications existed 
that the depreciated replacement costs 
exceeded the discounted future cash 
flows, the lower discounted future cash 
flow value has been determined and 
selected.
The valuation of intellectual property 
rights was determined as follows:
·  The fair value of the licensed 
technology was assessed by using the 
income approach, which calculates 
discounted cash flow values over the 
remaining economic lives based on 
existing contracts as well as expected 
future sales of licenses.
·  The fair value of the catalyst business 
was assessed by using the income 
approach based on existing catalyst 
sales contracts and customer 
relationships.
The valuation of investments in 
associates and joint ventures  
followed the following criteria:
·  Market approach, wherever a  
market value was available.
· The income approach.
·  The cost approach (current cost to 
purchase or to replace the asset) has 
been applied in cases where neither 
market approach nor application of  
the income approach was appropriate.
Inventories of finished goods were 
valued at expected selling prices less the 
costs of disposal and a reasonable profit 
margin for the selling effort. Inventories 
of raw materials are valued at current 
replacement costs.
Defined benefit plans are valued using 
the present value of the obligation less 
the fair value of any plan assets. The key 
assumptions used for the fair valuation 
are disclosed in note 21.
Contingent liabilities are recognised at 
fair value based on the exposure at time 
of the acquisition taking into account the 
probability of future cash outflows.
Government grants received prior to 
acquisition as well as deferred income 
related to cash flows prior to acquisition 
do not carry any fair value.
In situations where a Group company is 
engaged in third party purchase contracts 
for raw materials which have unfavourable 
pricing compared to industry standards, 
a provision for unfavourable contracts 
has been recognised based on discounted 
future cash flows representing the 
difference between the contracted 
purchase price and a purchase price 
following the industry standard.
Interest-bearing loans and 
borrowings with a fixed interest rate 
have been valued based on interest rates 
applicable to similar loans and borrowings 
at the date of acquisition.
Fair values determined upon acquisitions 
are treated as deemed costs thereafter, 
with the exception of derivative financial 
instruments, financial instruments held 
for trading, and financial instruments 
classified as available-for-sale.
Assets or liabilities not described above 
are primarily recognised in accordance 
with the Group’s regular accounting 
policies set out in note 3 of this 
document.
Certain of the above mentioned fair values 
of assets and (contingent) liabilities are 
provisional estimates based on best 
information available at the time of 
determining those values. IFRS 3 allows 
adjustments to this provisional accounting 
within a timeframe of 12 months after 
acquisition if it can be demonstrated 
that new information does provide better 
evidence about the fair value of any asset 
or (contingent) liability at the date of 
acquisition.
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6. Changes in provisional accounting for business combinations 2005
During 2005 the company directly or indirectly acquired shares in the following companies:
TRANSACTION ACQUISITION DATE SHARES ACQUIRED DIRECT INTEREST POST-
ACQUISITION
Former Basell group 1 August 100.00 % 100.00 %
Petroken Petroquimica Ensenada S.A. 1 September 50.00 % 100.00 %
Basell Brasil Participaçoes Ltda. 1 September 50.00 % 100.00 %
Société du Craqueur de l’Aubette S.A.S. 29 December 50.00 % 100.00 %
This provisional accounting was adjusted 
for new information obtained within 
a timeframe of 12 months after the 
acquisition date. These adjustments to the 
fair value determined in the provisional 
purchase price allocations are not treated 
as movements for the year 2006, but as a 
change to the comparative numbers as at 
31 December 2005.
The following table shows a (condensed) 
reconciliation of significant line items in 
the Consolidated Financial Statements for 
the period 20 April 2005 to 31 December 
2005 and the comparative numbers 
used in these Consolidated Financial 
Statements.
These acquisitions qualify as Business 
Combinations in accordance with IFRS 3. 
The fair values of the assets, liabilities 
and contingent liabilities acquired, as 
included in the Consolidated Financial 
Statements for the period 20 April 2005 
to 31 December 2005, were determined 
based on all information available at the 
acquisition date (‘provisional accounting’).
€ MILLION CONSOLIDATED 
FINANCIAL 
STATEMENTS 31-
DEC 2005 (ISSUED)
FAIR VALUE 
ADJUSTMENTS
ADJUSTMENTS 
DUE TO CHANGE 
IN ACCOUNTING 
POLICY IN 2006
COMPARATIVE 
FINANCIAL 
STATEMENTS 
31-DEC 2005 
(ADJUSTED)
ASSETS
Property, plant and equipment 2,554 10 – 2,564
Intangible assets including goodwill 589 (6) (42) 541
Investments in associates and  
joint ventures
585 – – 585
Other non-current assets 160 12 (1) 171
Total non-current assets 3,888 16 (43) 3,861
Inventories 1,001 1 – 1,002
Trade receivables 1,402 2 74 1,478
Other current assets 298 1 – 299
Cash and cash equivalents 590 – – 590
Total current assets 3,291 4 74 3,369
Total assets 7,179 20 31 7,230
Equity 944 40 14 998
LIABILITIES
Interest-bearing loans and borrowings 2,745 – – 2,745
Employee benefits 509 – – 509
Deferred income 27 – 9 36
Deferred tax liabilities 296 9 8 313
Provisions 333 (28) – 305
Other non-current liabilities 27 – – 27
Total non-current liabilities 3,937 (19) 17 3,935
Total current liabilities 2,298 (1) – 2,297
Total liabilities 6,235 (20) 17 6,232
Total equity and liabilities 7,179 20 31 7,230
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The main fair value adjustments are 
explained below:
The acquisition accounting for Basell 
Brasil Participaçoes Ltda. and Petroken 
Petroquimica Ensenada SA was finalised 
during the third quarter resulting in an 
increase of property, plant and equipment 
of €12 million and a corresponding 
increase of negative goodwill.
Part of the purchase price consideration 
for Société du Craqueur de l’Aubette 
S.A.S. (‘SCA’) is contingent on the 
operating performance in the period 2006 
– 2008 (‘earn-out’). The payment of the 
earn-out is not due until the beginning 
of 2009. The initial 2005 estimate of the 
contingent purchase price of €95 million 
was adjusted in December 2006 based 
on current business plan assumptions. 
Accordingly the cost of the acquisition 
and hence goodwill in the 2005 
comparative figures were reduced  
by €30 million.
New information allowed the Company 
to increase the value of the Intellectual 
Property Rights (included in intangible 
assets including goodwill) acquired  
as of 1 August 2005 by €23 million
Further insight into new US legislation 
regarding other post retirement benefits 
(see note 21) allowed Basell to recognise a 
non-current other employee benefit asset 
of €7 million. Furthermore a favourable 
settlement of a claim affecting one of 
Basell’s associates was reached during 
2006, allowing for an increase of €5 
million of the fair value of the group’s 
loan (included in ‘other non-current 
assets’) to the associate.
7. Specials
Apart from the results of Basell’s regular business operations, the profit for the year 2006 was impacted by a number of special items. 
€ MILLION 2006 BEFORE 
ADJUSTMENTS 
FOR SPECIALS
2006 
SPECIAL 
ITEMS
2006 AFTER 
ADJUSTMENTS 
FOR SPECIALS
Revenue 10,495 – 10,495
Cost of sales (a) (9,388) 16 (9,372)
Gross profit 1,107 16 1,123
Other income (b) 66 (61) 5
Selling expenses (a) (155) 1 (154)
General and administrative expenses (a) (240) 12 (228)
Research and development expenses (103) – (103)
Other expenses (c) (56) 56 –
Operating profit before finance costs 619 24 643
Finance income 35 – 35
Finance expense (273) – (273)
Net finance costs (238) – (238)
Net results from associates and joint ventures  
accounted for under the equity method (d)
102 (17) 85
Profit before tax 483 7 490
a) Redundancy costs
During the year 2006 the Group incurred 
further costs related to redundancy 
programmes in Europe and North America 
(see note 24).
b) Other income
Basell recognised a €10 million a gain 
on the sale of Components business 
and Custom Catalysts assets (see note 
30) as well as a €12 million gain from 
restructuring certain Asian entities (see 
notes 9 and 30). In addition €37 million  
of receivables related to a property 
damage insurance claim were recognised 
(see note 30).
c) Other expense
Other expenses include impairment  
losses of €56 million (see notes 11,  
12, 24 and 31). 
d) Dilution gain
The issue of new shares by HMC  
resulted in a dilution gain of €17 million 
(see notes 9 and 30). 
The income tax consequences of these 
special items amount to tax expenses 
of €7 million. In addition a temporary 
difference on $-bonds was eliminated in 
the Netherlands resulting in a tax benefit 
of €23 million (see note 33), which was 
largely off-set by the income tax expense 
resulting from the write off of the net 
deferred tax asset in France (€19 million).
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8. Events after the balance 
sheet date
North American post retirement 
benefit plans
In February 2007 Basell management 
in North America communicated to 
employees affected its decision to align 
existing post-retirement benefit plans 
in the United States and Canada with 
prevailing terms & conditions commonly 
adopted in the relevant market place. The 
announced changes will affect all present 
plans (see note 21) and reduce the risk 
exposure of Basell’s legal entities in North 
America in connection with its defined 
benefit plans. At the same time certain 
conditions under existing or newly opened 
defined contribution plans are expanded. 
The most significant changes are:
·  No additional benefits under existing 
defined benefit retirement plans can be 
earned after 31 December 2007.
·  Existing defined contribution retirement 
plans will be transferred to new 
extended defined contribution schemes 
as at 1 January 2008 and employees 
will be automatically enrolled in these 
plans. Under such new plans Basell’s 
contribution will be expanded.
·  Benefits provided under existing 
defined benefit post-retirement health 
care plans will be capped and higher 
deductibles applied starting 1 January 
2008 (Canada: 1 July 2007) effecting 
both active employees and retirees. 
These changes in the employee benefit 
schemes will have a significant impact 
on the Group’s consolidated financial 
statements in 2007 and future years. 
Relocation of North American 
regional headquarter
During January 2007 Basell management 
in North America communicated to its 
employees management’s decision to 
relocate its North American regional 
headquarters in Elkton, Maryland/USA, 
within the region. In connection with 
this relocation Basell will also reorganise 
its service functions currently located 
in Elkton. The overall financial impact 
of these measures is expected not to 
significantly impact the Group’s financial 
statements.
9. Acquisitions/disposals 2006
The fair values of the acquired assets and (contingent) liabilities below are considered final unless indicated.
Acquisition of Polymerisation Catalyst & Components business, USA
On 31 March 2006, the Group acquired Akzo Nobel’s Polymerisation Catalyst & Components business. The business includes catalyst 
manufacturing and other assets in Edison, New Jersey, USA. The fair values of the acquired assets and (contingent) liabilities are as 
follows:
€ MILLION FAIR VALUE
Property, plant and equipment (provisional) 25
Total non-current assets 25
Inventories 9
Trade and other receivables 2
Total current assets 11
Total assets 36
Trade and other payables 1
Employee benefits 2
Total current liabilities 3
Total liabilities 3
Net assets acquired 33
Purchase price (33)
Goodwill –
Disposal of Components business 
and Custom Catalyst assets, USA
On 2 June 2006, Basell completed the 
sale of the Components business and 
Custom Catalyst assets located at Edison, 
New Jersey USA to W.R. Grace for a total 
amount of $20 million, including $4 
million of working capital. The resulting 
gain amounted to €10 million (see  
note 30).
Restructuring of certain Asian entities
Basell announced on 24 July 2006 that it had 
agreed to sell its subsidiary Basell Taiwan 
Holdings B.V. to Lee Chang Yung Chemical 
Industry Corporation of Taiwan, a leading global 
thermoplastic elastomer manufacturer. The  
sole activity of this subsidiary was holding a  
36 % interest in Taiwan Polypropylene Co. Ltd. 
(‘TPP’). The sale was completed early September 
2006 and resulted in a gain on disposal of  
€4 million which is included in the income 
statement as ‘Other income’.
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In conjunction with this disposal the Group acquired additional interests held by TPP in three joint ventures. The effect on the Group’s 
share in these entities is summarised in the following table:
€ MILLION DIRECT 
INTEREST 
PRE-ACQUISITION/
(IN-) DIRECT 
INTEREST 
PRE-ACQUISITION
(IN-) DIRECT 
INTEREST 
POST-ACQUISITION
SunAllomer Ltd., Japan 33.33 % 39.33 % 50.00 %
PolyMirae Co. Ltd., South Korea 25.18 % 34.61 % 42.59 %
HMC Polymers Company Ltd., Thailand 41.46 % 43.33 % 46.64 %
The combined purchase price paid for these acquisitions exceeded the fair value of the net-assets acquired. 
€ MILLION
Total cash consideration 44
Of which related to shareholding previously indirectly owned via TPP (16)
Cash consideration regarding increase in shareholding (now directly owned) 28
Fair value of share in net assets acquired 24
Goodwill 4
After the acquisition of the additional 
interest in HMC, PTT Public Company 
Limited (‘PTT’), a listed natural resource 
company of Thailand, acquired a 40.00 %  
share in HMC through the purchase of 
newly issued and existing shares. As 
a consequence, the Group’s (indirect) 
share in HMC was reduced from 46.64 % 
to 30.77 %. The financial impact of the 
share dilution in HMC amounted to a €17 
million gain. Subsequently, Basell divested 
a further 2.21 % interest (to 28.56 %) in 
HMC to PTT which resulted in a gain on 
disposal of €8 million, which is included 
in Other income.
Acquisition of naphtha cracker 
business in Münchsmünster, 
Germany
On 29 December 2006, the Company’s 
German subsidiary Basell Polyolefine 
GmbH acquired the Münchsmünster 
cracker business from Ruhr Öl GmbH, 
Deutsche BP AG and BP Gelsenkirchen 
GmbH (‘sellers’). The business includes  
a twin-train cracker, land, pipelines  
and shares in associated companies.  
As the transaction was completed just 
before year-end it did not contribute  
any revenues or net income in 2006.
The total purchase price consideration 
was €64 million. This includes €36 
million of contingent consideration Basell 
currently expects to pay. Payment will 
depend on the sellers ensuring the supply 
of certain feedstock volumes and quality 
from their refineries for a period of up to 
ten years after the acquisition date. €45 
million of the total purchase price was 
paid at the acquisition date (including an 
up-front payment of part of the contingent 
consideration of €17 million).
The fair values of the acquired assets and liabilities compared to the cost of the acquisition are as followed:
€ MILLION FAIR VALUE
Property, plant and equipment (provisional) 62
Intangible assets 1
Available-for-sale financial assets 7
Total non-current assets 70
Inventories 7
Total assets 77
Employee benefits 7
Deferred tax liabilities 1
Provisions 1
Total non-current liabilities 9
Trade and other payables 3
Total liabilities 12
Net assets acquired 65
Total purchase price consideration 64
Excess of fair value of identifiable assets, liabilities and contingent liabilities  
of acquired business over the cost of the acquisition
1
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10. Segment reporting
Primary segment information 2006
€ MILLION POLYOLEFINS ADVANCED 
POLYOLEFINS
TECHNOLOGY OTHER ELIMINATIONS 
/UNALLOCATED
CONSOLIDATED
External revenue 8,704 1,517 274 – – 10,495
Inter-segment revenue 391 19 95 – (505) –
Total revenue 9,095 1,536 369 – (505) 10,495
Depreciation and 
amortisation
(210) (43) (102) – – (355)
Impairment of  
non-current assets
(56) – – – – (56)
Operating result 401 110 104 4 – 619
Net results from 
associates and joint 
ventures accounted for 
under the equity method
97 5 – – – 102
Net financing costs – – – – (238) (238)
Income tax expenses – – – – (207) (207)
Excess of fair value 
of identifiable assets, 
(contingent) liabilities of 
acquired business over 
the cost of the acquisition
– – – – 1 1
Profit for the period 498 115 104 4 (444) 277
Capital expenditure 
of property, plant & 
equipment
166 18 19 6 – 209
SEGMENTS ASSETS
OF WHICH
Property, plant  
and equipment
1,881 457 187 2 (1) 2,526
Intangible assets 2 – 400 15 – 417
Investments in associates 
and joint ventures
739 61 2 – – 802
Other investments 6 7 – – – 13
Available-for-sale  
financial assets
43 – – 2 – 45
Receivables and 
inventories
1,916 485 167 – (1) 2,567
Unallocated assets – – – – 1,057 1,057
Total assets 4,587 1,010 756 19 1,055 7,427
SEGMENT LIABILITIES 
OF WHICH
Trade payables 1,005 98 20 – – 1,123
Deferred income – – 90 – – 90
Non-current provisions 238 – – – 51 289
Unallocated liabilities – – – – 4,655 4,655
Total liabilities 1,243 98 110 – 4,706 6,157
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Primary segment information 2005 (20 April – 31 December)
€ MILLION POLYOLEFINS ADVANCED 
POLYOLEFINS
TECHNOLOGY OTHER ELIMINATIONS 
/UNALLOCATED
CONSOLIDATED
External revenue 3,097 550 122 – – 3,769
Inter-segment revenue 132 5 41 – (178) –
Total revenue 3,229 555 163 – (178) 3,769
Depreciation and 
amortisation
(68) (19) (54) – – (141)
Impairment of  
non-current assets
(40) – – – – (40)
Operating result 109 (6) 10 (33) – 80
Net results from 
associates and joint 
ventures accounted for 
under the equity method
23 2 – – – 25
Net financing costs – – – – (112) (112)
Income tax benefit – – – – 2 2
Excess of fair value 
of identifiable assets, 
(contingent) liabilities of 
acquired business over 
the cost of the acquisition
– – – – 139 139
Profit for the period 132 (4) 10 (33) 29 134
Capital expenditure 
of property, plant & 
equipment
76 19 13 1 – 109
SEGMENTS ASSETS
OF WHICH
Property, plant  
and equipment
1,865 505 188 6 – 2,564
Intangible assets 38 – 480 23 – 541
Investments in associates 
and joint ventures
524 60 1 – – 585
Other investments 10 – – – – 10
Available-for-sale  
financial assets
36 – – 5 – 41
Receivables and 
inventories
1,833 448 204 – (5) 2,480
Unallocated assets – – – – 1,009 1,009
Total assets 4,306 1,013 873 34 1,004 7,230
SEGMENT LIABILITIES  
OF WHICH
Trade payables 940 105 17 – 3 1,065
Deferred income – – 36 – – 36
Non-current provisions 206 – – – – 206
Unallocated liabilities – – – – 4,925 4,925
Total liabilities 1,146 105 53 – 4,928 6,232
In both years presented, the unallocated assets relate to Deferred charges, Other financial assets, Deferred tax assets,  
Receivables from tax authorities, Other receivables, Prepayments and Cash and cash equivalents.
The unallocated liabilities relate to Interest-bearing loans and borrowings, Employee benefits, Deferred tax liabilities,  
certain Provisions, Other non-current liabilities, Other payables, Payables to tax authorities and Accrued liabilities.
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Secondary segment information 2006
€ MILLION EUROPE NORTH AMERICA INTERNATIONAL ELIMINATIONS 
/UNALLOCATED
CONSOLIDATED
Revenue 8,210 1,716 945 (376) 10,495
Segment assets 4,072 888 951 1,516 7,427
Capital expenditure 156 14 39 – 209
Secondary segment information 2005
€ MILLION EUROPE NORTH AMERICA INTERNATIONAL ELIMINATIONS 
/UNALLOCATED
CONSOLIDATED
Revenue 2,702 655 412 – 3,769
Segment assets 4,525 975 737 993 7,230
Capital expenditure 74 6 29 – 109
11. Property, plant and equipment
MOVEMENTS IN 2006 
(€ MILLION)
LAND AND 
BUILDINGS
PLANT AND 
EQUIPMENT
CONSTRUCTION 
IN PROGRESS
TOTAL
BALANCE AT 1 JANUARY 2006 302 2,085 177 2,564
Acquisition through business combinations 18 68 1 87
Additions 3 4 197 204
Transfers 24 238 (262) –
Depreciation charge for the year (13) (247) – (260)
Impairments – (22) – (22)
Disposals and other movements (4) 9 (5) –
Currency exchange adjustments (5) (39) (3) (47)
At 31 December 2006, net  
of accumulated depreciation  
and impairment
325 2,096 105 2,526
AT 31 DECEMBER 2006
Gross carrying amount 345 2,444 105 2,894
Accumulated depreciation and impairment (20) (348) – (368)
Net carrying amount 325 2,096 105 2,526
Property, plant and equipment 
acquisitions through business 
combinations relate to the acquisition  
of Akzo Nobel’s Polymerisation Catalyst  
& Components business in Edison,  
New Jersey, USA in March 2006 and  
the acquisition of the cracker business  
in Münchsmünster, Germany, on  
29 December 2006.
Impairment charges relate to SCA’s 
cracker (note 24) and the polypropylene 
plant in Sarnia, Canada. At current 
exchange rates between the US $ and 
Canadian $ and existing feedstock 
supply contracts the Sarnia plant was not 
competitive in 2006. With little changes 
expected until the end of the plant’s 
useful life in December 2007 the carrying 
amount of €6 million was determined not 
to be recoverable.
Disposals and other movements of land 
and buildings relate to land owned in 
Camperdown, Scotland which was sold 
in August 2006 (€3 million) and an office 
building in Lansing, USA which was sold  
in December 2006 (€4 million).
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MOVEMENTS IN 2005 
(€ MILLION)
LAND AND 
BUILDINGS
PLANT AND 
EQUIPMENT
CONSTRUCTION 
IN PROGRESS
TOTAL
Balance at 20 April 2005 – – – –
Acquisition of former Basell group 304 1,816 166 2,286
Acquisition of subsidiaries (see note 6) 1 264 10 275
Additions – 1 107 108
Transfers 3 103 (106) –
Depreciation charge for the year (6) (84) – (90)
Impairments (1) (18) – (19)
Currency exchange adjustments 1 3 – 4
At 31 December 2005, net of 
accumulated depreciation and 
impairment
302 2,085 177 2,564
AT 31 DECEMBER 2005
Gross carrying amount 309 2,188 177 2,674
Accumulated depreciation and impairment (7) (103) – (110)
Net carrying amount 302 2,085 177 2,564
In September 2005, Basell management decided to discontinue the cracker expansion project in Wesseling, Germany.  
The capitalised project costs of €12 million have been written-off.
As a consequence of an explosion on 10 December 2005 in the Group’s polyethylene plant in Münchsmünster, Germany,  
plant assets of €7 million were impaired.
12. Intangible assets
MOVEMENTS IN 2006 
(€ MILLION)
INTELLECTUAL 
PROPERTY 
RIGHTS
DEVELOPMENT 
COSTS
SOFTWARE GOODWILL OTHER TOTAL
BALANCE AT  
1 JANUARY 2006
471 9 23 34 4 541
Additions – 2 5 – – 7
Amortisation (81) (1) (13) – – (95)
Impairment – – – (34) – (34)
Disposals and  
other movements
– – – – (2) (2)
At 31 December 2006, 
net of accumulated 
amortisation and 
impairment
390 10 15 – 2 417
AT 31 DECEMBER 2006
Gross carrying amount 521 11 23 34 2 591
Accumulated 
amortisation and 
impairment
(131) (1) (8) (34) – (174)
Net carrying amount 390 10 15 – 2 417
The intellectual property rights mainly reflect proprietary technologies (Spheripol, Spherizone, Hostalen, Spherilene, Lupotech T and 
Lupotech G) licensed by the Group and developed catalyst product families sold to the market. These values have been determined 
upon acquisition of the Basell group as described in note 4.
The capital expenditures for development costs, which are included in intellectual property rights, are related to the ‘Continuous 
Titanation’ and Polybutene projects.
The capital expenditures for software primarily reflect the development and further roll-out of the Group’s common SAP ERP platform.
The impairment of goodwill relates to the goodwill acquired as part of the 2005 acquisition of SCA (see note 24).
Amortisation of intangible assets is included in Cost of sales, with the exception of amortisation of Development costs, which  
is included in Research and development expenses.
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MOVEMENTS IN 2005  
(€ MILLION)
INTELLECTUAL 
PROPERTY 
RIGHTS
DEVELOPMENT 
COSTS
SOFTWARE GOODWILL OTHER TOTAL
BALANCE AT  
20 APRIL 2005
– – – – – –
Acquisition of former 
Basell group
517 9 27 – 25 578
Acquisition of 
subsidiaries
– – – 55 – 55
Additions – – 1 – – 1
Amortisation (46) – (5) – – (51)
Impairment – – – (21) – (21)
Disposals and other 
movements
– – – – (21) (21)
At 31 December 2005, 
net of accumulated 
amortisation and 
impairment
471 9 23 34 4 541
AT 31 DECEMBER 2005
Gross carrying amount 517 9 28 55 4 613
Accumulated amortisation 
and impairment
(46) – (5) (21) – (72)
Net carrying amount 471 9 23 34 4 541
Goodwill acquired relates to the acquisition of the remaining 50 % of the shares of SCA on 30 December 2005. As the cost of the 
acquisition exceeded the fair value of the acquired interest, an impairment charge of €21 million has been recorded. The impairment 
charge was offset by an increase of the deferred tax asset on losses carried forward in the French tax group of €28 million following 
this acquisition.
13. Investments in associates and joint ventures
A list of significant investments in associated companies and joint ventures as held by the Group’s companies is included  
in Appendix A. The movements in investments in associates and joint ventures are as follows:
€ MILLION 2006 2005
Balance at 1 January (2005: 20 April) 585 –
Acquisition of former Basell group – 700
Share in net result 86 25
Dilution gain 17 –
Dividends received (33) (27)
Additions 222 15
Disposals (39) –
Effect of full consolidation of Petroken Petroquimica Ensenada S.A.  
as of 1 September 2005
– (47)
Effect of full consolidation of Société du Craqueur de l’Aubette S.A.S.  
as of 30 December 2005
– (96)
Change in unrealised gain for securities available-for-sale – 1
Change in the fair value of the cash flow hedge – 1
Currency exchange effects (36) 13
At 31 December 802 585
The dilution gain of €17 million relates to the shareholding in HMC, following the issuance of shares by HMC to PTT, where the 
issuance value exceeded the equity value.
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The additions reflect:
·  Basell’s investment made of €128 million into the newly formed joint venture Saudi Ethylene & Polyethylene Company Ltd.  
in Saudi Arabia in the second quarter 2006.
·  The investment of €66 million made into the newly formed joint venture Al-Waha Petrochemicals Ltd. in Saudi-Arabia during  
the second half year of 2006.
·  The acquisition of shares in SunAllomer Ltd. (Japan), PolyMirae Co. Ltd. (South Korea) and HMC Polymers Co. Ltd. (Thailand) 
previously owned by Taiwan Polypropylene Co. Ltd. (Taiwan) for a total amount of €28 million.
The disposal relates to the sale of Basell Taiwan Holdings B.V., which was holding a 36 % interest in Taiwan Polypropylene Co. Ltd.
A summarised statement of assets and liabilities as at 31 December of the associated companies and joint ventures accounted  
for under the equity method, and the Group’s share thereof, is set out below:
€ MILLION ASSOCIATES AND JOINT VENTURES  
ASSETS AND LIABILITIES
GROUP’S SHARE
2006 2005 2006 2005
Non-current assets 2,461 1,795 848 689
Current assets 1,385 1,044 523 415
Total assets 3,846 2,839 1,371 1,104
Non-current liabilities 742 720 272 275
Current liabilities 695 596 297 244
Net assets 2,409 1,523 802 585
A summarised income statement, for the year 1 January through 31 December 2006 (2005: 20 April through 31 December), for 
associated companies and joint ventures accounted for under the equity method, and the Group’s share thereof for the periods for 
which the respective companies have been accounted for by the Group as associates and joint ventures accounted for under the equity 
method, is set out below:
€ MILLION ASSOCIATES AND JOINT  
VENTURES RESULTS
GROUP’S SHARE
2006 2005 2006 2005
Revenue 3,153 1,484 1,284 617
Cost of sales (2,752) (1,356) (1,135) (571)
Gross profit 401 128 149 46
Net operating expenses (95) (44) (39) (18)
Operating profit before finance costs 306 84 110 28
Finance income 12 18 4 8
Finance expense (32) (16) (13) (6)
Net results from associates  
and joint ventures
34 4 11 2
Profit before taxation 320 90 112 32
Income tax expense (70) (20) (26) (7)
Profit for the period 250 70 86 25
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14. Available-for-sale financial assets
The investments of Group companies in German limited partnerships with a limited company as general partner have been classified  
as available-for-sale financial assets based on IAS 32/39 and amounted to €43 million as at 31 December 2006 (2005: €36 million).
The Group owns shares in Royal Dutch Shell plc and BASF AG in relation to former management compensation schemes.  
These shares are recorded at a fair value of €2 million as at 31 December 2006 (2005: €5 million).
15. Inventories
€ MILLION 31 DEC 2006 31 DEC 2005
Finished goods 777 775
Raw materials and supplies 236 224
Work in process 3 3
Total 1,016 1,002
Allowances to adjust inventories to net realisable value are deducted from inventories and charged to Cost of sales, and amounted  
to €7 million (2005: €6 million).
16. Trade receivables
€ MILLION 31 DEC 2006 31 DEC 2005
Trade receivables 1,417 1,343
Amounts owed by associates and joint ventures 115 82
Receivables from licensing activities 68 112
1,600 1,537
Allowance for doubtful accounts (of which related to licensing receivables €5 million) 
(2005: €5 million)
(49) (59)
Total 1,551 1,478
Under the European receivables securitisation programme, receivables for an amount of €431 million (2005: €377 million) were 
sold. Receivables for an amount of $167 million (2005: $163 million) were sold under the North American receivables securitisation 
programme. Due to the fact that Basell acts as collection agent and is retaining the majority of the credit and currency risks, the 
securitisation programmes do not qualify for de-recognition in compliance with IAS 39, the Group continues to recognise receivables 
under both programmes. The associated liability is recognised under current liabilities.
17. Other receivables
€ MILLION 31 DEC 2006 31 DEC 2005
Receivable from insurance companies (see note 30) 62 16
Environmental indemnity from previous shareholder of Basell Group (see note 24) 30 23
CO2 emission rights 24 21
Fair value of derivative instruments (see note 34) 14 18
Receivable from the sale of assets 1 5
Other receivables 30 33
Total 161 116 
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19. Issued capital and reserves
At 1 August 2005, the issued and paid-up capital of the Company amounted to 403,226 shares (with common voting rights) of  
€124 each, totalling €50 million. Upon incorporation of the Company, its shareholder BI S.à r.l., contributed €860 million worth  
of net assets to the Company. The excess over the issued and paid-up capital was accounted for as share premium and amounted  
to €810 million.
The acquisition of additional shares of certain Asian entities (see note 9) was treated as a step-acquisition. Basell fully fair valued the 
underlying net assets of its total investment at the date of the transaction. Basell’s share in the fair value uplift of the investment’s 
inventory amounted to €2 million, which was credited directly to the revaluation reserve within equity at the transaction date. As  
the related inventory was fully sold as per 31 December 2006, the €2 million revaluation reserve was realised and transferred to 
retained earnings.
Other reserves changed as followed:
€ MILLION TRANSLATION 
RESERVE
HEDGING 
RESERVE
FAIR VALUE 
RESERVE
CAPITAL 
CONTRIBUTION
TOTAL
Balance at  
20 April 2005
– – – – –
Change during  
the year
3 4 1 (4) 4
Balance at  
31 December 2005 
3 4 1 (4) 4
Change during  
the year
(19) 12 – – (7)
Balance at  
31 December 2006
(16) 16 1 (4) (3)
Transactions recorded in other reserves are recognised net-of-tax. In 2006 no tax effect resulted from exchange differences  
on translation of foreign operations (2005: €2 million).
Translation reserve
The translation reserve comprises all foreign currency differences arising from the translation of the financial statement of  
foreign operations as well as from the translation of liabilities that hedge the Company’s net investments in foreign subsidiaries.  
The translation reserve is inclusive of the effects of the net investment hedges as further described in note 34.
Hedging reserve
The hedging reserve comprises the effective portion of the cumulative net change in the fair value of cash flow hedging instruments 
related to hedged transactions that have not yet occurred.
Under the Senior Facility Agreement and 
the Italian Facility Agreement, the Group is 
obliged to deposit certain proceeds from 
disposals and certain insurance proceeds 
into designated bank accounts. The Group 
can use such proceeds only to carry out 
certain acquisitions, capital expenditures 
and debt repayment in the 12 month 
period following the deposit. Afterwards 
the unused amounts are applied to 
mandatory repayment of the debt.
In 2005 the Group deposited on such 
accounts the proceeds from the sale 
of the 100 % subsidiary Basell Brasil 
Poliolefinas Ltda. (Brazil). The total 
amount on such bank accounts at  
31 December 2005 was €199 million. 
In 2006 further disposals took place 
such as the disposal of the Components 
Business and Custom Catalyst assets  
and the disposal of the participations  
of Basell in HMC and TPP in the frame  
of the restructuring of certain Asia  
entities (see note 9).
The proceeds from sales and the 
outstanding funds were used for 
investments into the two newly founded 
joint ventures in Saudi Arabia and the 
purchase of participations in SunAllomer 
Co. Ltd. and PolyMirae Co. Ltd. As of 31 
December 2006, the balance outstanding 
on such designated bank accounts 
amounted to €28 million.
Short-term deposits were placed for 
periods less than 1 month.
An amount of $17 million of cash on bank 
accounts is pledged as stand-by equity for 
associated companies.
18. Cash and cash equivalents
€ MILLION 31 DEC 2006 31 DEC 2005
Cash 288 303
Short-term deposits 382 287
Total 670 590
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Fair value reserve
The fair value reserve comprises the cumulative net change in the fair value of available-for-sale financial assets until the investment  
is derecognised.
Capital contribution
Following the contribution of equity in Basell Holdings B.V., a tax assessment for capital tax duty was received for an amount of  
€4 million, which was recorded in Other reserves in 2005. Basell Holdings B.V. is contesting the assessment and to the extent the 
outcome is favourable the amount will be reversed.
20. Interest-bearing loans and borrowings
€ MILLION 31 DEC 2006 31 DEC 2005
NON-CURRENT INTEREST-BEARING LOANS AND BORROWINGS
Senior Facility Agreement and Italian Facility Agreement (a) 1,298 1,577
High Yield Notes, due 10 August 2015, $615 million, 8.375 % (b) 466 519
High Yield Notes, due 10 August 2015, €500 million, 8.375 % (b) 500 500
Bonds, due 15 March 2027, $300 million, 8.1 % (c) 228 253
Other (d) 61 34
2,553 2,883
Less: Current portion (107) (68)
Less: Financing fees and costs to be amortised (62) (70)
2,384 2,745
CURRENT INTEREST-BEARING LOANS AND BORROWINGS
Receivables securitisation programmes (e) 558 514
Current portion of non-current debt (a), (d) 107 68
Financial payables to associates (f) 9 8
Other 24 13
698 603
Total interest-bearing loans and borrowings 3,082 3,348
a) Senior Facility Agreement  
and Italian Facility Agreement
The Company and a number of its 
subsidiaries are party to a Senior Facility 
Agreement for an aggregate amount of up 
to €1,950 million (of which €1,600 million 
multicurrency term loans and €350 
million multicurrency revolving facility) 
and, in a separate transaction, Italian 
subsidiaries of the Company have become 
party to a term loan under a separate 
Italian Facility Agreement for an aggregate 
amount of €143 million (following which 
an equivalent amount was repaid under 
the Senior Facility Agreement). ABN Amro 
Bank N.V. is acting as agent and security 
agent of both facilities.
During the financial year 2006, the Group 
made mandatory semi-annual repayments 
in an amount of €41 million (2005: €27 
million), a mandatory repayment due to 
excess cash generated of €57 million 
(2005: nil) and a voluntary repayment  
of €150 million (2005: nil). As at  
31 December 2006, the total amount 
outstanding under the Senior Facility 
Agreement amounted to €1,181 million 
(2005: €1,441 million) and under the 
Italian Facility Agreement €117 million 
(2005: €136 million).
At 31 December 2006, the following 
subsidiaries of the Company were 
borrowers of term loans under the Senior 
Facility Agreement: Basell Polyolefine 
GmbH, Basell USA Inc., Basell Poliolefinas 
Ibérica S.L., Basell Production France 
S.A.S., Basell Benelux B.V. and Basell 
Holdings B.V. 
At 31 December 2006, the following 
subsidiaries of the Company were 
borrowers of term loans under the Italian 
Facility Agreement: Basell Poliolefine  
Italia S.r.l. and Basell Brindisi S.r.l.
The €350 million revolving facility is 
available for drawing by Basell Finance 
Company B.V. under which €20 million  
are allocated to an ad hoc ancillary 
facility to enable the issuance of bank 
guarantees. At 31 December 2006,  
€2 million was drawn under this facility  
in the form of bank guarantees.
Each borrower under the Senior Facility 
Agreement and/or the Italian Facility 
Agreement has granted security over 
all of its assets to secure its obligations 
as a borrower under such agreements, 
subject to typical limitations required in 
the relevant jurisdiction and obligations 
to third parties. The security granted 
by Basell Poliolefine Italia S.r.l., Basell 
Brindisi S.r.l. and Basell Benelux B.V. for 
their respective obligations as borrowers 
is, among others, limited to the amounts 
permitted to be secured under the 2027 
Bonds (see section b).
The Company and the following 
subsidiaries of the Company are providing 
guarantees for the borrowers and the 
other guarantors under the Senior Facility 
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Agreement, subject to typical limitations 
required in the relevant jurisdictions and 
other obligations to third parties: Basell 
Polyolefine GmbH, Basell Bayreuth Chemie 
GmbH, Basell Germany Holdings GmbH, 
Basell Polyolefins UK Ltd., Basell UK 
Holdings Ltd., Basell Canada Inc., Basell 
Asia Pacific Ltd., Basell Holdings B.V., 
Basell International Holdings B.V., Basell 
Benelux B.V., Basell Europe Holdings 
B.V., Basell Finance Company B.V., Basell 
Sales & Marketing Company B.V., Basell 
(Thailand) Holdings B.V., Basell Finance & 
Trading Company B.V., Basell Polyolefins 
Company B.V.B.A., Basell Poliolefinas 
Ibérica S.L., Basell Ibérica Poliolefinas 
Holdings S.L., Basell Production France 
S.A.S., Basell Polyéthylène S.A.S., Basell 
Polyoléfines France S.A.S., Société du 
Craqueur de l’Aubette S.A.S., Basell 
Funding S.à r.l., Nell Acquisition (US)  
LLC, Basell Finance USA Inc., Basell  
North America Inc. and Basell USA Inc.
The Company and the following 
subsidiaries of the Company are providing 
guarantees for the borrowers and the 
other guarantors under the Italian Facility 
Agreement, subject to typical limitations 
required in the relevant jurisdictions and 
other obligations to third parties: Basell 
Italy Holding S.r.l., Basell Poliolefine 
Italia S.r.l., Basell Brindisi S.r.l., Basell 
Polyolefine GmbH, Basell Bayreuth Chemie 
GmbH, Basell Germany Holdings GmbH, 
Basell Polyolefins UK Ltd., Basell UK 
Holdings Ltd., Basell Canada Inc., Basell 
Asia Pacific Ltd., Basell Holdings B.V., 
Basell International Holdings B.V., Basell 
Benelux B.V., Basell Europe Holdings 
B.V., Basell Finance Company B.V., Basell 
Sales & Marketing Company B.V., Basell 
(Thailand) Holdings B.V., Basell Finance & 
Trading Company B.V., Basell Polyolefins 
Company B.V.B.A., Basell Funding S.à r.l., 
Nell Acquisition (US) LLC, Basell Finance 
USA Inc., Basell North America Inc. and 
Basell USA Inc.
Each company acting as guarantor under 
the Senior Facility Agreement and/or the 
Italian Facility Agreement has granted 
security over all of its assets to secure 
its obligations as guarantor under 
such agreements. The security granted 
by Basell Poliolefine Italia S.r.l. for its 
obligation as guarantor is limited to the 
obligations of its subsidiary Basell Brindisi 
S.r.l. and is, like the security granted 
by Basell Benelux B.V., limited to the 
amounts permitted to be secured under 
the 2027 Bonds (see section b).
The companies providing guarantees 
and security under the Senior Facility 
Agreement and/or the Italian Facility 
Agreement aggregate in total more than 
85 % of the consolidated value of the 
Basell group in terms of total assets and 
EBITDA over the last 12 months as per 
contractual definitions.
The interest rate for the facilities under 
the Senior Facility Agreement is LIBOR 
or EURIBOR (on the loans in US dollars 
and Euro, respectively) for the relevant 
currency plus 175 – 300 basis points 
depending on each of the three tranches 
of the facility. The interest rate under the 
Italian Facility Agreement is EURIBOR plus 
175 basis points. Based on the Group’s 
performance the interest rate of two 
tranches was reduced during 2006 by 50 
and 25 basis points respectively. Based on 
future performance, the interest rate on 
a tranche with an outstanding amount at 
31 December 2006 of €282 million can be 
further reduced by 25 basis points. The 
commitment fee on the unutilised portion 
of the revolving facility amounts to 75 
basis points. 
Under the Senior Facility Agreement and 
the Italian Facility Agreement, the Group is 
required to comply with covenants related 
to its financial performance and condition 
and the conduct of its business and with 
monthly, quarterly and annual financial 
reporting obligations related to its 
financial performance and condition. Non 
compliance with any of these covenants 
would constitute an event of default under 
the relevant agreement. The Group is in 
compliance with these covenants and 
expects to remain so during the rest  
of 2007.
Financial covenants include ratios in 
respect of EBITDA to net interest expense, 
net total borrowings to EBITDA, net 
senior borrowings to EBITDA, cash flow 
to debt service and an agreed maximum 
capital expenditure in accordance with 
contractually agreed definitions. Financial 
covenants are calculated and tested 
quarterly. As at 31 December 2006, the 
Group was in compliance with these 
financial covenants. The financial outlook 
for the year 2007 indicates that the Group 
expects to meet its financial covenants.
The repayment obligation for the year 
2007 amounts to €41 million (2006: 
€54 million). Additional repayments 
are mandatory for 50 % of the excess 
cash generated by the Group in 2006 
(calculated according to contractual 
definitions) under an annually applied 
‘cash sweep’ mechanism. The amount of 
the cash sweep is determined based on 
these consolidated financial statements 
and is estimated at €64 million, which  
is included in the Current portion.
Any payment default or acceleration of 
payments under any other agreement 
related to financial indebtedness of 
the Company or any of its subsidiaries 
(including but not limited to the $300 
million bonds due 15 March 2027, 
the High Yield Notes due 2015, the 
securitisation programmes and certain 
local facilities), if in value higher than 
€15 million, would represent an event 
of default under the Senior Facility 
Agreement and the Italian Facility 
Agreement entitling the relevant  
lenders to accelerate the repayment  
of such facilities.
Under an Intercreditor Agreement, dated  
1 August 2005, the lenders under the 
Senior Facility Agreement, the Italian 
Facility Agreement, certain hedging 
banks, the Agent, Security Trustee and 
Issuing Bank of the High Yield Notes, 
the Company and all subsidiaries of 
the Company which are borrowers or 
guarantors under the Senior Facility 
Agreement and/or the Italian Facility 
Agreement and/or the High Yield Notes, 
have contractually agreed that the debt 
of the subsidiaries of the Company will 
rank in right and priority of payment in 
the following order: (1) the debt of the 
subsidiaries of the Company under the 
Senior Facility Agreement, the Italian 
Facility Agreement and certain hedging 
arrangements, pari passu between 
themselves; (2) the debt of the guarantors 
under the High Yield Notes guarantees 
and the debt of Basell Holdings B.V. 
to the Company for the on-lending 
of the High Yield Notes proceeds; (3) 
the intercompany debt (other than 
intercompany debt due, owing or incurred 
by the Company), and that the debt of the 
Company will rank in right and priority 
of payment in the following order: (1) the 
debt under the High Yield Notes, the debt 
under certain hedging arrangements, 
the debt of the Company as guarantor 
under the Senior Facility Agreement and 
the Italian Facility Agreement and (2) any 
debt by the Company to the shareholders 
and any intercompany debt due, owing or 
incurred by the Company.
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The repayment schedules of the Senior Facility Agreement and Italian Facility Agreement are:
€ MILLION TOTAL
2007 105
2008 46
2009 46
2010 47
2011 54
2012 31
2013 484
2014 485
Total 1,298
b) High Yield Notes due 2015
Under an indenture dated 10 August 
2005, the Company issued €500 million 
and $615 million High Yield Notes. The 
coupon rate for both High Yield Notes 
amounts to 8.375 % and the coupon dates 
are 15 August and 15 February. Both High 
Yield Notes mature on 10 August 2015. 
The Bank of New York acts as Trustee, 
Registrar, Paying Agent, Transfer Agent 
and Listing Agent. ABN AMRO Bank N.V. 
acts as Security Agent.
The High Yield Notes are not registered 
under the 1993 United States Securities 
Act and are offered only to qualified 
institutional buyers under Rule 144A 
under the Securities Act and to non-US 
persons outside the United States in 
reliance on Regulation S of the Securities 
Act. The High Yield Notes are not offered 
to the public as defined in the European 
Union Prospectus Directive 2003/71/EC.
Under the High Yield Notes the Group  
is required to comply with covenants 
related to the conduct of its business.  
Non compliance with any of these 
covenants would constitute an event  
of default. The Group is in compliance 
with these covenants and expects to 
remain so during the rest of 2007.
The following subsidiaries of the 
Company have provided guarantees 
for the obligations of the Company as 
issuer of the High Yield Notes subject 
to typical limitations required in the 
relevant jurisdictions: Basell Polyolefine 
GmbH, Basell Bayreuth Chemie GmbH, 
Basell Germany Holdings GmbH, Basell 
Polyolefins UK Ltd., Basell UK Holdings 
Ltd, Basell Canada Inc., Basell Asia 
Pacific Ltd, Basell Holdings B.V., Basell 
International Holdings B.V., Basell Benelux 
B.V., Basell Europe Holdings B.V., Basell 
Finance Company B.V., Basell Funding 
S.à r.l., Nell (US) Acquisition S.à r.l., Nell 
Acquisition (US) LLC, Basell Finance USA 
Inc., Basell North America Inc., Basell 
USA Inc. The guarantee granted by Basell 
Benelux B.V. is, among others, limited to 
the amounts permitted under the 2027 
Bonds (see below).
The Company as issuer of the High Yield 
Notes has granted a pledge over its 
shares in its subsidiary Basell Funding S.à 
r.l. and a pledge over the loan whereby 
the proceeds of the High Yield Notes 
have been on-lent to Basell Holdings B.V. 
Such security is a second rank security 
subordinated to any security granted 
to the lenders under the Senior Facility 
Agreement.
The Company, the subsidiaries of the 
Company providing guarantees for the 
debt of the Company under the High Yield 
Notes and the Agent, Security Trustee and 
Issuing Bank of the High Yield Notes, are 
party to an Inter-creditor Agreement dated 
1 August 2005 with the senior lenders. 
For details see section a).
c) Bonds due 2027
A subsidiary of the Company has 
outstanding fixed interest private 
placements in the US-bond market 
(exempt from registration under section 
144A of the United States Securities Act) 
issued on 17 March 1997 with JP Morgan 
Chase Bank acting as Fiscal and Paying 
Agent.
The bonds with a nominal value of $300 
million have an agreed maturity date on 
15 March 2027. The coupon rate amounts 
to 8.1 % and the coupon dates are  
15 September and 15 March.
The Bonds are guaranteed by Basell 
Holdings B.V. No guarantees are provided 
directly under the 2027 Bonds by any 
other subsidiaries of the Company. 
However, the 2027 Bonds provide certain 
restrictions with respect to the level of 
maximum debt that can be incurred 
and security that can be granted by 
the operating companies in Italy, The 
Netherlands and the United States and 
which are fully owned subsidiaries of 
Basell Holdings B.V. As at 31 December 
2006, such subsidiaries were, in The 
Netherlands, Basell Benelux B.V. (indirectly 
controlled by Basell Holdings B.V. through 
the intermediate holding company Basell 
Europe Holdings B.V.) and, in Italy, Basell 
Poliolefine Italia S.r.l. and Basell Brindisi 
S.r.l. (indirectly controlled by Basell 
Holdings B.V. through the intermediate 
holding company Basell Italy Holding 
S.r.l.).
d) Other non-current interest  
bearing loans and borrowings
On 10 October 2006, Basell Australia Pty. 
Ltd. has entered into an agreement for  
a secured committed revolving credit  
facility of Australian Dollar 70 million  
(€42 million) from an Australian branche 
of a commercial bank in the Netherlands. 
As at 31 December 2006, the facility 
was fully drawn. There is no mandatory 
repayment obligation for the year 
2007. The outstanding amount as at 31 
December 2005 of a previous facility in  
an amount Australian Dollar 20 million 
was fully repaid during 2006 and the 
facility cancelled in connection with the 
new financing. Basell Australia Pty. Ltd. 
has granted fixed and floating security  
on all of its assets to the new lender.
On 31 December 2006, Basell Holdings 
Middle-East GmbH had outstanding an 
amount of Saudi Riyal 74 million (€15 
million), guaranteed by a third party, 
which is repayable out of dividends and 
other proceeds from capital transactions 
from the Group’s joint venture in Saudi 
Arabia. Thereof an amount of €2 million 
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has been included in ‘Current portion  
of non-current debt’.
In addition, as at 31 December 2006 
the Group had outstanding financing 
arrangements in the USA (€1 million), 
Spain (€1 million) and China (€2 million).
The interest rates on these loans and 
borrowings are based on benchmark 
rates.
e) Receivables securitisation 
programmes
Two securitisation programmes were 
entered into on 29 July 2005 by 
subsidiaries of the Company in Europe 
and the US and Citibank, N.A., Citicorp 
Trustee Company Limited, Citigroup 
Centre and Eureka Securitisation plc. The 
programmes provide funding up to €500 
million and $200 million, respectively.
On 29 June 2006, in connection with the 
transfer of commercial activities from 
Basell Polyolefins Company B.V.B.A. to 
a newly incorporated company in The 
Netherlands, Basell Sales & Marketing 
Company B.V., a new European 
receivables securitisation programme was 
entered into by Basell Sales & Marketing 
Company B.V., at substantially the same 
terms as the previous programme. The 
two programmes ran in parallel up to 
6 October 2006, the date at which the 
contract with Basell Polyolefins Company 
B.V.B.A. was terminated.
As at 31 December 2006, an amount 
of €431 million was funded under the 
European receivables securitisation 
programme out of sold receivables and 
under the North American programme 
$167 million (€127 million). In 
compliance with IAS 39, these receivables 
securitisation programmes do not qualify 
for de-recognition and consequently are 
recognised as a liability.
As part of the security under the two 
securitisation programmes, pledges are 
granted over the bank accounts of the 
subsidiaries of the Company collecting  
the receivables.
The companies being party to the 
programmes are required to comply with 
covenants related to the conduct of their 
business and the nature of the receivables 
sold under the programmes. Non 
compliance with any of these covenants 
would constitute an event of default. The 
companies are in compliance with these 
covenants and expect to remain so during 
the rest of 2007.
f) Financial payables to  
associates and joint ventures  
and other bank debt
Other current interest bearing loans and 
borrowings represent amounts drawn 
under uncommitted credit facilities. 
Interest is based on market-related terms.
g) Average interest cost/effective 
interest rates
The weighted average rate of interest 
for interest bearing loans and borrowing 
for the period ended 31 December 2006 
amounted to 6.6 % (2005: 6.1 %). The 
effective interest rates of interest-bearing 
loans and borrowings outstanding as  
at 31 December 2006 are included in  
note 34.
h) Maturity
Based on the nature and mandatory 
repayment schedule of the interest 
bearing loans and borrowings, the 
aggregate maturities, before deduction  
of financing fees and costs to be 
amortised of €62 million, are:
€ MILLION TOTAL
2007 698
2008 49
2009 51
2010 50
2011 99
After 2011 2,197
Total 3,144
Basell Annual Report 2006 | Financials 06 – Notes
54
21. Employee benefits
€ MILLION 31 DEC 2006 31 DEC 2005
Present value of unfunded obligations 209 191
Present value of funded obligations 395 386
Total present value of obligations 604 577
Fair value of plan assets (294) (243)
Funded Status 310 334
Unrecognised actuarial gain 23 10
Recognised liability of defined benefit obligations 333 344
Other post retirement benefits 135 138
Post-retirement benefits 468 482
Termination benefits 13 15
Non-current portion management incentive schemes 23 17
Non-current employee benefits 504 514
Variable compensation schemes 65 34
Vacation days allowances 15 16
Termination benefits 5 5
Other personnel related costs 34 44
Current employee benefits 119 99
POST-RETIREMENT BENEFITS
a) Pensions
Substantially all of the Group’s employees 
in Germany are covered under several 
defined benefit pension plans, which 
provide for benefits based on years of 
service and average rates of pay. Up to a 
certain salary level, the benefit obligations 
regarding the majority of the German 
employees are covered by contributions 
of the Group and the employees to the 
Pensionskasse der BASF VVaG. In addition, 
for employees earning in excess of the 
social security ceiling, the Group offers 
an unfunded supplementary plan. For a 
separate group of employees there is a 
separate unfunded pension plan for the 
full pension obligations.
Some German pension schemes are  
multi-employer pension plans; however, 
these schemes are being accounted for  
as if they were defined contribution plans, 
because the Group is not in the position 
to identify its share of the financial 
position and performance with sufficient 
reliability for accounting purposes. 
This assessment is based on the fact 
that the schemes expose the Group to 
significant actuarial risks associated with 
the employees of the other participating 
member companies. As a consequence, 
no consistent and reliable basis for the 
allocation of the scheme assets and 
obligations is available to the Group.
The Group’s estimated share of the 
defined benefit obligation and plan assets 
as at 31 December 2006 amounted 
to €263 million (2005: €261 million) 
and €266 million (2005: €247 million), 
respectively, and has been calculated  
and based on a discount rate of 4.50 % 
(2005: 4.25 %).
Substantially all of the Group’s employees 
in the United States and Canada are 
covered under non-contributory, defined 
benefit pension plans, which provide for 
benefits based on years of service and 
average rates of pay. The Group’s funding 
policy is to contribute annually not less 
than the amounts set forth in employee 
benefit and tax laws. Employees in the 
United States are eligible to participate 
in defined contribution plans (Employee 
Savings Plans) by contributing a portion  
of their compensation. The Group 
matches a part of the employees’ 
contributions.
Outside Germany, the United States and 
Canada, group companies maintain plans 
that are at least in accordance with legal 
and fiscal requirements of the country in 
which the employees are engaged.
Following the acquisition of the Basell 
group, all employees who were members 
of previous shareholder pension 
schemes (except those in Germany) were 
obliged to leave such schemes for any 
benefits generated after 1 August 2005. 
Individuals affected were given the option 
of transferring their past service benefits 
to newly offered schemes or leaving them 
in the respective previous shareholder 
pension schemes as deferred members. 
The transfer values or cost implications 
of leaving previous shareholder schemes 
including 2005 have been fully considered 
in 2006.
In Italy, employees are covered by a 
benefit scheme provided for in accordance 
with local legislation. Benefits under this 
scheme are approximately one month’s 
pay for each year of service (yearly 
adjusted based on the cost-of-living 
index) and payable when the employee is 
leaving the Group. The recognised liability 
represents the defined benefit obligation 
of the Group.
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The following table sets forth changes in the benefit obligations and the fair value of plan assets of defined benefit pension plans other 
than multi-employer plans:
€ MILLION 2006 2005
Present value of benefit obligation at beginning of year (2005: 20 April) 577 –
Present value of benefit obligation acquired through business  
combinations and similar transactions
33 562
Current service cost 20 8
Past service cost 6 1
Interest cost 29 11
Actuarial (gains) / losses – (8)
Benefits paid (27) (8)
Exchange rate effects (34) 11
Present value of benefit obligation at year end 604 577
Fair value of plan assets at beginning of year (2005: 20 April) 243 –
Fair value of plan assets acquired through business combinations and similar transactions 28 225
Actual return on plan assets 27 7
Actuarial gains / (losses) 7 2
Contributions by employer 31 7
Benefits paid (20) (6)
Exchange rate effects (22) 8
Fair value of plan assets at year end 294 243
Funded status (310) (334)
Unrecognised actuarial gain (23) (10)
Liability recognised (333) (344)
In 2005 existing liabilities and plan assets of the former Basell group were acquired at 1 August 2005. In 2006 the Group acquired  
a cracker in Münchsmünster, Germany, and finalised the transfer of employees from schemes of former shareholders.
The present value of the defined benefit pension obligations as at 31 December 2006 comprises of €395 million (2005: €386 million) 
related to funded obligations and €209 million (2005: €191 million) related to unfunded obligations. These amounts exclude the plan 
assets and obligations related to the German multi-employer plan, which is treated as a defined contribution plan.
The Group’s pension plan asset allocation during the period and target allocation for its plans are as follows:
2006 2005
ACTUAL TARGET ACTUAL* TARGET
CANADA
Equity securities 62 % 60 % 60 % 60 %
Fixed income 38 % 40 % 38 % 40 %
Other – – 2 % –
UNITED KINGDOM
Equity securities 56 % 75 % 66 % 75 %
Fixed income 42 % 25 % 33 % 25 %
Other 2 % – 1 % –
UNITED STATES
Equity securities 61 % 60 % 61 % 60 %
Fixed income 33 % 40 % 33 % 40 %
Other 6 % – 6 % –
* 2005 actual relates to the period 20 April until 31 December 2005
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Funded plans in other European countries are insured plans and the asset allocation is not meaningful in these financial statements.
The investment strategy of the Group’s non-insured funded defined benefit plans is to achieve consistent positive returns, 
after adjusting for inflation, and to maximise long-term total return within prudent levels of risk. Risk is minimised through the 
diversification of investments across and within various asset categories.
Net periodic benefit cost includes the following components:
€ MILLION 2006 2005
Service cost 20 9
Interest cost 29 11
Expected return on plan assets (20) (7)
Curtailments and settlements 1 –
Amortisation of past service cost 6 –
Net periodic benefit cost for defined benefit plans 36 13
Net periodic benefit cost for defined contribution (incl. multi-employer plans) 9 6
Total benefit cost 45 19
The estimated employer cash contributions for all pension plans for the next period are:
€ MILLION 2007
Defined benefit schemes 38
Defined contribution schemes 4
Multi-employer schemes 5
Total benefit cost 47
The following table sets forth the principal assumptions on discount rates, projected rates of remuneration growth and expected rates 
of return on plan assets, where applicable. These assumptions vary for the different plans, as they are determined in consideration of 
the local conditions. The range of rates applicable to the principal plans is:
NORTH AMERICA EUROPE
2006 2005 2006 2005
Discount rate 4.75 % – 5.68 % 5.00 % – 5.50 % 4.20 % – 5.10 % 4.20 % – 5.00 %
Salary increase 4.00 % – 4.25 % 4.00 % – 4.25 % 2.50 % – 3.90 % 2.50 % – 3.75 %
Expected return on plan assets 7.50 % – 8.50 % 7.50 % – 8.50 % 5.45 % – 5.80 % 4.00 % – 6.30 %
The expected rate of return on assets was estimated based on the plan’s asset allocation, a review of historical capital market 
performance, historical plan performance and a forecast of expected future asset returns. The Group reviews this long-term 
assumption on a periodic basis.
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b) Other post retirement benefits
Some Group companies maintain defined benefit health care and life insurance plans covering eligible retired employees and their 
spouses. Generally, the medical plans pay a stated percentage of medical expenses reduced by deductibles and other coverage. 
These plans are unfunded. Life benefits are generally provided by insurance contracts. The Group retains the right, subject to existing 
agreements, to change or eliminate these benefits.
€ MILLION 2006 2005
Present value of benefit obligation at beginning of year (2005: 20 April) 141 –
Present value of acquired benefit obligation 2 138
Current service cost 5 2
Interest cost 7 3
Contributions by plan participants 1 1
Actuarial (gains) / losses 1 (1)
Benefits paid (6) (4)
Exchange rate effects (11) 2
Present value of benefit obligation at year end 140 141
Unfunded status (140) (141)
Unrecognised actuarial loss (5) (3)
Liability recognised (135) (138)
Net design of the plan of the United States (‘US’) as result of a change in legislation in 2005 entitles Basell to potential reimbursements 
from the US government. The present value of the reimbursements amounts to €7 million as at 31 December 2006 and is presented 
under non-current assets. 
Net periodic benefit cost for other post-retirement benefits includes the following components:
€ MILLION 2006 2005
Service cost 5 2
Interest cost 7 3
Net periodic benefit cost for other post retirement benefit plans 12 5
For the plans in the US a rate increase  
of 9.0 % in the per capita cost of covered 
health care benefits was assumed for the 
year 2007 (2005 assumption for 2006  
was 9.6 %).This rate was assumed to 
decrease gradually to 5.0 % in 2011 and 
remain at that level thereafter. For the 
plans in Canada a rate increase of 8.0 %  
in the per capita cost of covered health 
care benefits was assumed for the year 
2007 (2005 assumption for 2006 was  
9.0 %). This rate was assumed to decrease 
gradually to 5.0 % in 2010 and remain  
at that level thereafter.
Assumed health care cost trends have a 
significant effect on the amounts reported 
for the health care plans. The effect of a 
one percentage point increase (decrease) 
in the annual assumed health care cost 
trend rates would increase (decrease) 
the accumulated post-retirement benefit 
obligation by €6 million (€5 million)  
and the net periodic benefit cost by  
€0.5 million (€0.4 million).
Assumed discount rates are the same  
as for the pension plans.
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Termination benefits
In Germany, the Group has offered voluntary packages to employees (early retirement scheme) aged 55 and above to work part-time 
during the subsequent 3 years before early retirement. Upon signing of such a voluntary agreement, the Group is recognising the 
liability. The movement of the Termination benefits is the following:
€ MILLION 2006 2005 
(20 APR - 31 DEC) 
Termination benefits at beginning of period 20 –
Termination benefits upon acquisitions 1 21
Additions 2 2
Utilisations (5) (3)
Termination benefits as at end of period 18 20
Management incentive schemes
STOCK OPTIONS
The Group has granted stock options on shares of Royal Dutch Shell plc to senior management between 1999 and 2001. The options 
were granted according to the particular option plans and fully vested immediately for periods of ten years at prices not less than the 
fair market value at the date of grant. As from 1999, 10-year options were granted which can only be exercised after a period of three 
years following the date of grant.
The following table shows the movements in the number of outstanding options:
NUMBER OF STOCK OPTIONS 2006 2005
Options outstanding at beginning of year (2005: 1 August) 912,500 1,005,500
Exercised (66,000) (66,000)
Expired (9,000) –
Cancelled – (27,000)
Outstanding as at end of the year 837,500 912,500
The weighted average exercise price at 31 December 2006 of the outstanding options in Royal Dutch Shell plc (in the range of €23.55 
– €30.79) is €29.33 (2005: €28.92). The weighted average remaining contractual life of these options is 3.6 years (2005: 4.5 years).
STOCK APPRECIATION RIGHTS
Furthermore, the Group granted to senior management from 2001 to 2005 stock appreciation rights in relation to shares  
of Royal Dutch Shell plc and BASF AG. The tranche of stock appreciation rights 2005 were the last being granted.
The following table shows the movement in the outstanding stock appreciation rights:
NUMBER OF STOCK APPRECIATION RIGHTS ROYAL DUTCH 
SHELL PLC
BASF AG
Granted rights outstanding at 1 August 2005 in Basell group 744,444 388,774
Exercised in 2005 – (31,953)
Expired in 2005 (6,940) (2,770)
Granted rights outstanding on 31 December 2005 737,504 354,051
Exercised in 2006 (80,340) (83,578)
Granted rights outstanding on 31 December 2006 657,164 270,473
The weighted average 2006 reference 
prices for the rights for Royal Dutch 
Shell plc and BASF AG are €24.02 (2005: 
€23.44) and €47.48 (2005: €46.12) 
respectively in the range of €18.11 –  
€32.45 and €33.46 – €56.42 respectively. 
These reference prices reflect the market 
value of the underlying shares at the 
date of grant. The stock appreciation 
rights have a vesting period of 3 years as 
from the date of granting the rights and 
exercise periods up to 7 years thereafter. 
Upon exercise of these rights, the holders 
of the stock appreciation rights are 
entitled for each right to the difference 
between the price of the underlying 
shares at that date and the reference 
price, provided that the underlying shares 
have increased in value by at least 30 % 
since the grant date and, for the rights 
granted in 2001, with a maximum of  
100 % of the reference price. 
The weighted average remaining 
contractual period of the stock 
appreciation rights for Royal Dutch Shell 
plc and BASF AG are 6.7 years (2005:  
7.7 years) and 7.2 years (2005: 7.9 years), 
respectively.
Medium term management  
incentive plans
The Company introduced in 2005 two 
incentive schemes for key management 
replacing the former stock appreciation 
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right programme. One programme, the 
Medium Term Incentive (‘MTI’), is based 
on a certain EBITDA performance of the 
Group and provides an aggregate cash 
bonus amount of up to 1 % of the Group’s 
EBITDA if the EBITDA value exceeds a 
certain threshold amount. The pay-out 
to key management of this bonus is 50 
% in the current year and 25 % in each 
of the two subsequent years, subject to 
the Group’s EBITDA reaching in a pay-
out year again the relevant threshold 
amount. A further programme to other 
key management members, the Senior 
Management Performance Pay (‘SMPP’), 
allows for a cash bonus up to a certain 
percentage of the individual annual gross 
salary capped at a certain maximum 
amount and subject to the Group’s 
EBITDA reaching the threshold amount 
under the MTI program. The pay-out 
of this programme occurs in equal 
instalments over three years and is for 
the subsequent two years subject to the 
Group EBITDA exceeding the threshold 
amount in a given pay-out year.
Long term management  
incentive plan
Members of the Management Board and 
Management Team of the Group invested 
in a partnership holding an indirect  
share of 2.2 % in the total equity of  
the Company.
In addition, Members of the Management 
Board and Management Team of the 
Group receive cash bonuses that accrue 
over a period of 5 years as from 1 August 
2005. The employee expense in respect 
of the bonus element of the long term 
management incentive plan is recognised 
pro rata over the vesting period. This 
liability has been discounted using an 
interest rate of 4 %.
Under specific events, the possibility 
exists that certain transactions with 
regard to the partnership would have 
to be measured and recognised as an 
expense in the consolidated financial 
statements. 
Non-current liability recognised
At 31 December 2006, the fair value 
of stock options, stock appreciation 
rights as well as medium and long term 
management incentive plans amounted  
to €23 million (2005: €17 million 
including a re-classification of €5 million 
related to the non-current portion of 
the medium term incentive plans which 
previously had been presented as current 
variable compensation). 
Hedging
In connection with the stock option plan 
and stock appreciation rights, the Group 
hedged itself against share price increases 
by holding, at 31 December 2006, the 
beneficial interest in 1,442,004 shares 
(2005: 1,654,004 shares) in Royal Dutch 
Shell plc and 263,854 shares (2005: 
303,854 shares) in BASF AG through a 
total return swap (note 34). In addition, 
at 31 December 2006 the Group held 
52,460 shares (2005: 44,000 shares) in 
Royal Dutch Shell plc and 6,619 shares 
(2005: 53,400 shares) in BASF AG with  
a carrying value of €2 million (2005:  
€5 million).
22. Deferred income
Deferred income primarily relates to 
contractually agreed license fees which 
do not qualify for immediate revenue 
recognition (see accounting policy 3-6, 
subsection ‘licensing revenue’).
23. Deferred tax assets and liabilities
The tax effects of tax losses carried forward and the tax effects of temporary differences between the tax basis of assets and liabilities 
and their reported amounts in the consolidated financial statements, reduced by a valuation allowance where appropriate, are 
presented below:
€ MILLION 31 DEC 2006 31 DEC 2005
Property, plant and equipment 420 394
Intangible assets 89 98
Inventories 31 36
Investments 29 26
Deferred income 66 56
Other 55 52
Total deferred tax liabilities 690 662
Tax losses carried forward 341 368
Employee benefits 108 122
Non-current and contingent liabilities 47 52
Intangible assets 5 11
Deferred licensing income 23 24
Property, plant and equipment 8 15
Other 118 122
Total deferred tax assets 650 714
Less: Asset valuation allowance (319) (285)
Net deferred tax assets 331 429
Net deferred tax liability 359 233
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Amounts recognised in the balance sheet based on the net asset or liability position by tax jurisdiction consist of:
€ MILLION 31 DEC 2006 31 DEC 2005
Deferred tax assets 22 80
Deferred tax liabilities 381 313
€ MILLION TAX LOSSES 
CARRIED FORWARD
GROSS DEFERRED 
TAX ON LOSSES 
CARRIED FORWARD
YEAR
2007 – –
2008 – –
2009 – –
2010 1 –
2011 229 103
After 2011 462 94
Indefinite 436 144
1,128 341
In assessing the recoverability of deferred 
tax assets, management considers 
whether it is probable that some portion 
or all of the deferred tax assets will be 
realised. The ultimate realisation of 
deferred tax assets is dependent upon 
the generation of future taxable income 
during the periods in which the net 
operating losses can be utilised or the 
temporary differences become deductible. 
Management considers the scheduled 
reversal of deferred tax liabilities, 
projected future taxable income and tax 
strategies in making this assessment. 
In order to fully realise the deferred tax 
asset related to the net operating losses, 
the Group will need to generate sufficient 
future taxable income in the countries 
where these net operating losses exist. 
Based upon projections for future taxable 
income over the periods in which the net 
operating losses can be utilised or the 
temporary differences become deductible, 
management believes it is probable 
that the Group will realise the deferred 
tax assets, net of the existing valuation 
allowance.
At 31 December 2006, the Group had 
total tax losses carried forward for an 
amount of €1,128 million (2005: €1,144 
million), for which a gross deferred tax 
asset is recognised of €341 million (2005: 
€368 million). A valuation allowance of 
€319 million (2005: €285 million) was 
established for these tax losses and other 
deferred tax assets.
The expiration of the tax losses carried 
forward and the related deferred tax 
asset, before valuation allowance, is  
as follows:
The valuation allowances are provided 
against net deferred tax assets in France, 
the United Kingdom, the Netherlands,  
the United States of America and Canada. 
In most cases, provision for deferred 
taxes has not been made for taxes 
on possible future distribution of 
undistributed earnings by Group 
companies as such dividends will either be 
tax exempt and/or management expects 
to substantially reinvest the earnings 
of the companies concerned. Deferred 
taxes on possible future distributions of 
associated companies or joint ventures 
have been determined and are included 
in the deferred tax liability of €29 million 
(2005: €26 million) under Investments.
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24. Provisions
€ MILLION 31 DEC 2005 ADDITION PAYMENT RELEASE RECLASS- 
IFICATION
31 DEC 2006
Decommissioning 
obligations (a)
87 – – (4) 2 85
Earn out  
arrangement (b)
65 4 – – – 69
Unfavourable contracts (c) 56 5 (8) – – 53
Contingent liabilities (d) 45 – – – (1) 44
Environmental  
provisions (e)
26 5 – – – 31
Redundancies (f) 11 – – (2) (8) 1
Restructuring provision (f) 7 – – (3) (4) –
Other 8 – (2) – – 6
Non-current 305 14 (10) (9) (11) 289
Decommissioning 
obligations (a)
3 – (1) – (2) –
Redundancies (f) 16 29 (20) – (10) 15
Restructuring provision (f) – – – – 4 4
Other 18 5 (8) – – 15
Current 37 34 (29) – (8) 34
recoverability of the investment in SCA. 
As of year end 2006 this business, 
representing a separate cash-generating 
unit, comprised €185 million of property, 
plant and equipment and the adjusted 
goodwill of €34 million. Basell determined 
the recoverable amount, based on a 
value in use concept, at €169 million and 
consequently impaired the remaining 
goodwill (€34 million) and property,  
plant and equipment by €16 million.  
The impairment was reported under  
Other expense. The value in use was 
derived using the discounted cash flow 
method in line with the fair valuation 
performed upon acquisition of SCA in 
December 2005. For the years 2007 
– 2011 the cash flows were based on  
the business plan and for the years 2012 
– 2021 (2021 is the estimated end of the 
economic useful life), on management 
assumptions. Considerations were given 
to the premises used in the business  
plan, expected market developments  
and historical trends.
The main driver in estimating future 
cash flows is the assumption of the 
cracker margin. The cracker margin was 
determined using the industry’s market 
spot-price for ethylene (ICIS) reduced by 
the average actual discount in the years 
2001 to 2006 less costs (feedstock and 
manufacturing costs). If the estimated 
future cracker margin would have been 
approximately 4 % higher throughout the 
remaining economic useful life, Basell 
would not have recognised an impairment 
charge.
As Basell does not expect the 
consolidated French tax group (of which 
SCA is a member) to be tax paying within 
the foreseeable future income taxes were 
neither taken into account in determining 
the cash flows nor in calculating the 
discount rate using a weighted average 
cost of capital (WACC). This resulted in  
a discount rate of 7.67 %.
c) Unfavourable contracts
Unfavourable contracts provision 
represents a liability on third party 
monomer and products purchase 
contracts, which have unfavourable 
pricing conditions compared to industry 
standards. This provision will be 
consumed in line with the term of  
the contract until the end of 2013.
d) Contingent liabilities
Contingent liabilities were established 
under IFRS 3 Business Combinations (see 
note 5) in connection with potentially 
disputed transfer values under various 
pension schemes and potential 
environmental and commercial claims.  
As a result of provisional accounting 
under IFRS 3, new information obtained 
on contingent liabilities within the  
12 months timeframe after acquisition 
is adjusting the fair value as at the 
a) Decommissioning obligations
At some sites Basell is contractually 
obliged to decommission its plants upon 
site exit. Basell has provided for the net 
present value of the estimated net costs. 
Typically such costs are incurred within 
three years after a plant’s end of useful 
life. The release during 2006 relates to 
the dismantling of the Münchsmünster 
polyethylene plant following last year’s 
explosion.
b) Earn out arrangement  
and impairment of SCA
The earn-out provision is related to the 
acquisition of the second 50 % of SCA 
in December 2005. Part of the purchase 
price consideration is contingent on the 
2006 – 2008 financial performance of 
SCA (‘earn-out’). No payment is due until 
the beginning of 2009. The initial 2005 
estimate of the contingent purchase  
price of €95 million was reduced by  
€30 million in December 2006 based  
on current information. Any changes in a 
contingent purchase price consideration 
are considered to be an adjustment to the 
cost of the acquisition. Consequently the 
acquisition cost and hence the goodwill  
in the 2005 comparative figures was  
also reduced by €30 million resulting  
in a residual goodwill of €34 million.
Triggered by the reassessment of the 
earn-out liability Basell evaluated the 
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acquisition date. Any increases to the 
valuation of contingent liabilities after  
the 12 months timeframe are recognised 
in the income statement.
e) Environmental provisions
The environmental provision is 
established in connection with identified 
contamination at the Ferrara and 
Brindisi sites in Italy. This provision is 
covered by an indemnification from the 
previous owner of these sites, and a 
matching receivable has been recorded. 
Additionally, a contingent liability of  
€15 million related to these sites has been 
recognised. 
The timing of payments and the amounts 
required to settle the environmental 
provisions as well as the contingent 
liabilities are highly uncertain, as they 
are significantly influenced by the 
development of Italian legislation and 
business decisions of Basell’s contractual 
partners. 
f) Redundancies and  
restructuring provisions
During 2006 Basell continued to 
rationalise its European production foot 
print and to streamline its organisations 
in all businesses resulting in expected 
redundancy cost for staff reductions of 
€21 million. At year end a total obligation 
of €16 million is not related to contractual 
obligations (which are presented as 
liabilities).
Furthermore, the Group recognised a 
redundancy provision of €6 million and  
an employee benefits curtailment loss  
of €2 million in respect of its early 
retirement programme in North America.
The release during 2006 relates to 
the reversal of amounts provided for 
employees at the Münchsmünster site.
On 8 February 2006, Basell announced 
its intention to close its polypropylene 
plant in Pernis, The Netherlands by mid 
2007. In view thereof the relevant Group 
Company gave notice of termination 
under certain supply and service contracts 
before 31 December 2005. Based on 
contractual arrangements a provision 
of €7 million was made in 2005. An 
agreement with the site operator in late 
2006 allowed the group to release  
€3 million to income in 2006. 
25. Other non-current liabilities
€ MILLION 31 DEC 2006 31 DEC 2005
Non-current redundancies 13 13
Miscellaneous non-current liabilities 33 14
Total 46 27
Miscellaneous non-current liabilities includes the contingent purchase price payment related to the acquisition of the Münchsmünster 
cracker in December 2006 of €19 million.
26. Trade payables
€ MILLION 31 DEC 2006 31 DEC 2005
Trade payables 880 872
Amounts due to associates 210 167
Capital expenditures payable 33 26
Total 1,123 1,065
27. Payables to tax authorities
€ MILLION 31 DEC 2006 31 DEC 2005
Corporate income tax 32 76
Taxes other than on income 32 32
Social security premiums 9 12
VAT (Value Added Tax) 74 29
Total 147 149
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28. Accrued liabilities
€ MILLION 31 DEC 2006 31 DEC 2005
Accrued customer rebates and discounts 172 150
Accrued interest 49 53
Accrued CO2 emission rights 23 22
Negative fair value of derivative instruments 15 2
Accrued retrospective insurance premiums 15 21
Accrued utility and feedstock cost 12 13
Accrued consultancy fees 6 10
Accrued IT service fees 2 4
Other accrued expenses 38 35
Total 332 310
29. Employee expense and numbers
The employee expense is a component of cost of sales, selling expenses, general and administrative expenses and research  
and development expenses.
€ MILLION 2006 2005 
(20 APR - 31 DEC) 
Employee remuneration 452 179
Social security contributions 71 28
Redundancy expense 29 14
Post-retirement expense 42 17
Other personnel related expense 14 13
Total 608 251
On 31 December 2006, the number of employees totalled to 6,603 (2005: 6,716). Due to business combinations during the year,  
the year end number of employees deviates from the average.
AVERAGE NUMBER OF EMPLOYEES 2006 2005 
(20 APR - 31 DEC) 
Europe 5,061 5,176
North America 1,009 1,035
Rest of the world 609 456
Total 6,679 6,667
30. Other income 
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Gain on sale of non-current assets 24 –
Insurance proceeds 37 15
Other operating income 5 –
Total 66 15
In 2006 the Group recognised a gain of  
€10 million from selling the Components 
business and the Custom Catalyst assets 
in North America.
The Group recognised a gain on sale of 
€8 million related to the sale of a 2.21 % 
interest in HMC Polymers Company Ltd, and 
a gain on sale of €4 million related to the 
divestment of Basell Taiwan Holdings B.V.
Following the explosion in December 
2005 at the polyethylene plant in the 
Münchsmünster Industrial Park in 
Germany, Basell raised a claim under 
its Property Damage insurance program 
following the decision of management to 
rebuild a Hostalen ACP plant at the same 
location. The assets were insured at full 
replacement value for a plant of similar 
design and capacity. Based on estimates 
and pending final settlement with the loss 
adjuster, the Company recognised net 
proceeds of €37 million in addition to the 
€15 million which were already accounted 
for in December 2005.
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31. Other expenses
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Impairment losses on property, plant and equipment and goodwill (56) (40)
Exit fee supply and service contracts – (7)
Total (56) (47)
The 2006 impairment losses relate to the write-down of SCA as explained in note 24 and the write down of the Sarnia polypropylene 
plant (€6 million).
32. Net finance costs
€ MILLION 2006 2005 
(20 APR - 31 DEC) 
INTEREST INCOME 35 12
FINANCE EXPENSES
Interest expense (250) (104)
Amortised financing fees and costs (9) (17)
Currency exchange results (14) (3)
Total (273) (124)
Net finance costs (238) (112)
33. Income tax (expense)/benefit
€ MILLION 2006 2005 
(20 APR - 31 DEC) 
Current income taxes (77) (64)
Deferred income taxes (130) 66
(Expense)/benefit (207) 2
The Group’s operations are subject to income taxes in various jurisdictions with nominal income tax rates varying from 18 % to 40 %, 
which causes a difference between the weighted average nominal income tax rate, based on the taxable profits or losses and nominal 
tax rates in the applicable tax jurisdictions, and Luxembourg’s nominal income tax rate of 29.63 % in 2006 (2005: 30.38 %).
A reconciliation of the expected tax benefit / (expense) at a weighted average nominal income tax rate in 2006 of 40 % (2005: 25 %)  
to the actual tax expense or benefit is as follows:
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Expected tax expense at weighted average nominal income tax rates (152) 6
Tax credits on reinvesting proceeds of disposals 2 9
Local and state taxes (16) (7)
Net non-deductible costs / non-taxable income 1 (5)
Revisions to estimates made in prior year(s) 5 –
Release of deferred tax liability on deferred exchange gains US bonds 23 –
Release of valuation allowance on losses carried forward – 28
Tax effect on losses carried forward expected not to be realised (60) (24)
Other (10) (5)
(Expense)/benefit (207) 2
The increase in the ‘weighted average 
nominal income tax rate’ to 40 % is 
caused by profits mainly being made in 
jurisdictions with relatively high tax rates, 
while in other jurisdictions tax losses have 
been incurred.
The ‘release of deferred tax liability on 
deferred exchange gains’ of €23 million 
relates to a cumulative currency exchange 
gain (to Euro) on the $300 million Bonds 
due 2027 in the Netherlands, which used 
to be deferred for tax purposes. During 
2006, Basell changed its tax treatment 
and is now recognising such cumulative 
currency exchange effects immediately 
in line with the treatment under IFRS, i.e. 
the temporary difference was eliminated. 
The change in tax treatment effectively 
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reduced the tax losses carried forward  
in the Netherlands, which were not being 
recognised and therefore resulted in tax 
benefit of €23 million.
The ‘tax effect on losses carried forward 
expected not to be realised’ includes the 
write-off of the net deferred tax asset in 
France recognised in prior periods of €19 
million, which based on the business plan 
2007 – 2011 is not likely to be utilised.
The amount of income tax expense or 
benefit recognised directly in Equity is 
disclosed in note 19.
34. Risk Management
In the ordinary course of business, 
the Group is exposed to volatility in 
commodity prices as well as to interest 
rate and currency risks. The Group uses, 
to a limited extent, derivative financial 
instruments to hedge exposure to such 
volatilities or risks. 
By using derivative financial instruments 
to hedge exposures to changes in 
commodity prices, exchange and interest 
rates, the Group exposes itself to credit 
risk (unless exchange traded products 
are used, in which case the credit risk 
is covered by the clearing house related 
to the exchange) as well as market risk. 
The Group minimises the credit risk 
in derivative instruments by entering 
into transactions with high quality 
counterparties. The market risk associated 
with commodity price, foreign exchange 
and interest rate derivative contracts is 
managed by establishing and monitoring 
the exposure under such contracts.
Commodity prices
The Group enters, to a limited extent, into 
raw material short-term forward contracts 
for a portion of its anticipated contractual 
purchases to hedge the market price 
exposure. Exposures are typically hedged 
up to 3 months forward and are settled 
each month. 
The Group enters, to the extent it has  
a surplus, into spot transactions of  
EU Emission Allowances.
The Group has started with activities on 
the London Metal Exchange in plastics 
futures and warrants. For the time being 
these activities are linked to physical 
operations and limited in nature due to 
the low liquidity of this new market and 
the lack of correlation with the physical 
market which would allow hedging.
Foreign currency rates
Group companies enter into transactions 
denominated in other than the functional 
currency and are therefore exposed to 
the foreign currency risk on receivables 
and payables. The Group assesses foreign 
currency risk by continually identifying 
and monitoring changes in exchange 
rate exposures that may have an adverse 
impact on the income statement of the 
relevant companies. The Group maintains 
risk management control systems to 
monitor foreign currency risk attributable 
to both the outstanding foreign currency 
positions and commitments. The risk 
management control systems involve 
the centralisation of foreign currency 
exposure management, the offsetting 
of exposures from different group 
companies and to estimate the expected 
impact of changes in foreign currency 
rates on the Group’s income statement. 
The Group enters into foreign currency 
contracts to minimise exchange results  
of the Group net exchange position.
For contracts that economically hedge 
recognised monetary assets and liabilities 
in foreign currencies no hedge accounting 
is applied. Changes in the fair value of 
foreign currency forward contracts are 
reported in the income statement as 
currency exchange results offsetting the 
exchange results recognised on the assets 
and liabilities denominated in foreign 
currencies.
The Group has designated the $300 
million of outstanding 8.1 % Bonds 
(due 15 March 2027) and $250 million 
of outstanding 8.375 % High Yield 
Notes (due 10 August 2015) as net 
investment hedges of part of the 
Group’s investment in US Dollar or US 
Dollar related currencies, denominated 
subsidiaries and associates directly or 
indirectly owned by Basell AF S.C.A. The 
changes in the Euro value of the Bonds 
and Notes, to the extent that they are 
designated as a hedge, are recorded 
in Other reserves within Equity for an 
amount of €35 million. The cumulative 
translation difference (gain) recorded in 
shareholders’ equity as at 31 December 
2006 amounts to €29 million (2005: 
gain €6 million). Due to the overall tax 
loss situation in the Netherlands and the 
elimination of the temporary difference on 
cumulative currency exchange gains in the 
Netherlands (see note 33), no tax effect 
was taken into account as at 31 December 
2006 (2005: positive tax effect of  
€2 million).
Directly upon the issuance on 10 August 
2005 of the $615 million subordinated 
high yield bonds, the Group entered into 
a cross currency interest rate swap for 
a notional amount of $365 million. The 
fixed $-interest has been swapped into 
fixed €-interest and the notional $-amount 
has been swapped in a notional €-amount. 
The Group entered into the cross currency 
interest rate swap to have its financing 
costs linked to its cash flows. The cross 
currency interest rate swap is designated 
as a cash flow hedge with changes in fair 
value recognised in Other reserves within 
Equity.
Interest rates
The Group has outstanding interest rate 
swaps, maturing in October 2008, for a 
notional amount of €470 million changing 
the floating interest rate of the drawings 
under its senior secured credit facility 
agreement to fixed interest rates. The 
Group entered into these swaps in line 
with its strategy that the floating interest 
should not exceed 50 % of its total debt 
portfolio, including derivatives.
Stock option plans
The Group has outstanding total return 
swaps on shares in Royal Dutch Shell 
plc and BASF AG, which form a hedge 
against the upward risk of the obligations 
stemming from the stock option plans 
(note 21). In the total return swaps, 
the Group obtained the beneficial 
interest in the underlying shares without 
owning these shares. The total return 
swaps mature in 2008 and are settled 
semi-annually. The Group receives the 
dividends paid on the underlying shares. 
At maturity of the swap, the Group will 
pay or receive the difference between 
the price of the underlying shares at 
the settlement date and the price at 
the inception of the swap, adjusted for 
dividends paid by Royal Dutch Shell plc 
and BASF AG and for the payment of 
financing costs. The total return swaps are 
valued at fair value with any results being 
included, as results from derivatives, in 
the income statement.
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The notional contracted amounts and the fair values of the Group’s derivative financial instruments outstanding as at 31 December 
2006 are the following:
€ MILLION NOTIONAL AMOUNT FAIR VALUE
Raw material short-term forward contracts 1 –
Foreign currency forward contracts 187 –
Cross currency interest rate swap 277 (15)
Interest rate swaps 470 11
Total return swap 54 3
The notional contracted amounts and the fair values of the Group’s derivative financial instruments outstanding as at 31 December 
2005 were the following:
€ MILLION NOTIONAL AMOUNT FAIR VALUE
Raw material short-term forward contracts 25 1
Foreign currency forward contracts 155 1
Cross currency interest rate swap 308 12
Interest rate swaps 470 3
Total return swap 69 (2)
Effective interest rates and re-pricing analysis
In respect of interest-earning financial assets and interest-bearing financial liabilities, the following table indicates their effective 
interest rates at 31 December 2006 and the periods in which they re-price.
€ MILLION EFFECTIVE 
INTEREST 
RATE
TOTAL 6 MONTHS 
OR LESS
6-12 
MONTHS
1-2 YEARS 2-5 YEARS MORE THAN 
5 YEARS
Cash and cash equivalents 3.50 % 670 670 – – – –
Senior and Italian Facility 
Agreement
5.99 % 1,298 1,298 – – – –
Effect of interest rate swaps (0.74 %) 470 – – 470 – –
High Yield Notes (due 2015) 8.55 % 966 – – – – 966
Effect of cross currency  
interest rate swap
(1.63 %) 277 – – – – 277
Bonds (due 2027) 8.26 % 228 – – – – 228
Receivable securitisation 
programmes
4.75 % 558 558 – – – –
Other interest-bearing loans  
and borrowings
5.91 % 95 80 – – 15 –
As at 31 December 2005 the table was as follows:
€ MILLION EFFECTIVE 
INTEREST 
RATE
TOTAL 6 MONTHS 
OR LESS
6-12 
MONTHS
1-2 YEARS 2-5 YEARS MORE THAN 
5 YEARS
Cash and cash equivalents 2.96 % 590 590 – – – –
Senior and Italian Facility 
Agreement
5.40 % 1,577 1,577 – – – –
Effect of interest rate swaps 0.58 % 470 – – – 470 –
High Yield Notes (due 2015) 8.55 % 1,019 – – – – 1,019
Effect of cross currency  
interest rate swap
(1.62 %) 297 – – – – 297
Bonds (due 2027) 8.26 % 253 – – – – 253
Receivable securitisation 
programmes
3.69 % 514 514 – – – –
Other interest-bearing loans  
and borrowings
6.12 % 55 38 – – 17 –
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Fair values
Financial instruments in the consolidated balance sheet, other than derivative instruments, include:
· Available-for-sale financial assets
· Trade receivables
· Other receivables
· Cash and cash equivalents
· Interest-bearing loans and borrowings
· Trade payables
· Accrued liabilities
For most of the financial instruments the estimated fair values approximate their carrying amounts due to their short-term nature, the 
frequent re-pricing or the short period since inception. As at 31 December 2006, for the following financial instruments the fair value, 
based on market quotations, is different from their carrying value:
€ MILLION CARRYING AMOUNT FAIR VALUE
High Yield Notes, $615 million 466 478
High Yield Notes, €500 million 500 535
Bonds, $300 million 228 218
1,194 1,231
Net higher fair value 37
As at 31 December 2005, the carrying amounts and fair values were the following:
€ MILLION CARRYING AMOUNT FAIR VALUE
High Yield Notes, $615 million 519 518
High Yield Notes, €500 million 500 508
Bonds, $300 million 253 234
1,272 1,260
Net lower fair value 12
35. Commitments, litigation 
and other matters
Guarantees
On 31 December 2006, the Group had 
outstanding guarantees to commercial 
banks for a total of €29 million (2005:  
€24 million) for bank loans to associated 
companies which expire in 2011.
In the previous year the Group had 
outstanding guarantees for projects being 
undertaken by an associated company in 
the amount of €38 million. The guarantee 
expired as a result of the refinancing 
undertaken by that company.
As part of its technology licensing 
contracts, the relevant Group company 
gives an indemnification to its licensees 
against liability arising from possible 
claims of patent infringement in respect 
of the proprietary licensed technology. 
In a number of technology licensing 
contracts, the relevant Group company 
provides bank guarantees for its financial 
obligations with respect to delivery of 
process design packages and technology 
performance warranties. At 31 December 
2006 the outstanding amount was  
€4 million (2005: €8 million).
Several other guarantees have been 
provided to third parties, within the 
ordinary course of business, for an 
amount of €14 million.
No provision has been made in the 
balance sheet for the Group’s obligations 
under these guarantees, as management 
believes that the fair value of these 
guarantees is negligible.
For the guarantees issued in respect of 
the outstanding loans and borrowings, 
reference is made to note 20. Pledges on 
the Group’s assets related to financing 
arrangements are disclosed in notes  
18 and 20.
Litigation and other matters
A number of Group companies are involved 
as claimants or defendants in various legal 
proceedings and other claims considered 
in the ordinary course of its businesses.  
In the judgement of management no 
losses, in excess of provisions made 
or covered by insurance programmes, 
which would be material in relation to the 
Group’s financial position are likely to arise 
in respect of these matters, although their 
occurrence may have a significant effect  
on periodic results.
Lease commitments and  
IT service contract
The Group leases office facilities, railcars, 
vehicles, and other equipment under 
long-term operating leases. Some leases 
contain renewal provisions, purchase 
options and escalation clauses. 
Additionally, the Group has entered into 
a long term agreement with an IT service 
provider that is cancellable by the Group 
with a 6-month notice period and against 
payment of a cancellation fee. This 
agreement is classified as an operational 
lease.
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The aggregate future estimated payments under these commitments are: 
YEAR € MILLION
2007 63
2008 46
2009 38
2010 25
2011 24
After 2011 132
Total 328
Long-term purchase obligations
In the ordinary course of business, the Group companies enter into long term purchase and supply contracts for raw materials, end 
products and energy with third parties, associated companies and joint ventures. These contracts are for varying duration and at 
market related terms. As the commitments vary with the requirements of the relevant Group company and the development of market 
prices, no value can be determined for the future amounts to be paid or received under these contracts.
Other commitments
At 31 December 2005/2006, the Group did not have significant commitments under capital expenditure projects.
36. Related-party transactions
Identity of related parties
The Group has a related party relationship with the Access Industries group (including BI S.à r.l. and Basell AFGP S.à r.l.), its associates 
and joint ventures, the Pensionskasse der BASF VVaG and funded post-retirement benefit schemes (see note 21) as well as key 
management of the Group.
Sales and purchases of goods
In the normal course of business the Group purchases from and sells products to its associates and joint ventures. All purchases and 
sales are transacted on an arm’s length basis at market related terms.
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Products purchased 819 400
Products sold 489 79
 Rendering and receiving of services
On some of the Group’s manufacturing sites associates and joint ventures provide certain services, utilities, materials and facilities to 
the Group and on other sites the Group provides services to associates and joint ventures. These services are governed by contractual 
agreements between the parties at arm’s length and on prevailing market conditions.
The Group entered into a management agreement with AI Petrochemicals LLC on 1 August 2005. In 2006 the annual management 
fee for ongoing services amounted to €5.0 million as EBITDA exceeded €800 million. In addition €1.0 million (2005: €0.8 million) for 
expense reimbursements were accrued. The management agreement entitles AI Petrochemicals LLC to receive an additional fee in 
connection with any new financing, acquisition or disposal transactions equal to a fixed percentage of the gross transaction value of 
such transaction. Due to the acquisition of the cracker in Münchsmünster in December 2006, an accrual of €0.6 million was made.
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Services provided by associates and joint ventures 51 24
Services provided to associates and joint ventures 3 1
Services provided by AI Petrochemicals LLC 7 19
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Trade receivables / payables
As of 31 December, the Group had the following trade balances with related parties outstanding:
€ MILLION 31 DEC 2006 31 DEC 2005
AI Petrochemicals LLC 4 2
ASSOCIATES AND JOINT VENTURES
Trade receivables 115 82
Trade payables 210 167
Financing arrangements
The interest income and expense for the period ended 31 December as well as financial receivables and payables with associates and 
joint ventures as at 31 December are as follows:
€ MILLION 2006 2005 
(20 APR - 31 DEC)
ASSOCIATES AND JOINT VENTURES
Interest income 3 1
Interest expense – –
Current interest-bearing loans and borrowings 9 8
Non-current interest-bearing loan provided 4 5
Key management compensation
Key management includes the Basell Holdings B.V.’s Management Board and the Group’s Management Team, in total 12 members.  
In addition to their salaries, the relevant Group companies also provide non-cash benefits and contribute to post-employment 
employee benefits. Key management also participate in the Group’s share-based payment schemes. New management incentive plans 
have been implemented in 2005. Share-based payment schemes and long term management incentive plans are described in note 21.
The expense for these plans in the period is included in ‘Salaries and other short term benefits’ and in ‘Other long term benefits’ in the 
table below. 2005 comparative amounts reflect the period following the acquisition of the Basell group, however, performance related 
compensation was based on the full year 2005.
€ MILLION 2006 2005 
(20 APR - 31 DEC)
Salaries and other current benefits 17 10
Post-employment benefits 1 1
Other non-current benefits 2 1
Total 20 12
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List of Companies as at 31 December 2006
This appendix includes all significant directly and indirectly owned subsidiaries, associates and joint ventures of the Company.  
With the exception of the Polish Joint Venture the Company has a 100 % interest in all significant European and North American 
subsidiaries listed below.
EUROPE COMPANY NAME PLACE OF REGISTRY
Belgium Basell Polyolefins Company B.V.B.A. Zaventem
Basell Coordination Company B.V.B.A. Zaventem
France Basell Polyoléfines France S.A.S. Nanterre 
Société du Craqueur de l’Aubette S.A.S. Berre
Basell Polyéthylène S.A.S. Nanterre
Basell Production France S.A.S. Nanterre
Basell Fos S.A.S. Nanterre
Germany Basell Bayreuth Chemie GmbH Wesseling
Basell Polyolefine GmbH Wesseling
Basell Germany Holdings GmbH Wesseling
Italy Basell Italy Holding S.r.l. Milan
Basell Brindisi S.r.l. Milan
Basell Poliolefine Italia S.r.l. Milan
Netherlands Basell Benelux B.V. Rotterdam
Basell Service Company B.V. Hoofddorp
Basell Finance Company B.V. Hoofddorp
Basell Holdings B.V. Hoofddorp
Basell Europe Holdings B.V. Hoofddorp
Basell International Holdings B.V. Hoofddorp
Basell Sale Marketing Company B.V. Rotterdam
Poland Basell Orlen Polyolefins Sp. z o.o. (50 %) Plock
Spain Basell Poliolefinas Ibérica S.L. Barcelona
Basell Ibérica Poliolefinas Holdings S.L. Barcelona
UK Basell Polyolefins UK Ltd. Carrington
Basell UK Ltd. Carrington
NORTH AMERICA COMPANY NAME PLACE OF REGISTRY
Canada Basell Canada Inc. Corunna, Ontario
USA Basell North America Inc. Wilmington, Delaware
Basell USA Inc. Wilmington, Delaware
Basell Capital Corporation Wilmington, Delaware
Basell Polyethylene Inc. Wilmington, Delaware
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REST OF WORLD COMPANY NAME PLACE OF REGISTRY DIRECT INTEREST 
(%)
DIRECT 
AND INDIRECT 
INTEREST (%)*
Argentina Petroken Petroquimica Ensenada S.A. Buenos Aires 100.00 100.00
Australia Basell Australia Pty. Ltd. Melbourne, Victoria 100.00 100.00
PolyPacific Pty. Ltd. Dandenong, Victoria 50.00 50.00
Brazil Basell Poliolefinas Ltda. São Paolo 100.00 100.00
China Basell Asia Pacific Ltd. Hong Kong 100.00 100.00
Japan SunAllomer Ltd. Tokyo 50.00 50.00
Saudi Arabia Saudi Polyolefins Company Riyadh 25.00 25.00
Saudi Ethylene & Polyethylene 
Company Ltd.
Riyadh 25.00 25.00
Al-Waha Petrochemicals Ltd. Riyadh 20.95 20.95
South Korea PolyMirae Co. Ltd. Seoul 35.18 42.59
Basell Korea Ltd. Seoul 100.00 100.00
Thailand HMC Polymers Company Ltd. Bangkok 28.56 28.56
Basell Advanced Polyolefins  
(Thailand) Company Ltd.**
Bangkok 80.00 87.50
* Inclusive of interest through associates and joint ventures.
** The proportion of voting power held equals Basell’s interest in the share capital.
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We have audited the accompanying 
consolidated financial statements of 
Basell AF S.C.A., which comprise the 
consolidated balance sheet as at 31 
December 2006 and the consolidated 
income statement, consolidated  
statement of changes in equity and 
consolidated cash flow statement for  
the year then ended, and a summary  
of significant accounting policies  
and other explanatory notes.
Board of managers’ responsibility for 
the consolidated financial statements
The board of managers is responsible for 
the preparation and fair presentation of 
these consolidated financial statements 
in accordance with International Financial 
Reporting Standards as adopted by the EU. 
This responsibility includes: designing, 
implementing and maintaining internal 
control relevant to the preparation and 
fair presentation of consolidated financial 
statements that are free from material 
misstatement, whether due to fraud or 
error; selecting and applying appropriate 
accounting policies; and making 
accounting estimates that are reasonable 
in the circumstances.
Responsibility of the Réviseur 
d’Entreprises
Our responsibility is to express an opinion 
on these consolidated financial statements 
based on our audit. We conducted our 
audit in accordance with International 
Standards on Auditing as adopted by 
the Institut des Réviseurs d’Entreprises. 
Those standards require that we comply 
with ethical requirements and plan and 
perform the audit to obtain reasonable 
assurance whether the consolidated 
financial statements are free from  
material misstatement.
An audit involves performing procedures 
to obtain audit evidence about the 
amounts and disclosures in the 
consolidated financial statements.  
The procedures selected depend on the 
judgement of the Réviseur d’Entreprises, 
including the assessment of the risks of 
material misstatement of the consolidated 
financial statements, whether due to 
fraud or error. In making those risk 
assessments, the Réviseur d’Entreprises 
considers internal control relevant to the 
entity’s preparation and fair presentation 
of the consolidated financial statements in 
order to design audit procedures that are 
appropriate in the circumstances, but not 
for the purpose of expressing an opinion 
on the effectiveness of the entity’s internal 
control. An audit also includes evaluating 
the appropriateness of accounting 
policies used and the reasonableness of 
accounting estimates made by the board 
of managers, as well as evaluating the 
overall presentation of the consolidated 
financial statements. We believe that  
the audit evidence we have obtained  
is sufficient and appropriate to provide  
a basis for our audit opinion.
Opinion
In our opinion, the consolidated financial 
statements give a true and fair view of 
the consolidated financial position of 
Basell AF S.C.A as of 31 December 2006, 
and of its financial performance and its 
consolidated cash flows for the year then 
ended in accordance with International 
Financial Reporting Standards as adopted 
by the EU.
Luxembourg, 23 February 2007 
KPMG Audit S.à r.l.
Réviseurs d’Entreprises
Ph. Meyer
Auditor’s Report
To the Shareholders of  
Basell AF S.C.A. 
15-17, avenue Gaston Diderich 
L-1420 Luxembourg
Report of the Reviseur d’Entreprises
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Basell at a Glance
Core Businesses
·  Technology Business: Licensing, 
catalysts, technology services and  
new projects
·  Advanced Polyolefins Business: 
Polypropylene-based compounds, 
resins from the Catalloy process, 
polybutene-1 and specialty 
polyethylene products
·  Polyolefins Business:  
Polypropylene and polyethylene
KEY FACTS 2006
 Annual turnover: €10.5 billion
 6,850 employees
 Manufacturing operations in 19 countries (including joint ventures)
 Global leader in the production of polypropylene, with capacity  
of more than 7.6 million tonnes (including joint ventures)
 7th largest producer of polyethylene in the world (#1 in Europe), with 
capacity of more than 2.5 million tonnes (including joint ventures)
 Internet address: www.basell.com
PIctured left (both 
images): Blown film 
produced using Basell’s 
Hostalen HDPE resin. 
(Note: the film lining the 
industrial drum is the 
blown film application)
Injection-moulded cups produced using Basell’s Metocene metallocene-based polypropylene
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Polyolefin Processes  
Licensed by Basell
·  Spheripol – leading polypropylene 
technology for the production 
of homopolymer, random and 
heterophasic copolymers
·  Spherizone – latest generation 
polypropylene technology based 
on new multi-zone reactor for the 
production of polypropylene and  
novel polyolefins
·  Spherilene – advanced swing gas 
phase process for the production  
of LLDPE, MDPE and HDPE
·  Hostalen – leading low-pressure  
slurry process for the production  
of bi-modal HDPE
·  Lupotech T – leading high  
pressure tubular reactor process  
for the production of LDPE and  
EVA copolymers
·  Metocene – technology for the 
production of specialty polypropylene 
products based on proprietary  
single-site catalyst systems
Basell’s Catalyst Systems
·  Avant ZN – Ziegler-Natta catalysts  
for polypropylene
·  Avant Z – Ziegler catalysts  
for polyethylene
·  Avant C – chromium catalysts  
for polyethylene
·  Avant M – Metallocene catalysts  
for polypropylene
Adflex, Adstif, Adsyl, Avant, Catalloy, Clyrell, Hifax, Histif, Hostacom, Hostalen, Hostalen PP, Lucalen, 
Luflexen, Lupolen, Lupolex, Lupotech T, Metocene, Moplen, Pro-fax, Pro-fax Ultra, Purell, Softell, 
Spherilene, Spheripol and Spherizone are trademarks owned or used by Basell. Adflex, Adstif, Adsyl, 
Clyrell, Hifax, Hostacom, Hostalen, Lucalen, Luflexen, Lupolen, Lupotech, Moplen and Pro-fax are 
registered in the U.S. Patent and Trademark Office. 
Before using a Basell product, customers and other users should make their own independent 
determination that the product is suitable for the intended use. They should also ensure that 
they can use the Basell product safely and legally. (Material Safety Data Sheets are available from 
Basell at www.basell.com). This document does not constitute a warranty, express or implied, 
including a warranty of merchantability or fitness for a particular purpose. No one is authorised to 
make such warranties or assume any liabilities on behalf of Basell except in writing signed by an 
authorised Basell employee. Unless otherwise agreed in writing, the exclusive remedy for all claims is 
replacement of the product or refund of the purchase price at Basell’s opinion, and in no event shall 
Basell be liable for special, consequential, punitive, or exemplary damages.
* Basell does not sell polybutene-1 for use in pipe applications intended for use in North America, 
and requires its customers not to sell products made from PB-1 into North America pipe applications.
Basell’s Main Product Lines
·  Adflex – very soft, flexible polyolefins 
based on Catalloy process
·  Adstif – high crystallinity 
polypropylene with very high stiffness
·  Adsyl – low seal initiation temperature 
resins based on Catalloy process
·  Clyrell – PP resins with outstanding 
transparency and impact strength
·  Hifax – grades with outstanding 
impact performance for use in 
customer industrial, exterior 
automotive applications; grades  
for wire & cable and grades with  
flame retardant properties
·  Histif – high molecular weight,  
high density polyethylene with  
high stiffness properties 
·  Hostacom – glass fibre-reinforced, 
mineral-filled grades and unfilled 
coloured grades for use in customer 
electrical appliances, automotive 
interiors and under-the-hood 
applications
·  Hostalen – high density polyethylene 
for use in customer applications such 
as film, blow moulding, pipe, injection 
moulding, tapes, monofilaments  
and fibres
·  Hostalen PP – grade based on high 
molecular weight polypropylene 
for use in customer pipe and sheet 
applications
·  Lucalen – ethylene/acrylic acid/
acrylate copolymer for use in customer 
film and steel pipe coating applications
·  Luflexen – Metallocene-based linear 
low-density polyethylene for use in 
customer film applications
·  Lupolen – low density polyethylene 
and medium density polyethylene; 
high density polyethylene for use in 
customer applications such as film, 
blow moulding, steel pipe coating,  
pipe and injection moulding
·  Lupolex – linear low-density 
polyethylene for use in customer  
film applications
·  Metocene – homopolymer, random 
and impact copolymer products based 
on single-site metallocene catalysts
·  Moplen – homopolymer, random  
and impact copolymer products  
based on Ziegler-Natta catalysts
·  Polybutene-1 – resins for use in 
customer applications such as easy-
open packaging, film modification, hot 
melt, polyelefin modification and pipe*
·  Pro-fax – homopolymer, random  
and impact copolymer products  
based on Ziegler-Natta catalysts
·  Pro-fax Ultra – high performance 
polypropylene resins
·  Purell – specialty PP and PE products 
for use in customer medical and 
pharmaceutical applications
·  Softell – exceptionally soft,  
flexible, soft touch resins based  
on Catalloy process
Food packaging produced using  
Basell polypropylene
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You can find out more about Basell by  
visiting our website at: www.basell.com
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This annual report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E 
of the Securities Exchange Act of 1934. These forward-looking statements may include statements concerning our plans, objectives, goals, 
strategies, future events, future revenue or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, 
business trends and other information that is not historical information. When used in this commentary, the words “estimates,” “expects,” 
“anticipates,” “projects,” “plans,” “intends,” “believes,” “forecasts,” or future or conditional verbs, such as “will,” “should,” “could” or “may,” and 
variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements, including, 
without limitation, management’s examination of historical operating trends and data are based upon our current expectations and various 
assumptions. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. 
However, there can be no assurance that management’s expectations, beliefs and projections will be achieved. There are a number of risks and 
uncertainties that could cause our actual results to differ materially from those expressed in or implied by forward-looking statements contained 
in this document. Such risks, uncertainties and other important factors include, among others: our ability to service our substantial leverage; 
limitations on flexibility in operating our business contained in our loan agreements; cyclical demand for our products; movements of oil prices 
affecting raw material costs causing volatility in the results and changes in the requirement for working capital; difficulties in securing the raw 
materials; increases in interest rates as a result of our variable rate indebtedness; fluctuations in currency exchange rates; high competition in 
the markets in which we operate; pricing pressure from our customers; uncertainties caused by our international operations, including political, 
economic and social conditions in the geographic markets where we operate; our ability to develop new products and process technologies; 
adverse changes to environmental, health and safety regulations; operating hazards in our production facilities, including environmental and 
physical risks; inability to achieve expected cost savings; our ability to realise the full value of our intangible assets; our ability to attract and 
retain skilled employees, particularly research scientists, technical sales professionals and engineers; our ability to protect our intellectual 
property rights; and the possibility that our owners’ interests will conflict with ours. There may be other factors that may cause our actual 
results to differ materially from the forward-looking statements. Forward-looking statements speak only as of the date of this annual report. 
Except as it may be required by any applicable law or regulation, we disclaim any obligation or undertaking to release publicly any updates or 
revisions to any forward-looking statements contained herein to reflect any change in the our expectations with regard thereto or any change in 
events, conditions or circumstances on which any such statement is based.
